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Preface 
 
Just before the start of this PhD a new method for DNA cross-linking was developed in our 
group.  It efficiently exploits the masked aldehyde functionality present in furan.  Cis-1, 4-
butene-dial is formed upon oxidative ring-opening of furan and is known to react with the 
nucleobases of DNA.  By incorporating a furan moiety into an oligonucleotide duplex, this 
reactivity could be used to form an interstrand cross-link.   
 
The furan ring was attached to the C2’ position of the natural nucleoside deoxyuridine (see 
1a, b).  Cross-linked DNA duplexes could be efficiently produced but no information about 
the exact nature of the covalent bond formed or the specific site of cross-link was obtained.  A 
summary of these results can be found in paragraph 2.1. 
NH
O
ON
O
HO
HO
NH
O
O
1a: Arabino (2')
1b: Ribo (2")  
Figure 1: Structure of the first generation building blocks 
One of the applications of cross-linked DNA-duplexes can be found in the study of DNA 
repair.  For these studies, uniformly cross-linked DNA duplexes for which the exact structure 
is known are needed.  As it had not been possible to answer these questions it was envisaged 
to try to solve the structure of a cross-linked duplex by NMR.  As the specific knowledge for 
this type of study was not present in the lab, this research was initiated during a stay abroad in 
the Nucleic Acid Centre in Denmark. 
 
To learn the required procedures and manipulations for these studies a project from the 
research group of Prof. Dr. M. Petersen on the dynamics of LNA base pair opening was 
started (see chapter 6).  The goal of this project was to see how the base pair dynamics of a 
DNA-duplex is altered upon incorporation of locked nucleic acid (LNA) modifications in a 
DNA duplex.  It was found that opening of bases occurs one at a time and the LNA 
nucleotides influence the opening behavior of bases in both strands of the modified duplex.  
As the LNA nucleotides are already in N-conformation this results in a decrease in base pair 
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lifetimes (i.e. the time between two opening events of the same base).  The guanine bases 
which are complementary to LNA nucleotides display strongly increased base pair lifetimes, 
the highest base pair lifetimes reported to date in DNA. 
 
Once this project was running, the preparations for the second project –the study of the cross-
linked duplex– were started.  After finding an ideal non-modified DNA duplex for the NMR 
study, the cross-link was introduced into this sequence.  However, no NMR-structure 
determination was possible from this sample as the signals were not sharp enough and showed 
too much overlap (see paragraph 2.2).  Especially the region around the cross-link showed 
significant differences between the modified and non-modified duplex.  Therefore it was tried 
to get as much information as possible from other techniques but the exact position of the 
cross-link could not be determined.  The results thereof are covered in paragraph 2.3.   
 
O
O
O
HOHO
HO HO
2 3  
Figure 2: Structure of the second generation building blocks 
In order to find an answer to this last question, an easier route to furan-modified nucleosides 
would facilitate the synthesis of large quantities cross-linked duplexes and hence more 
techniques could be used for sequence analysis.  It would also be desirable to find a more 
selective cross-linker which only cross-links to the complementary base.  Therefore two new 
acyclic building blocks were proposed with a furan moiety replacing the nucleobase (Figure 
2).  They were both synthesized and incorporated into oligonucleotide duplexes for studying 
the cross-link selectivity.  This part of the research is presented in chapter 3. 
 
 
Figure 3: Structure of the third generation building blocks 
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Finally cross-link studies were performed with building block 4, obtained through 
collaboration with Prof. Dr. M. Hocek from the Academy of Sciences of the Czech Republic.  
In this building block the phenylfuran moiety was connected to a cyclic sugar in the hope to 
restore part of the duplex destabilization.  A description of this research is the subject of 
chapter 4. 
 
As introduction to this thesis an overview of the existing cross-link methods (paragraph 1.3) 
and the use thereof (paragraph 1.2) will be given to situate the subject within the field of 
chemistry and chemical biology.  The inspiration to this work, based on the toxicity of furan, 
will be explained in more detail in introductory paragraph 1.4. 
 
In summary the scope and limitations of a recently developed furan-oxidation DNA cross-
linking strategy were explored in the course of this work. 
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Nederlandse samenvatting 
Synthese en NMR-analyse van gemodificeerde duplexen: op weg naar een 
nieuwe methode voor DNA cross-linking 
 
Dit werk stelt zich tot doel nieuwe methodes te ontwikkelen voor het vormen van interstreng 
crosslinks in DNA duplexen en deze te analyzeren met behulp van NMR.  Gecrosslinkte DNA 
duplexen zijn een belangrijk instrument in tal van biologische studies.  Zo worden deze 
gemodificeerde duplexen gebruikt om te achterhalen hoe resistentie-mechanismen in 
kankercellen werken (DNA-herstel enzyme studies)1 alsook voor het conformationeel 
verankeren van bepaalde nucleinezuur structuren die in de natuur slechts transiënt aanwezig 
zijn.2  Verder kunnen DNA interstreng crosslinks ook toegepast worden in medicinale 
strategieën zoals antigen en antisense.  Zij worden verondersteld een sterkere binding te 
maken tussen de antisense of antigen streng en de doelsequentie in het natuurlijke DNA 
waardoor de efficiëntie zou stijgen.  Wegens deze talrijke toepassingen hebben verschillende 
onderzoeksgroepen zich gespecialiseerd in het bereiden van gecrosslinkte duplexen op een 
efficiente manier.  Er zijn evenwel een aantal problemen die consequent terugkomen in de 
gepubliceerde methodes namelijk het rendement en de complexiteit van de bereiding. 
 
Recent werd hiertoe een nieuwe strategie ontwikkeld in onze onderzoeksgroep.  Deze 
methode steunt op een furaan eenheid die werd ingebouwd in een gemodificeerde DNA-
streng waarna deze furaan molecule kan worden geoxideerd met vorming van een 4-oxo-enal 
derivaat (Schema 1).  Deze zeer reactieve molecule is in staat om een covalente binding te 
vormen met een complementaire DNA-streng terwijl een niet-complementaire DNA streng 
niet reageert.3   
 
 
Schema 1: Schematische voorstelling van de crosslink strategie 
De nucleoside bouwsteen die hiervoor wordt gebruikt is weergegeven in Figuur 1.  De furaan-
eenheid wordt ingebouwd op de C2’ positie van een natuurlijk deoxyuridine derivaat.  De 
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reden waarom positie C2’ werd gekozen is dat in principe de base-paring niet verstoord wordt 
bij het aanbrengen van een verandering aan de suikerring.  Bovendien is van alle 
suikerposities C2’ de eenvoudigste om een modificatie aan te brengen.  Door de nabijheid van 
de complementaire DNA-streng laat een verandering op deze positie ook toe om de afstand 
voor reactie met de complementaire streng te overbruggen met een korte linkerlengte. 
NH
O
ON
O
HO
HO
NH
O
O
1a: Arabino (2')
1b: Ribo (2")  
Figuur 1: Structuur van de eerste generatie nucleoside analogen 
Tijdens de ontwikkeling van deze methode3 bleven echter een aantal vragen onbeantwoord.  
Zo werd niet gevonden welk type van covalente binding gevormd wordt tussen de twee DNA-
strengen en ook de exacte positie van de crosslink kon niet achterhaald worden.  Omdat de 
antwoorden op deze vragen essentieel zijn voor de toepasbaarheid van deze methode zijn deze 
dan ook het uitgangspunt van dit doctoraat.  Van alle technieken voorhanden om deze 
problemen te bestuderen is NMR de meeste geschikte.  Gezien de kennis voor het bestuderen 
van oligonucleotide duplexen met NMR niet aanwezig was in de onderzoeksgroep werd dit 
deel van de studie uitgevoerd in het Nucleic Acid Centre in Denemarken.  De groep van Prof. 
Dr. Michael Petersen is gespecialiseerd in de NMR studie van modificaties in DNA en RNA.  
Om vertrouwd te raken met de benodigde technieken werd eerst gewerkt op een project uit de 
onderzoeksgroep van Prof. Petersen.  Hierbij werd de dynamica van een duplex bestudeerd 
waarvan de ene DNA streng vervangen werd door een streng met “locked” nucleinezuren 
(LNA).  De suikerring van LNA is conformationeel geblokkeerd in noord conformatie door 
C4 en O2’ met elkaar te verbinden via een methyleenbrug (Figuur 2). 
 
 
Figuur 2: Structuur van LNA 
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De dynamica van secundaire DNA structuren kan bestudeerd worden door relaxatie 
experimenten in NMR.  Het proces van base-paar opening werd specifiek in dit project 
bestudeerd.  Dubbele helixen van DNA zijn geen starre structuren maar de base-paring is 
dynamisch.  De waterstofbruggen tussen de verschillende base paren kunnen breken wat de 
base de mogelijkheid geeft om uit de helixstructuur te bewegen (=flipping).  De  impact van 
deze bewegingen moet gezien worden in het licht van herkenning van DNA basen door tal 
van proteinen.  Door deze beweging uit de helix worden de reactieve groepen op de base 
blootgesteld aan de omgeving en kan er onder andere uitwisseling van protonen gebeuren.  
Doordat imino-protonen enkel uitwisselbaar zijn in deze uitgeflipte toestand kan de dynamica 
van base paar flipping bestudeerd worden door te volgen hoe snel deze imino-protonen 
uitwisselen.  Door toevoeging van een proton acceptor worden deze imino-protonen sneller 
uitgewisseld, dus de snelheidsbepalende stap is hier de chemische uitwisseling van het 
betrokken proton en niet de opening van het base paar zelf.  Extrapolatie naar oneindige 
katalysator concentratie geeft een idee van de tijd tussen twee base paar openingen.  Deze 
waarde is de base paar levenduur. 
 
De resultaten tonen dat de base paar levensduur van LNA-nucleosides verkort zijn en deze in 
de complementaire DNA sterk verhoogd.  De basen in de DNA-streng vertonen zelfs de 
hoogste base paar levensduur die ooit voor duplex DNA gerapporteerd zijn.  Een verklaring 
voor dit gedrag moet gezocht worden in de rigiditeit van LNA-nucleosides.  Umbrella 
sampling simulations hebben aangetoond dat tijdens de beweging van een base uit de dubbele 
helix de suikerring een transitie ondergaat van S naar N.  Gezien de suikerring van LNA altijd 
in de N-conformatie is zou hierdoor de beweging uit de helix makkelijker worden.  De 
verhoogde base paar levensduur voor de DNA streng kunnen worden toegewezen aan het feit 
dat de opening ook gepaard gaat met het buigen van de dubbele helix.  Door de rigiditeit van 
de LNA nucleotides wordt deze globale duplexbeweging moeilijker waardoor het bewegen 
van de base zelf wordt bemoeilijkt.  Deze resultaten ondersteunen de voorspelde koppeling 
tussen base paar opening en duplex buiging.4 
Na deze eerste NMR studie werd gezocht naar een sequentie die geschikt is voor het 
bestuderen van de crosslink.  Hierbij werd er op gelet dat de context van de basen naast het 
gemodificeerde residue niet werden gewijzigd (CAC*G1G) in vergelijking met de reeds 
gepubliceerde sequentie.3  De gekozen ongemodificeerde sequentie (ON1 + ON2 met 1 
vervangen door dU) vertoonde een goede signaaldispersie zodat volledige toewijzing 
mogelijk was.  Het inbouwen van het gemodificeerde nucleoside 1 werd geoptimaliseerd en 
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een crosslink reactie op grote schaal (~600 nmol) werd uitgevoerd.  De gecrosslinkte duplex 
werd gezuiverd door ultracentrifugatie met een size-exclusion filter waarna een gedeutereerde 
buffer werd geintroduceerd.  Na concentratie tot 500 µl werd dit staal geanalyseerd met NMR.  
De signalen van dit staal (ON1+ON2 crosslinked) waren breed, een teken van dynamisch 
gedrag, waardoor een volledige toekenning van de signalen nagenoeg onmogelijk bleek. 
 
Duplex ON1+ON2 
ON1 5’-C1  T2   G3 A4 C5 G6 G7 1  G9 T10G11C12-3’ 
 
ON2 3’-G24A23C22T21G20C19C18A17C16A15C14G13-5’ 
 
Gezien het niet mogelijk was het volledige NMR spectrum toe te kennen en dus ook geen 
rechtstreekse informatie betreffende de natuur en locatie van de crosslink kon worden 
bekomen, werd gezocht naar alternatieve methodes om info te verkrijgen over de 
gecrosslinkte duplex.  In eerste instantie werd gekeken naar de chemische stabiliteit van de 
structuur.  Het behandelen van een duplex met zuur gaf aanleiding tot volledige degradatie 
van de crosslink.  Dit werd aangetoond door de afwezigheid van een signaal corresponderend 
met de massa van de gecrosslinkte duplex in een MALDI-TOF experiment waarbij een matrix 
wordt gebruikt met pH < 2.  Bij het behandelen van een gecrosslinkt staal met een reductans 
zoals natriumcyanoboorhydride werd het wel mogelijk de massa van de gecrosslinkte duplex 
waar te nemen onder dezelfde experimentele omstandigheden.   
 
Verder werd de gecrosslinkte duplex geanalyseerd met denaturerende gel-electroforese.  Hier 
werd duidelijk dat het staal, bereid voor NMR-analyse, bestond uit drie verschillende 
structuren.  Omdat de intensiteiten variëerden met de tijd werd besloten dat deze onderling 
interconverteerbaar zijn.  De gevormde binding is waarschijnlijk een imine, gevormd langs de 
aldehydekant van het 4-oxo-enal.  Op basis van deze informatie werd overgegaan tot het 
maken van een moleculair model van de duplex gecrosslinkt naar de complementaire 
adenosine en één van de naburige cytidines.  Hierbij werd gevonden dat de crosslink vooral 
de duplexstructuur lokaal verstoort en dat deze invloed niet verder dan twee base paren van de 
crosslink reikt, wat in overeenstemming is met de NMR-resultaten. 
 
Aangezien de positie van de crosslink niet kon bepaald worden, werd gezocht naar 
alternatieve nucleosides die makkelijker aan te maken waren in grote hoeveelheden.  Hiervoor 
werden nucleosides voorgesteld die geen suikerring bevatten, maar als ruggengraat een 
acyclische glycol-eenheid hebben.  Omdat in het moleculair model van de gecrosslinkte 
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duplex duidelijk werd dat de baseparing sterk verstoord was, werd geen nucleobase ingevoerd 
maar werd deze vervangen door een furaanring.  Dit zou tevens de mogelijheid moeten bieden 
om de furaan-eenheid in de duplex te houden terwijl de vorige modificatie volgens de 
quantummechanische berekeningen voornamelijk in de grote groef resideerde.  Als gevolg 
hiervan zou de crosslink enkel naar de complementaire base moeten gaan zodat slechts één 
structuur wordt gevormd in tegenstelling tot de vorige bouwsteen.   
 
O
O
O
HOHO
HO HO
2 3  
Figuur 3: Structuur van nucleoside 2 en 3 
Nucleosides 2 en 3 werden voorgesteld en als initiële test werden deze molecules 
gemodeleerd in een referentieduplex.  De niet-geoxideerde furaaneenheid resideerde een groot 
deel van de tijd in de helix voor nucleoside 2, terwijl voor nucleoside 3 de benzylfuraan 
eenheid continu in de helix zat en dus een beperktere mobiliteit vertoonde.   
O
O
O
O
O
DMTO DMTO
P
N CN P
N CN
6 7  
Figuur 4: Structuur van de fosforamidieten om nucleoside 2 resp. 3 in een DNA streng in te bouwen 
Deze verminderde mobiliteit was volgens de verwachtingen wegens de extra stacking 
mogelijkheden van het grotere geconjugeerde systeem.  De hoofdreden van de invoering van 
deze fenyl-eenheid was om de destabilisatie, die verwacht werd omwille van de hogere 
flexibiliteit van de acyclische ruggegraat, te compenseren. 
 
De positieve modeleer resultaten waren de aanleiding om deze beide nucleosides ook effectief 
te synthetizeren.  De molecules konden worden ingevoerd in een DNA-streng door middel 
van de standaard fosforamidiet methode.  De koppelingsefficiëntie van de furaan-
fosforamidieten 6 en 7 was heel goed en werd geschat op meer dan 99%.5  Er werden vier 
verschillende sequenties gesynthetiseerd voor elke bouwsteen waarbij telkens de naburen van 
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de modificatie werden veranderd.  Verder werd bij duplex vorming de base tegenover de 
modificatie gevarieerd om zo tot 16 mogelijke duplexcombinaties te komen.  De evaluatie van 
de crosslink mogelijheid van al deze duplexen zou het mogelijk moeten maken om de 
volledige sequentie selectiviteit, en dus ook de locatie van de crosslink te bestuderen. 
 
De crosslink experimenten werden uitgevoerd op kleine schaal (~1 nmol) door het mengen 
van equimolaire hoeveelheden van gemodificeerde streng en natuurlijk complement.  Deze 
duplexen werden in een oplossing bij pH 7 gevormd en door toevoeging van NBS werd de 
furaaneenheid geoxideerd.  Per kwartier werd één equivalent NBS toegevoegd tot de 
gemodificeerde streng volledig weggereageerd was.  De vooruitgang van de reactie werd 
gevolgd met RP-HPLC.  Voor oxidatie van modificatie 2 was telkens minder dan drie 
equivalenten NBS nodig (dus een reactietijd van maximaal 45 minuten) terwijl modificatie 3 
meestal vier tot vijf equivalenten NBS nodig had voor volledige oxidatie (60 tot 75 minuten).  
De oorzaak voor deze moeilijkere oxidatie is zonder meer toe te wijzen aan de aanwezigheid 
van de fenylring.  De waargenomen crosslinks zijn weergegeven in Tabel 1.  In alle 
sequenties wordt enkel een crosslink gevormd als het nucleoside tegenover modificatie 2 of 3 
een adenosine of een cytidine is.  Thymidine heeft geen exocyclische amino-functies dus 
crosslink vorming bij dit nucleoside zou wijzen op crosslink vorming met één van de naburige 
basen.  Guanosine heeft een amino-groep gericht naar de kleine groef maar gezien er nergens 
een crosslink werd geobserveerd met deze base is de kleine groef waarschijnlijk niet 
toegankelijk voor de crosslinker.   
 Base complementair aan de crosslinker X 
Sequentie A C T G 
5’-CTG ACG GXG TGC-3’ + + - - 
5’-CTG ACG CXC TGC-3’ + + - - 
5’-CTG ACG AXA TGC-3’ + + - - 
5’-CTG ACG TXT TGC-3’ + + - - 
Tabel 1: Crosslink vorming met X zijnde het gemodificeerde nucleoside 2 of 3 
De rendementen na zuivering varieren voor nucleoside 2 tussen 23 en 73%.  De rendementen 
bekomen met nucleoside 3 waren lager, tussen 10 en 29%.  Deze lagere rendementen kunnen 
voor een deel verklaard worden door een nevenreactie met dit nucleoside.  De initiële 
brominatie van de furaan-ring kan gevolgd worden door twee reacties (Schema 2).  
Reactieweg b is de aanval van een watermolecule op het carbokation op C5 van furaan dat 
aanleiding geeft tot het derivaat dat verantwoordelijk is voor crosslink vorming.  In de 
alternatieve reactieweg a daarentegen wordt het proton, aanwezig op C2, onttrokken waardoor 
de furaan-ring zijn aromaticiteit herwint.  De resulterende 2-bromofuraan structuur is niet 
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meer reactief zodat hiermee geen crosslink vorming meer mogelijk is.  Deze nevenreactie kan 
in de toekomst worden vermeden door een alternatief oxidans te gebruiken dat niet 
afhankelijk is van halogenatie van furaan. 
 
C5 C2
O O
BrR
H
Base
O
HH
R Br
OR
O
a
b
a
b
O
O
O
NBS
 H2O
R
O
 
Schema 2: Mogelijke reactiewegen voor furaan oxidatie met NBS 
De covalente binding tussen beide DNA strengen zou een stabiliserend effect moeten hebben 
op de duplex.  Dit kan onder andere getest worden door de thermische stabiliteit van de 
duplexen te meten.  Deze experimenten steunen op de verschillen in extinctie-coefficient 
tussen een duplex en zijn twee samenstellende DNA-strengen.  De resulterende smeltcurves 
uit deze experimenten geven de temperatuur weer waarbij de duplex overgaat in twee enkele 
strengen, het zogenaamde smeltpunt.   
 
Figuur 5: Smeltcurves van de natuurlijke referentie-duplex en de gemodificeerde duplexen met (XL) en 
zonder crosslink 
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Zoals voorgesteld in Figuur 5 vertoonde de natuurlijke DNA duplex een smelttemperatuur 
rond 55°C.  Indien nucleoside 2 werd ingevoerd resulteerde dit in een destabilisatie van 
ongeveer 17°C terwijl de invoering van nucleoside 3 “slechts” een destabilisatie van 11°C 
veroorzaakte.  Indien beide duplexen gecrosslinkt werden steeg hun thermische stabiliteit 
echter aanzienlijk.  De smelttemperaturen van de resulterende duplexen waren consistent 
boven 68°C voor alle geteste duplexen.  Een aantal vertoonde zelf een smelttemperatuur 
boven de limiet die nauwkeurig bepaalbaar is volgens deze methode, namelijk 84°C in deze 
opstelling.  De duplexen met modificatie 2 vertoonden de hoogste smelttemperaturen met dA 
terwijl deze met modificatie 3 de hoogste stabiliteit vertoonden met dC. 
 
Om de positie van deze crosslinks verder te analyzeren werd overgegaan tot de enzymatische 
degradatie van deze duplexen.  Locale structurele effecten kunnen er altijd voor zorgen dat 
naburen betrokken zijn in de crosslink vorming.  Om dit uit te sluiten is enzymatische 
degradatie dé techniek bij uitstek.  Exonuclease III, een enzyme dat DNA-duplexen afbreekt 
startende vanaf het 3’-einde werd hiervoor gebruikt.  De degradatie werd uitgevoerd op 0.6 
nmol duplex gedurende 50 minuten.  Achteraf werd het reactiemengsel rechtstreeks op RP-
HPLC ingespoten en de verschillende fracties werden opgevangen.  Elk van deze fracties 
werd uitgedampt en onderworpen aan MALDI-TOF analyse.  De resultaten hiervan 
bevestigden dat de crosslink in alle duplexen enkel naar de complementaire base ging en dus 
niet naar de naburen.  Er was evenwel één uitzondering, namelijk in het geval waar nucleotide 
3 geflankeerd werd door twee guanosines en als complementair nucleotide een cytidine had.  
In dat geval werd crosslink waargenomen niet enkel naar de complementaire C maar ook naar 
de C die aan de 3’-zijde van de complementaire C gepositioneerd was.  In de gemodificeerde 
streng stopte het enzyme op twee bases van de crosslink, waarschijnlijk omdat de structuur te 
veel verstoord werd door het acyclische nucleotide. 
 
De chemische stabiliteit van deze duplexen verschilt met die van de duplexen met 
modificatie 1.  Waar gecrosslinkte duplexen met 1 niet bestand zijn tegen zuur, zijn deze met 
2 en 3 dat wel.  MALDI-TOF spectra voor alle gecrosslinkte duplexen werden opgenomen en 
hun massa kon worden bevestigd.  Hierbij werd opgemerkt dat deze gecrosslinkte speciës 
water konden verliezen.  Dit alles wees er op dat er geen imine werd gevormd.  De structuur 
rechtstreeks achterhalen door de duplex enzymatisch te degraderen tot op het dinucleoside 
stadium was echter niet mogelijk omdat enzymes geïnhibeerd worden door acyclische 
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nucleosides.6  Als alternatief werd elk van de beschermde nucleosides van 2 en 3 geoxideerd 
in de aanwezigheid van deoxycytidine.   
O
OH
HO
N
N3
N
O
O
OH
HO
N
N3
N
O
OHOH
O
O
O
O
O
OO
8 9  
Figuur 6: Structuur van de gevormde crosslinks van de verschillende nucleosides met dC 
De resulterende molecules werden geanalyseerd met NMR zodat een volledige 
structuurbepaling werd bekomen.  De structuur zowel met 2 als met 3 is weergegeven in 
Figuur 6.  Deze adducten zijn analoog aan de structuren die gevormd worden door cis-
buteen-dial, het natuurlijke oxidatieproduct van furaan, met dC.  Initiële hemi-aminal vorming 
werd gevolgd door een 1,4-additie van N3 van dC op het onverzadigde keton  in het 
geoxideerde nucleoside waardoor een ringstructuur ontstaat.  Hierbij werden twee nieuwe 
stereocentra gevormd, waardoor vier diastereomeren aanwezig waren.  Deze molecules 
hebben de mogelijkheid water te verliezen waarbij de nieuw gevormde ring aromatiseert.  Dit 
strookte met de observatie dat de duplexen water konden verliezen en is dus extra bewijs dat 
deze structuren worden gevormd. 
 
Alhoewel deze resultaten nagenoeg alle voorbeelden uit de literatuur overtreffen wat betreft 
crosslink opbrengst en snelheid, vormt de thermische stabiliteit van deze modificaties wel een 
nadeel.  De destabilisatie veroorzaakt door de introductie van deze acyclische eenheid in niet-
geoxideerde toestand kan mogelijks gecompenseerd worden door de flexibiliteit ervan te 
verlagen.  Dit kan onder andere gedaan worden door in een natuurlijk deoxynucleoside de 
nucleobase te vervangen door de fenylfuraan eenheid van het acyclisch nucleoside 3.  Het 
resulterende nucleoside 4 (Figuur 7) was een milde schenking van Prof. Dr. M. Hocek. 
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O
OH
HO
O
4  
Figuur 7: Structuur van nucleoside 4 
Ook hier werd het nucleoside ingebouwd in dezelfde oligonucleotide sequenties.  De 
koppeling tussen het gemodificeerde fosforamidiet en de groeiende DNA-keten op vaste fase 
verliep minder efficiënt in dit geval.  De koppelingsefficiëntie werd geschat op 80%.  Na 
zuivering werden tests uitgevoerd op de gemodificeerde DNA-strengen naar analogie met de 
vorige nucleoside bouwstenen.  Op basis van de crosslink reacties met verschillende 
complementen werd een eerste selectiviteit bepaald.  Crosslink vorming was mogelijk met 
deoxyadenosine en deoxycytidine als complement wanneer de modificatie geflankeerd werd 
door twee G.C paren.  Wanneer de modificatie geflankeerd werd door twee A.T base paren, 
dan was crosslink vorming enkel mogelijk met een complementaire dC base.  De opbrengsten 
met deze bouwsteen waren lager dan de vorige twee bouwstenen: er werden rendementen 
tussen 3 en 21% gehaald na zuivering. 
 
Enzymatische degradatie van de gecrosslinkte duplexen toonde aan dat crosslink vorming 
naar de complementaire base gebeurde behalve in de context G4G*CAC waar zowel naar A 
als naar C een crosslink werd gevormd.  Het was evenwel niet mogelijk te bepalen welke van 
de twee naburige C’s precies reageerde.  De crosslink veroorzaakte in dit geval een kleinere 
verstoring van de duplexstructuur gezien het enzyme voorbij het gemodificeerde nucleoside 
kon degraderen. 
 
De thermische stabiliteit van de niet-gecrosslinkte duplexen was, in tegenstelling tot de 
verwachtingen, niet hoger dan de stabiliteit van de analoge sequentie met nucleoside 3 
(Figuur 8).  Deze observatie werd verklaard door de verminderde flexibiliteit in 4 waardoor de 
fenylfuraan eenheid niet het maximaal stabiliserende stacking patroon zou kunnen vinden 
terwijl dit wel mogelijk zou zijn bij het flexibele nucleoside.  De thermische stabiliteit van de 
gecrosslinkte duplexen was echter wel in analogie met nucleoside 3.   
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Figuur 8: Smelttempraturen van DNA duplexen met incorporatie van nucleoside analoog 2, 3 en 4 alsook 
de natuurlijke, niet-gemodificeerde referentie.  Er werden geen mismatches geïntroduceerd. 
In een laatste stadium werd nucleoside bouwsteen 3 uitgetest voor de vorming van crosslinks 
in een DNA triplex context.  Nucleoside 3 werd ingevoerd in een DNA streng die gekend is te 
binden in de grote groef van een DNA duplex, een zogenaamde triplex vormende streng 
(TVS).  In eerste instantie werd 3 ingevoerd in een centrale positie van een TVS.  Aangezien 
de omstandigheden om triplexen te vormen verschillen met die van duplexen, werden de 
experimenten met deze sequenties uitgevoerd bij PH 5 in een oplossing van 10 mM 
natriumacetaat buffer in aanwezigheid van 2 mM Mg2+ en 100 mM NaCl.  Door de grootte 
van deze triplex structuren kon crosslink vorming niet gevolg worden met HPLC.  Enkel de 
afname in intensiteit van het TVS RP-HPLC-signaal kon worden gevolgd.  Voor de 
werkelijke analyse van crosslink vorming moest beroep worden gedaan op gel-electroforese.  
Crosslink vorming werd getest in verschillende contexten en met verschillende base paren 
tegenover nucleoside 3 maar nergens werd een band waargenomen op gel-electroforese die 
correspondeerde met een crosslink. 
 
Indien de bouwsteen 3 werd bevestigd aan de 3’-terminus van een natuurlijk oligonucleotide 
werd echter wel crosslinking waargenomen.  Hiertoe werd nucleoside 3 geïmmobiliseerd op 
vaste drager als eerste nucleoside voor DNA synthese.  Er werd crosslink waargenomen 
zowel wanneer een A.T paar modificatie 3 complementeerde en alsook wanneer een G.C paar 
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3 complementeerde.  Verder werd ook getest of crosslink vorming nog mogelijk was indien er 
drie mismatches werden geïntroduceerd in het midden van de duplex.  Drie mismatches 
bleken voldoende om er voor te zorgen dat geen crosslink vorming mogelijk is.  Deze 
resultaten zijn zeer hoopgevend al zijn zeker verdere experimenten nodig om na te gaan wat 
de crosslink en mismatch selectiviteit is. 
 
Tijdens dit werk werden een aantal nucleoside bouwstenen die een reactieve furaan-eenheid 
bevatten gesynthetiseerd.  Elk van deze nucleosides werd geïncorporeerd in verschillende 
DNA-duplexen en de mogelijkheid tot crosslink vorming werd voor elk van deze duplexen 
nagegaan.  Crosslink vorming was mogelijk met alle nucleosides en de selectiviteit werd 
geanalyseerd door enzymatische degradatie van de desbetreffende duplexen.  De opbrengsten 
van de crosslink reacties varieerden tussen 3 en 73% na zuivering, het hoogste gepubliceerde 
rendement tot op heden.  De structuur van de crosslink werd achterhaald op basis van de 
chemische eigenschappen van de gecrosslinkte duplex en door deze te vergelijken met de 
structuur die bekomen werd indien een gemodificeerd nucleoside geoxideerd werd in 
aanwezigheid met dC.  Zo werd aangetoond dat nucleosides 2, 3 en 4 crosslinks vormen die 
een structuur hebben analoog aan de adducten die worden gevormd tussen dC en 
cis-buteen-dial. 
 
Tot slot werd ook de dynamica van LNA bevattende duplexen bestudeerd met behulp van 
NMR.  LNA basen vertonen een lage base paar levensduur terwijl de basen van de 
complementaire DNA streng sterk getabiliseerd worden.  Hieruit bleek dat de LNA streng de 
complementaire DNA streng stabiliseert door zijn grotere rigiditeit. 
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1 Introduction 
1.1 Chemical synthesis of oligonucleotides 
 
The ability to produce substantial quantities of sequence defined synthetic DNA has been 
invaluable to nucleic acids research.  Therefore loads of research effort has been put into the 
chemistry to synthesize oligonucleotides before coming to the phosphoramidite approach 
which is now the standard method for synthesizing short to medium-length DNA and RNA 
oligonucleotides.  The basic strategy (Scheme 1) resembles that of the stepwise synthesis of 
polypeptides.   
O
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Scheme 1: The oligonucleotide synthesis cycle 
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Typically, a reactive 3’-phosphorous group of one nucleotide, which is delivered in solution, 
is coupled to the 5’-hydroxyl of another nucleotide which is immobilized on a solid support.  
This leads to the formation of an internucleotide linkage.  The coupling reaction is followed 
by three other reactions, capping, oxidation and DMT-deprotection, in order to prepare the 
growing DNA chain for the next coupling.  When the chain is complete the oligonucleotide 
must be cleaved from the solid support and deprotected before it can be further purified in 
order to prepare the oligonucleotide strand for usage in the desired tests. 
 
1.2 Cross-linking DNA: why? 
1.2.1 DNA repair 
 
DNA repair is a collection of processes by which a cell identifies and corrects damage in the 
DNA of its genome.  When this damage is not repaired it would lead to cell cycle arrest, 
apoptosis or mutations which can cause cancer (Figure 4).  To circumvent the action of this 
damage, every human cell undergoes daily 104-106 repair events which are carried out by 
DNA-repair enzymes.7   
 
 
Figure 4: Schematic overview of the connection between DNA-damage and –repair 
The damage can be caused by endogenous factors such as formation of 8-oxoguanine during 
the cell’s oxygen metabolism or it can be caused by exogenous factors which is the case with 
pyrimidine dimers (T.T) formed by UV light or adduct formation with certain bifunctional 
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chemotherapeutics (see further).  Especially interstrand cross-links are an extremely lethal 
type of damage: 40 interstrand cross-links result in cell death in a repair deficient cell.8 
 
Next to their beneficial role in DNA repair, repair enzymes can cause also negative effects. 
The effectiveness of certain chemotherapeutics, based on DNA alkylation or cross-linking, 
can be counteracted by these repair enzymes.  Repair of the chemotherapeutically induced 
DNA damage is one of the causes of resistance.  Better understanding of the repair 
mechanism would help in the development of more efficient chemotherapeutics.  Certain 
diseases are associated with a defect in their repair enzymes such as xeroderma pigmentosum, 
cockayne syndrome and fanconi anemia.  Patients with these diseases are extremely sensitive 
to sunlight as they cannot repair T.T dimers, which often leads to cancer at very young age. 
 
Various types of DNA repair are known depending on the type of lesion they act on.  Direct 
reversal of damage corrects methylation of O6-guanine9 while base excision repair acts on 
deaminations, oxidations and alkylations of the DNA bases.10  As the name of the latter type 
of repair indicates, it removes the base of a nucleoside and replaces it based on the sequence 
context of the complementary strand.  Mismatch repair is quite unique as it recognizes one of 
two bases in a mismatch as aberrant.  This is a very complex mechanism that is not resolved 
to date.  It is a very important process as replication polymerases introduce one erroneous 
base every 105 bases.11  Double strand breaks are lesions that also occur quite often in cells as 
they are intermediates of cellular pathways and they can occur as a result of ionizing 
radiation.12  They are especially lethal because they can easily lead to losses of genetic 
information.  They can be repaired by homologous recombination13, which works with a 
template molecule, or non-homologous end joining which is a fairly simple ligation method 
that often leads to loss of some bases.11 
 
Finally, nucleotide excision repair (NER) is the pathway that removes bulky base adducts 
from DNA.14  It is the main defense against the genotoxic effects of UV light and acts on a 
surprisingly broad variety of lesions.15  For recognition by NER it is necessary that the 
modification is bulky and the DNA itself should be altered chemically.16  The more the DNA 
structure is destabilized the more efficient the damage is repaired.17  Lesions formed by 
certain chemotherapeutic agents, such as inter chain cross-links (ICL’s), are one of the targets 
where NER is involved.  The NER itself is an extremely complex process that involves the 
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action of about 30 proteins.  The exact mechanism of NER is not completely understood and 
the removal of interstrand cross-links itself is even less known.1   
 
The study of ICL repair is hampered by the difficulty of producing suitable substrates for the 
mechanistic studies: as the ICL’s only represent a minor fraction of all lesions formed by 
chemotherapeutics it is impossible to selectively extract one specific cross-linked sequence 
from biological material in sufficient quantity.  Therefore considerable research effort has 
been invested in synthesizing short cross-linked oligonucleotide duplexes as model 
substrates.18  Further challenges for ICL repair study can be found in the fact that different 
cross-links –and sometimes even different orientations of the same cross-link– result in 
different repair pathways and the fact that repair of ICL is not one single process but involves 
different repair pathways.19 
 
1.2.2 Antisense 
 
The pharmaceutical industry’s primary quest in drug discovery is drug specificity.  The more 
precisely a drug interacts with its intended target –and not with unintended molecules– the 
more likely it is to produce a therapeutic effect without undesired side effects.  Because 
oligonucleotide drugs would interact on the basis of the genetic code rather than shape and 
charge like traditional drugs, they represent a very interesting class of potential therapeutics.  
Another advantage is that oligonucleotide drugs would be able to target the genetic sequence 
of proteins that are “undruggable” because these proteins display too much similarity with 
other proteins. 
 
Figure 5: Schematic view of the antisense strategy 
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The idea that it was possible to transfer heritable traits by transfer of genetic material was 
already documented in 1944.20  This idea of interfering with gene expression was proven by 
the use of antisense oligonucleotides that inhibited the Rous sarcoma virus protein 
production.21   
 
The antisense strategy is based on the interaction of a (modified) DNA strand that binds to its 
complementary messenger RNA (mRNA) thereby blocking translation into proteins (Figure 
5).  This synthesized nucleic acid is termed an "anti-sense" oligonucleotide because its base 
sequence is complementary to the gene's mRNA which is called the "sense" sequence. 
 
In the antisense strategy, several mechanisms of action can be observed after the recognition 
of the mRNA strand by the antisense oligonucleotide.  In the most important mechanism, 
RNAse H, which hydrolyzes the RNA strand of a RNA/DNA duplex at the site of 
hybridization, is activated.22  The RNAseH activation strategy is limited to oligonucleotides 
based on a phosphodiester or phosphorothioate backbone and a deoxyribose moiety.23  A 
second mechanism prevents the splicing or translation in a physical way by binding very 
tightly to the mRNA.  It can be expected that antisense oligonucleotides that bind tighter, for 
example by covalent bond formation, will be more effective as they will not dissociate 
without chemical bond cleavage. 
 
Antisense drugs are being researched to treat cancers (including lung cancer, colorectal 
carcinoma, pancreatic carcinoma, malignant glioma and malignant melanoma), diabetes, 
ALS, Duchenne muscular dystrophy and diseases such as asthma and inflammatory arthritis.  
Most potential therapies have not yet produced significant clinical results.  One antisense 
drug, fomivirsen (marketed as Vitravene), was approved by the US Food and Drug 
Administration (FDA) but has in the mean time been withdrawn from the market.  It was used 
as a treatment for cytomegalovirus retinitis.  The main problems with antisense 
oligonucleotides are associated with the need to get into the cell nucleus and still be resistant 
to all enzymes present inside the cell. 
 
Micro-RNA’s (miRNA’s) are a last family of antisense molecules.  These molecules 
themselves are RNA strands produced inside the cell in contrast to traditional antisense 
molecules.  They appear to serve as master regulatory molecules for many biological 
processes, including translation.  The production of mature miRNA is the result of a series of 
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RNA processing steps.24  All of these processing steps could be targeted with traditional 
antisense oligonucleotides for miRNA production inhibition.   By influencing the production 
of these miRNA’s two opposite effects can be obtained.  Genes can be downregulated in order 
to stop the production of a protein which is a process equivalent to traditional antisense.  On 
the other hand genes can be upregulated so that specific proteins are made.   
 
1.2.3 Antigene 
A. Triplex DNA 
 
Normally, DNA exists in a duplex form.  Under certain circumstances a third DNA strand can 
bind to a duplex in the major groove.25  The third strand can be build up with purines or 
pyrimidines depending on the nature of the target sequences and requires a DNA homopurine-
homopyrimidine sequence tract of ideally 15 to 30 nucleotides.   
 
Figure 6: Parallel triplex motif and Hoogsteen base pairing 
In the case of a polypyrimidine triplex forming strand (TFO), the third strand binds in the 
major groove by Hoogsteen base pairing (Figure 6).  This third strand binds parallel to the 
polypurine strand which explains why this type of triplex is classified as the parallel or 
pyrimidine motif.  In the Hoogsteen base pairing the Watson-Crick base pairing is not altered.  
The extra pyrimidine base forms two extra hydrogen bonds with the central purine.   
 
As cytosine does not have an imino proton on N3 this nitrogen needs to be protonated for 
Hoogsteen base pairing as can be seen in Figure 6.  As a result this type of triplex will only be 
formed at lower pH (typically below pH 5).  The pKa value of isolated protonated 
deoxycytidine is 4.6, but its apparent pKa is raised due to the polyanionic character of the 
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nucleic acid environment.26  This protonation leads to a decrease in repulsion between the 
negatively charged backbones of the oligonucleotides. 
 
 
Figure 7: Antiparallel triplex motif and reverse Hoogsteen base pairing 
In the so-called antiparallel (or purine) motif the TFO mainly consists of purines.  The third 
strand is positioned antiparallel to the polypurine strand (Figure 7).  This time the TFO bases 
bind by reverse Hoogsteen pairing to the purine bases in the major groove.  As there are no 
cytidines in the TFO these triplexes can be formed under pH independent conditions but they 
are expected to be less stable than their parallel counterparts.27  Therefore, most research has 
focused on parallel triplexes in the past. 
 
B. Triplex antigene strategy 
 
As mentioned before, selectivity is a main issue in pharmaceutical development and the 
highest selectivity to recognize oligonucleotides can only be obtained by oligonucleotides 
themselves.  In the antisense strategy the mRNA is targeted.  Many duplicates of this mRNA 
are present in a cell while from the DNA itself there are only two copies.  Therefore it seems 
an intelligent strategy to target the gene rather than the mRNA.  This is called antigene 
strategy.28  This gene targeting can be achieved by triplex formation (Figure 8). 
 
Antigene therapy has been used to deliver DNA damaging agents to a target sequence in the 
genome (site directed mutagenesis), to specifically cleave target DNA or to modulate gene 
expression.29  Furthermore triplex formation can lead to stimulation of DNA repair as it is 
recognized by the nucleotide excision repair complex as a lesion.30 
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Figure 8: Antigene and antisense strategy 
The modulation of gene expression by triplex formation can be affected in different ways: (a) 
the TFO can bind the recognition site of one of the components of the transcription 
machinery31, (b) the structure of the DNA changes upon TFO binding so, possibly, it is no 
longer recognized by the protein factors or (c) the TFO can form a “roadblock” for the 
transcription or replication enzymes.26  The problem associated with this last strategy is that 
short ON’s will probably not be strong enough ligands to stop the enzymatic machinery.  
Therefore only irreversible binding is expected to block the enzymatic machinery.  Cross-
linking the TFO to the duplex thus seems an ideal strategy for this purpose.26   
 
However the antigene approach also has several limitations associated with production of new 
drugs.  G-rich oligonucleotides for example have a tendency to form G-quadruplexes that are 
extremely stable.32  Another problem associated with the antigene strategy is that the binding 
of a negatively charged third strand is not very favorable as it increases the presence of 
negative charges even more.  This repulsion can be neutralized in experiments by adding 
higher levels of Mg2+ but inside the cell this is impossible.  Backbone modifications such as 
phosphoramidates introduce positive charges into the TFO backbone resulting in a strong 
stabilization of the triplex, even at neutral pH.33  Stronger binding can also be achieved by 
changing the sugar part of the oligonucleotides.34  Other shortcomings associated with this 
triplex technology are related to their stability towards nucleases and the difficulty to deliver 
the TFO inside the nucleus.  Even when the TFO gets inside the nucleus it is still a difficult 
task to really target the duplex as the chromosomal DNA is stored in nucleosomes where the 
DNA is packed very tight around the histones.  The DNA only becomes accessible during 
transcription or cell replication so this limits the time period where the antigene drugs can be 
active. 
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Since triplex formation is limited to polypurine-polypyrimidine tracks it was initially thought 
that there would be relatively few potential targets.  However it was found upon analysis of 
the human genome that many genes of possible therapeutic interest show large possible 
triplex forming sites especially in their promoter region.35  These results suggest that there is a 
huge potential for triplex strategies in the control of gene expression. 
 
C. Transcription factor decoys 
 
A different type of antigene strategy involves the use of transcription factor decoys.  These 
molecules are short synthetic oligonucleotide duplexes containing an enhancer element that 
will bind to sequence specific DNA-binding proteins and will interfere with transcription in 
vitro and in vivo. 
 
Transcription of a specific gene is controlled by several proteins that are called transcription 
factors.36  They bind specific DNA motifs and also interact with RNA polymerases to increase 
or decrease the rate of transcription.  Double stranded decoy DNA’s can bind with high 
affinity to target transcription factors thereby altering gene transcription as the transcription 
factor is occupied by the decoy (Figure 9).37  Transfection of cells with this double stranded 
DNA resulted in modulation of gene expression.38  As transcription factors can be gene 
activators or gene silencers, both up- and down-regulation of genes is possible.39 
 
 
Figure 9: Decoy DNA strategy 
This approach is attractive for different reasons: there are loads of drug targets (transcription 
factors) and they are readily available.  It is unnecessary to know the exact structure of the 
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transcription factor and finally one DNA duplex might be recognized by several transcription 
factors so an entire group of genes can be regulated with one decoy DNA. 
 
One of the strategies used to enhance the stability of the decoy DNA is to introduce an 
interstrand cross-link in the double stranded DNA.40  Not only do cross-links impose 
continuous double strand formation, they would also have the potential of constraining the 
oligonucleotide in a form that is more active towards the transcription factor.41 
 
1.2.4 Structural applications 
 
Cross-linking of DNA can be used for various purposes in structural biology and 
nanotechnology.  To produce unfavourable DNA conformations such as strained DNA 
structures, cross-linking the relevant parts is the standard method.42  In this way R-shaped 
DNA43 as well as n, h and H-type DNA44 have been constructed.  Furthermore it was also 
shown that cross-linking the termini of a hairpin can be used to constrain the structure 
continuously in the hairpin conformation.45 
 
A different application that uses DNA interstrand cross-linking is the detection of single 
nucleotide polymorphisms (SNP’s).46  The basic idea behind this method is to discriminate 
between matched and mismatched oligonucleotides on the basis of their difference in melting 
temperature.  A modified probe is constructed with a cross-linker inside the single strand and 
a biotin moiety attached at the 5’-terminus of the strand.  Upon complexation with the target 
strand the matched duplex will have a higher melting temperature and cross-linking will occur 
when duplex is formed.  The resulting large complex can be isolated from the single strands 
by size exclusion centrifugation.   
 
Figure 10: Detection of SNP’s with cross-linking probes 
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After transfer of the resulting cross-linked duplex to a microtiter plate the biotin label in the 
modified strand can be conjugated with a molecule for fluorescence detection.  Only the 
cross-linked complexes will exhibit fluorescence and these are exactly the strands that contain 
the target sequence.  The main advantage of the cross-link step in this method is that it allows 
detection of complexes that would otherwise be too unstable to detect.46 
 
1.3 Existing DNA cross-link methods 
 
Existing cross-link methods can be divided into three categories: On the one hand, externally 
added bifunctional cross-linkers can react with both strands of the double helix.  Some of 
these are used as chemotherapeutic agents.  A second strategy involves the use of 
oligonucleotides that are reactive towards their complementary strand.  In this strategy one or 
both strands can be modified.  The last strategy for DNA cross-link formation incorporates a 
cross-linked dinucleotide during DNA synthesis.   
 
1.3.1 Bifunctional cross-linkers 
 
A large variety of bifunctional cross-linking molecules has been developed.  Some of the most 
important examples are listed below.  A more comprehensive overview of bifunctional DNA 
cross-linkers can be found elsewhere.47   
 
A. Cis- and Trans-diamminedichloroplatinum 
 
Cis-diamminediplatinum (cis-DDP, 10) was invented 150 years ago but only in the last 30 
years it was recognized as an antitumor agent.  It triggers cell death by apoptosis but its 
mechanism of action is not completely elucidated yet.  Its cytotoxicity is believed to originate 
from the formation of intra- and interstrand cross-links (ICL) within guanosine rich DNA 
regions.   
 
The main lesion formed is the N7-N7 interstrand cross-link at 5’GpG3’ (Figure 11, A) which 
accounts for 65% of the cross-link lesions.  The N7-N7 cross-link at 5’ApG3’ (not shown) 
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represents another 15%.48  The remaining cross-link lesions are 1,3 intrastrand cross-links at 
5’GNG3’ and 5’GpC3’ interstrand cross-links.49  In total the ICL’s represent only up to 20% of 
the total bound platinum but they are recognized as the most toxic lesions. 
 
Platination of 5’GpG3’ is extremely lethal and therefore it is supposed to be the source of the 
cis-DDP toxicity.47  The structural effects of this lesion have been extensively studied.  The 
cross-link induces unwinding of the duplex and the complementary cytosines are completely 
flipped out.  The cross-link itself resides in the minor groove and a change of right-handed B-
DNA to left-handed Z-DNA occurs at the binding site.50 
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Figure 11: Cross-linking with cis- and trans-platin 
 
Trans-diamminediplatinum (Figure 11, 11) on the other hand is clinically ineffective.  Cross-
links with trans-DDP are formed between G and its complementary C (Figure 11, B).  It has 
therefore been speculated that the difference in antitumor activity may arise from the nature of 
the different distortions induced by the cross-links.  The trans-isomer also forms much slower 
ICL’s in vivo.51 
 
Selective platination can be achieved in oligonucleotide duplexes with only one target site by 
platination of one strand followed by duplex formation.52 
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B. Nitrogen mustards 
 
Nitrogen mustards represent the oldest class of DNA interstrand cross-linking agents.  They 
were introduced in the 1920’s as potential chemical warfare reagents.  Their two most 
prominent examples, mechlorethamine (Figure 12, 12) and chlorambucil (Figure 12, 13) are 
two of the most used anticancer agents today.  They are used in a cocktail for treating 
Hodgkin's disease, non-Hodgkin's lymphoma, as palliative chemotherapy in lung and breast 
cancers and as a lotion for skin lesions of mycosis fungoides (cutaneous T-cell lymphoma).53  
Their toxicity is attributed to their interstrand cross-link formation potential. 
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Figure 12: Structure of mechlorethamine and chlorambucil 
The nitrogen mustards form a highly reactive aziridinium intermediate which is alkylated by 
the N7 of guanine.  In a second step the same reaction occurs with a second G residue.54  
Nitrogen mustard-like functionality has also been introduced into single stranded 
oligonucleotides for the creation of alkylating sequences. 
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Scheme 2: Cross-linking strategy with nitrogen mustards 
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C. Psoralen 
Psoralenes (Figure 13, 17) are furocoumarins capable of forming T-T cross-links in 3’-TA-5’ 
or 5’-TA-3’ sequences upon photo activation.  The reactions are highly regio- and 
stereospecific with formation of two different mono-adducts next to the cross-link.55  The 
cross-linking occurs by 2+2 cycloaddition with the highlighted bonds (Figure 13).  Psoralen is 
also known to intercalate into DNA. 
 
O O O
17  
Figure 13: Structure of psoralen 
This class of compounds is found in plants and fungi.56  Psoralen is used to treat skin 
problems such as psoriasis and cutaneous T-cell lymphoma.57  Psoralen is also commonly 
used in the cross-link strategy with modified DNA strands (see further).   
 
D. Reactive aldehydes 
 
Acrolein (18) and crotonaldehyde (19) are mutagens and tumor initiators formed via lipid 
peroxidation and they are also present in tobacco smoke.58  Acrolein is used as herbicide and 
microbiocide in water for oil exploitation and is also a common intermediate for chemical 
synthesis.59  The type of cross-links they form is unstable as they react via Michael addition 
with formation of a Schiff base.  Malondialdehyde (20) reacts in a similar manner as 
crotonaldehyde.60   
 
 
Figure 14: Structure of acrolein, crotonaldehyde, malondialdehyde 
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1.3.2 Oligonucleotides containing reactive units 
 
As the former group of DNA interstrand cross-link preparation methods generally results in 
complex mixtures of adducts and low yields of interstrand cross-links, serious effort has been 
invested in synthesizing cross-linked oligonucleotides based on incorporation of reactive 
units.  These entities can than react with the complementary strand which can be also 
modified or non-modified.  The methods receiving most attention in the last years will be 
discussed as well as the strategies with a long history that are still in use such as disulfide 
bridge formation and conjugated psoralens. 
A. Cross-linking by disulfide bridge formation 
 
Cross-linking by disulfide bridge formation is one of the methods with the longest history for 
cross-linking oligonucleotides.  Very early it was reported to work on the nucleoside level61 
but only later it was shown to also work in a DNA duplex.62  Incorporation of a sulfide 
containing nucleoside in each of the two DNA strands allows disulfide bridge formation upon 
oxidation with iodine.  Reduction of the disulfide, for example by dithiothreitol, shows this is 
a completely reversible type of cross-link.  The sulfide can be introduced either 
enzymatically63 or during DNA synthesis as a mixed disulfide that is stable during DNA 
synthesis.64  Cross-link yields are in general high but the need for modifying two strands can 
be seen as the major drawback of this method. 
B. Photoactivated cross-linkers 
 
Cross-linking DNA-termini with photoactive molecules is an approach introduced in the mid 
80’s by Hélène and co-workers.65  Their approach used 3-azido-6-(3-bromopropylamino)-
acridine (21) to react with a terminal thiophosphate of an oligonucleotide.  Irradiation resulted 
in good cross-link formation for both duplexes and triplexes.66  This approach however is 
somewhat limited as cross-linking cannot be induced at any position. 
 
A photo cross-linker such as psoralen has the ability to form interstrand cross-links upon UV 
irradiation.  However large amounts of uniformly cross-linked material are inaccessible as 
they would require high intensity lasers and they would form multiple lesions if more than 
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one 5’-TA-3’ site is present.  Psoralenated oligonucleotides are accessible by incorporation of 
a psoralen unit into an oligonucleotide strand.   
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Figure 15: Structure of 3-azido-6-(3-bromopropylamino)-acridine 
The earliest example of incorporation of a psoralen modified nucleoside inside a DNA duplex 
was reported by the Essigman-group (Figure 16, 22).67  Their approach consists of 
incorporating the thymidine monoadduct of psoralen into oligonucleotides by standard 
phosphoramidite chemistry.  For the synthesis of this nucleoside a thymine residue is reacted 
on the furan side of psoralen as the monoadduct from the pyrone side, an unsaturated lactone, 
is unstable towards the basic deprotection conditions during DNA synthesis.68  This 
nucleoside approach allows incorporating psoralen cross-links in virtually every sequence in 
contrast to the oligonucleotide approach of Spielmann69 which requires selective adduct 
formation of one strand at the furan side followed by duplex formation and subsequent 
irradiation to induce cross-link formation with the second side of the psoralen (the pyrone 
side). 
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Figure 16: Structure of photo-cross-linkers for incorporation into oligonucleotides 
Since psoralen is very popular as cross-linking agent a psoralen phosphoramidite is 
commercially available from Glen Research (Figure 16, 23) for cross-linking of 
oligonucleotide termini.45  Several other psoralen conjugated oligonucleotides have been 
reported70 but a full description of these is out of the scope of this work. 
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C. Chloroethyl thymine 
 
Similar to adducts formed by chloroethylnitrosoureas, interstrand cross-links can be formed 
by modifying a thymidine residue with a chloroethyl linker (Scheme 3, 24).71  It has been 
hypothesized that the chlorine of this linker does not undergo direct substitution but reacts by 
intramolecular SN2 reaction with formation of a cationic intermediate (25).  In that case the 
ring can be opened by attack of the guanine oxygen, because of its partial anionic character, 
with subsequent formation of an interstrand cross-link (26).  
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Scheme 3: Cross-link strategy with chloroethyl thymine 
Cross-link formation is slow: over two weeks a yield of 25 to 30% was obtained with an 
excess of five equivalents of the modified strand.  The major advantage of this approach is 
that the modified thymidine is easy to synthesize.  Cross-linking was smooth with guanosine 
and also in the case of cross-linking to adenosine some cross-linking was observed (6%).  
Cross-linking to cytidine gave 3% yield and no cross-linking to T was observed. 
 
D. Cross-linking with selenium or sulphur modified nucleosides 
 
A very interesting cross-link approach was introduced in 2005 by Marc Greenberg and co-
workers.  They synthesized a phenylselenide modified deoxyuridine (27) which upon UV 
irradiation with 350 nm UV light forms a nucleotide radical localized on the methyl group 
(Scheme 4, 29).72  This radical has the ability to form an interstrand cross-link with a 
complementary adenosine (30).73  This strategy can also be applied to methoxy-substituted 
arylsulfides (28a and b).74   
 
Cross-link yields are typically in the range of 25% and cross-link formation is very fast: after 
a reaction time of thirty minutes no further cross-link formation is observed.74  It is believed 
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that the primary reaction is alkylation of N1 which is followed by isomerisation to the 
thermodynamically more stable N6 product as shown in Scheme 4. 
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Scheme 4: The Greenberg strategy 
The phenylselenide-modified oligonucleotide duplex can also be irradiated with 137Cs, a γ-
radiator, in order to form cross-links.  The activation mechanism does not involve a direct 
homolytic cleavage of the C-Se bond but is based on oxidation by H2O2 which is formed 
through radiolysis of water (Scheme 5).75   
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Scheme 5: Cross-link strategy using selenium modified oligonucleotides and H2O2 
It was further shown that the nucleoside triphosphate of the phenylselenide modified 
nucleoside 27 could be recognized as a substrate for DNA polymerases.  Random 
incorporation into a 7200 nucleotide duplex followed by exposure to radiation resulted in 
cross-link formation.75   
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E. Cross-linking with 2-amino-6-vinylpurines 
 
2-Amino-6-vinylpurines (Figure 17, 33) are reactive nucleosides that can form interstrand 
cross-links upon duplex formation with a complementary cytidine.  The amino group of 
cytosine has the possibility to attack the terminal position of the vinyl-group.  These 
modifications do not require activation, only proximity.   
 
The very first example was reported in 1995 and yields cross-link in a conversion rate up to 
80%.76  One of the advantages of this system is that the cross-linking can be adjusted to the 
conditions: cross-linking becomes slower if an electron donor is attached to the vinyl bond77 
whereas introduction of an electron withdrawing group such as a sulfoxide fastens the cross-
link reaction and allows cross-link formation also under neutral conditions. 
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Figure 17: Structure of 2-amino-6-vinylpurine and a possible precursor 
This sulfoxide can be generated upon oxidation of a phenylsulfide derivative (Figure 17, 34) 
but this oxidation is not necessary for cross-link formation.  It has been shown that a cytidine 
residue at the target site in the complementary strand enhanced the elimination step of the 
phenylsulfide derivative to the vinylpurine which than undergoes a Michael-type addition.   
 
Next to psoralens this is the only cross-linking system reported to date showing in vivo 
antisense activity and it has the advantage that it does not require photoactivation.78  The 
system showed higher activity in cell lysates than in simple laboratory setups and its high 
sequence discrimination may allow single nucleotide discrimination inside cells.  This type of 
system is also reported to work for triplex cross-linking79 and it has the possibility to induce 
mutations by triplex cross-link formation.80  
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F. Reversible cross-link formation with aldehydes 
F.1 Cross-linking with abasic sites 
 
Abasic sites are the most common type of cellular damage.81  Inspired by this damage the first 
approach for cross-linking using an abasic site was reported by Isis pharmaceuticals back in 
1999.82  They used DNA-uracil glycosylase to heterolytically cleave the glycosidic bond of a 
single uracil residue.  As a result the sugar ring will be part of the time in the open aldehyde 
form while 99% of the time in the closed hemiacetal form (Scheme 6 36 respectively 35).  
This aldehyde can react with an amino-group attached to a nucleoside in the complementary 
strand.  This type of cross-link is reversible as the bond between the two strands is an imine.  
To stabilize this system for further studies the imine can be reduced with sodium 
cyanoborohydride which generates a secondary amine.  Cross-link yields are excellent with a 
conversion rate of >95%. 
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Scheme 6: Formation of abasic sites with DNA-glycosylase 
Similar to this approach, it was also reported that introduction of an amine in the 
complementary strand is not necessary but cross-linking is possible if a guanosine is present 
in the complementary strand near the position of the abasic site.83  However it is sterically 
impossible to cross-link to a complementary guanosine.  The guanosine must be positioned at 
the 3’-side of the complementary base in order to produce interstrand cross-links. 
 
F.2 Cross-linking by chemical introduction of aldehydes 
 
If one has the possibility to incorporate or induce an aldehyde inside a DNA duplex by a 
chemical method it could be possible to cross-link to a complementary strand.  Introduction of 
aldehydes can be achieved by postsynthetic oxidation of a 1,2-diol.84  There are two examples 
of this in literature. 
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The first method applying this oxidation was developed to detect 5-formyluracil, the major 
oxidative lesion of thymidine in DNA.  To incorporate 5-formyluracil in a DNA duplex a 
postsynthetic oxidation of 5-(1,2-dihydroxyethyl)uracil (37) with sodium periodate was 
performed to generate the required amounts of aldehyde (38).85  5-Formyluracil can react only 
with the exocyclic 5-aminogroup of 5-aminocytidine (Scheme 7).  As a result this 
aminocytidine is ideal for detection of the 5-formyluracil lesion.  For cross-link purposes 
however it is less suited as both strands need postsynthetic modification and cross-linking is 
slow.  As the formed cross-link (39) is an imine it must be reduced to be applicable for further 
analysis. 
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Scheme 7: Postsynthetic introduction of aldehydes by oxidation with NaIO4 
Similar to this approach an aldehyde was introduced on purine bases.  Protected 2-
fluoroinosine 40 can be reacted, after DNA synthesis, with amines containing a vicinal diol by 
nucleophilic aromatic substitution.86  Diol 41 can be oxidized as in the previous example.  The 
resulting aldehyde will immediately react intramolecularly with N1 of a guanine to form a 
hemi-aminal (Scheme 8).  Upon complexation with a complementary strand an interstrand 
cross-link can be formed with the amino-group of a complementary guanine.87   
Similar papers mimicking other mutagenic products of DNA damage were published.88,89,90 
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Scheme 8: Equilibrium resulting from postsynthetic introduction of aldehydes in guanines 
 In
tro
du
ct
io
n 
41 
 
1.3.3 Solid phase based approach 
 
In what is called the solid phase approach, a cross-linked nucleoside dimer is incorporated in 
the growing DNA strand during solid phase DNA synthesis.  This method was introduced by 
Hopkins and Sigurdsson.91  They wanted to prepare a nitrous acid cross-linked duplex for the 
study of ICL repair.  As nitrous acid treatment of an oligonucleotide duplex would result in 
random deaminations they synthesized a nucleoside dimer that could be introduced into 
oligonucleotide duplexes. 
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Figure 18: Structure of dimer for nitrous acid cross-linked DNA 
The dinucleotide, necessary for the cross-link incorporation, was accessible by palladium 
coupling.  A series of protection and deprotection steps yielded molecules 44 or 45 (Figure 
18).  These dinucleotides can be used in the DNA synthesis via two different strategies, both 
yielding symmetrically cross-linked duplexes.   
OAc5' OH5' OH
dimer 44 Alloc deprotection
DNA synthesis
AllocOH
OAlloc
DNA synthesis
 
Scheme 9: The first approach for solid phase synthesis of cross-linked duplexes 
The strategy used with nucleoside 44 is ilustrated in Scheme 9.  DNA synthesis is started as 
usual and the modification is introduced.  Subsequently the two identical 5’-arms are 
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simultaneously synthesized.  Endcapping with Ac2O is followed by Alloc deprotection after 
which the last arm of the duplex can be synthesized.  After deprotection the duplex is purified 
by gel-electrophoresis to give an overall yield of 10%.   
OH5'
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45 1)DNA synthesis
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3) Rotation around 
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Scheme 10: The second approach for solid phase synthesis of cross-linked duplexes 
The second strategy uses controlled pore glass (CPG) with a very high loading so one dimer is 
able to react with two growing oligonucleotide chains (Scheme 10).  This approach is simpler 
than the previous one: the phosphoramidite 45 is easier to synthesize and the DNA synthesis 
itself is less work intensive.  The overall yield is however not increased as this product also 
requires purification by gel electrophoresis and sometimes even additional RP-HPLC steps.92 
N
X
YN
O
O
O
O
O
N
N
O
O
5' 3' 5' 5' 3'
3'
n-type h-type H-type
 
Figure 19: Structure of n, h and H-type DNA and the dinucleotide used to obtain these structures 
Both of these strategies have also been used for other cross-linked duplexes.  The group of 
Kishi reported six variants of the first system with modified, covalently bound nucleosides 
mimicking A-T and G-T pairs as proof of the feasibility to synthesize n, h or H type DNA 
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(Figure 19).44  Coupling yields during DNA synthesis after insertion of the modified residue 
were very low and no overall yields were reported.   
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Figure 20: Different dinucleotides for use in the solid-phase approach 
The group of Miller and Noronha further reported a series of C-C (48)93 and T-T (49)94 cross-
linked oligonucleotides using the first strategy and more recent G-G (50) cross-linked 
duplexes were reported using the second strategy (Figure 20).95  The mismatched T-T and 
C-C cross-link mimic the natural adducts formed by mechlorethamine while the G-G cross-
link is supposed to have the same structural effect as the lesions caused by hepsulfam.  
Overall yields are around 10% in all cases. 
 
Given the complexity of the protection strategy none of these examples seems ideal for fast 
and easy preparation of cross-linked duplexes.  Furthermore the coupling yields after 
incorporation of the cross-linked dimer are low.  
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1.4 Furan toxicity 
 
Furan is an industrial chemical used as solvent or as synthesis intermediate.  It is found in 
foods and beverages,96 and it was also detected as a contaminant in smog and tobacco 
smoke.97  Furan is both liver and kidney toxicant98 and hepatocarcinogenic99 in mice and rats.  
The toxicity does not originate from furan itself, but from a metabolized form of furan.  The 
major metabolite of furan is CO2 as was shown in studies with 14C labeled furan.100  It was 
shown that furan can be oxidized in the liver by cytochrome P450.101  The resulting reactive 
metabolite, cis-butene-dial, is supposed to be formed either directly or by intermediate 2,3-
epoxide formation (Scheme 11).  It is this intermediate that is held responsible for its reaction 
with biomolecules such as proteins102 and DNA.103   
O O
O O
O
51
52  
Scheme 11: Suggested bioactivation pathway of furan 
Initial reports about the nature of the toxicity of cis-butene-dial suggested that reaction with 
nucleosides only forms unstable adducts.104  However under biological conditions stable 
adducts can be formed.   
 
Deoxycytidine, deoxyadenosine and deoxyguanosine can form stable adducts with cis-butene-
dial.103,105  It was shown that one of the aldehydes in cis-butene-dial reacts with an exocyclic 
amino-group of a dA or dC to form a hemi-aminal (53 respectively 56).  In a next step N1/N3 
adds to the unsaturated aldehyde with formation of a five-membered ring (Scheme 12).  The 
alcohol present on the ring finally adds to the second aldehyde with formation of a hemi-
acetal.  The presence of the hemi-acetal form was confirmed by NMR.  The adducts formed 
by dC are significantly more stable compared to those of dA.  The half life time of dC adducts 
is 275 hours while dA adducts only have a half life time of 6.1 hours.   
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Scheme 12: Suggested reaction mechanism for cis-butene-dial adduct formation with dA and dC 
The reaction of guanosine with cis-butene-dial could proceed in two distinct ways which are 
difficult to distinguish.  The first adduct is formed by initial attack of N1 to one of the 
aldehydes followed by ring formation while the second pathway is similar to those of dC and 
dA where initial attack of the exocylcic amine is followed by Michael addition by the 
endocyclic N1.  The first pathway is supposed to contribute most to the final adduct 
composition.106  The adducts 60 and 63 are also known to dehydrate.  Under acid catalyzed 
conditions the alcohol can be protonated which is followed by elimination with an extra 
aromatic ring as result.  This aromatization is also reported, next to dG, for dA.107 
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Scheme 13: Suggested reaction mechanism for cis-butene-dial adduct formation with dG 
 
Cis-butene-dial and derivatives thereof can also be produced from precursors other than furan.  
5’-Oxidation of deoxyribose sugars can yield trans-butene dial.108  Trans-butene-dial can form 
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similar adducts with the nucleobases and the rate at which these reactions happen is about ten 
times faster compared with the cis-form of the dialdehyde.109  Polyunsaturated fatty acids can 
be oxidized to lipid hydroperoxides.  These hydroperoxides can undergo homolytic 
decomposition mediated by FeII, CuI or vitamin C to form α,β-unsaturated aldehydes such as 
4-oxo-enal derivatives.  As these are structurally very similar to trans-butene-dial they react 
with free nucleobases and also with nucleobases in double stranded DNA.110  The formed 
adducts are identical to those reported for cis- and trans-butene-dial.  All of the reported 
reactions with DNA nucleobases lead to toxic effects as they alter the DNA structure and have 
the potential to induce mutations in the genome. 
 
1.5 Existing furan nucleosides 
 
In the past, various approaches have been used for incorporating furan moieties into 
nucleosides and oligonucleotides.  The ideal furan building block should be accessible via fast 
and easy synthesis, the furan unit should have only one substituent, namely the point of 
attachment to the nucleoside, and it should be pointing towards the complementary base.  The 
presence of substituents can lead to different oxidation patterns of furan.111  For our strategy, 
only the oxidation to 4-oxo-enal derivatives is desirable. 
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Figure 21: Structure of various existing furan-modified nucleosides 
 
The earliest example of a furan bearing nucleoside is reported by the group of Herdewijn.112  
They synthesized 5-furan-3-yl-2’-deoxyuridine (65) by Stille coupling of 
3-(tributylstannyl)furan with 5-iodo-2’-deoxyuridine.  Because furan is attached via its 
3-position to the nucleoside it was not considered for incorporation in our cross-linking 
oligonucleotides.   
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Other examples of nucleosides synthesized for their possible antiviral properties come from 
the Johansson group.113  They introduced a furan moiety on the 8-position of guanine (Figure 
21, 66) and on the 2-position of adenine (not shown).   
 
The last series of nucleoside analogues (67) for medicinal applications are the furanfurin 
analogues reported by Franchetti.114  They introduced a decorated furan on a ribose sugar unit.  
In the first stage of the currently described project, substituted furans were not considered.  
Therefore, the nucleosides represented by 68 were not considered for this work.115  Moreover 
the synthesis of these two series of compounds is low yielding.   
 
O
OHOH
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O
OHOH
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O
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69 70
 
Figure 22: α-substituted ribonucleosides containing a furan moiety replacing the nucleobase  
The undecorated furan analogue 69 as well as a variant with a phenyl ring between the sugar 
unit and the furan moiety (Figure 22, 70) were reported but only in the ribose form so with an 
extra 2’ OH.116  In this case the aromatic substituents were introduced by addition of their 
lithium salts to the aldehyde of the sugar ring.  Ring closing was performed under Mitsunobu 
conditions.  However, the α-nucleosides were the major products obtained. 
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Figure 23: Furan-containing nucleosides for attachement of fluorophores 
A fourth example of furan decorated nucleosides in literature was found in an application for 
internal labeling of oligonucleotides via Diels-Alder cycloadditions.117  Furfurylamine was 
coupled to pentynoic acid by amide bond formation followed by a Sonogashira coupling to 
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5-iodo-2’-deoxyuridine.  In view of the long linker, molecule 71 was not considered a suitable 
candidate building block.   
 
Modified building block 72 is also used for Diels-Alder cycloadditions with fluorophore tags.  
Only recently, it became commercially available as a phosphoramidite from Tri-link 
Technologies.  It is currently under investigation in our group for its cross-link potential.   
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Figure 24: Modified nucleosides bearing a furan unit on the base. 
Compound 73 was synthesized in search for artificial base pairs.118  The furan unit was again 
introduced by Stille coupling.  In a similar way furan was also introduced on the 5-position of 
dC and dT and on the 8-position of dG and dA for development of new fluorescent probes 
that maintain high structural similarity with the natural nucleobases (74-76, Figure 24).119 
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1b: Ribo(2")  
Figure 25: Structure of the first generation furan modified cross-linkers 
Finally, examples 1a and 1b were developed in our group and tested for their cross-link 
potential.3  A furan unit was introduced on the 2’/2” position of the 2”-deoxyuridine by means 
of an amide bond.  The functionality was introduced on the 2’/2” position of the sugar 
because this would allow preservation of the Watson-Crick base pairing120 in contrast to all 
other furan decorated nucleosides here described.  This compound is discussed in more detail 
in 2.1 and 2.2.  
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1.6 Aim and objectives 
 
Recently, a new method for DNA interstrand cross-linking based on the use of a furan moiety 
as masked reactive aldehyde, was developed in the laboratory for Organic and Biomimetic 
chemistry (Figure 26).  The idea for this new method was found in the known carcinogenity 
of furan, which comes from the cytochrome P450 mediated oxidation of furan to 1, 4-butene-
dial.  This reactive dialdehyde has been shown to react with proteins and nucleic acids giving 
rise to the observed toxic effects of furan.   
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Figure 26: Cross-link strategy 
Based on this principle a furan containing nucleoside building block 1a/b was synthesized and 
inserted near the terminus of a modified oligonucleotide duplex.  Oxidation with NBS 
allowed isolation of a new product which was shown to be a cross-linked duplex by ESI-MS.  
Upon evaluating these results several questions arose.  First the selectivity of the cross-link 
formation should be investigated as this is a key property towards potential applications.  
Second, a structural investigation of the cross-link should also be performed as the type of 
duplex distortion is a critical parameter for the study of ICL repair.  The most evident 
methods for this analysis are NMR and X-ray diffraction. 
 
In a first stage of the work, the cross-linked duplexes based on incorporation of 1a/b will be 
structurally investigated by 1H NMR methods (see paragraph 2.2). 
 
In a further stage, new acyclic furan modified building blocks will be developed (see 
paragraph 3.3).  As these building blocks are more straightforward to synthesize, more 
elaborate study of the cross-link selectivity should be possible by incorporating them into a 
series of duplexes were both the complementary base and the neighbouring bases can be 
varied. 
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The design of nucleoside building block 2 was based on (S)-9-(3,4-dihydroxybutyl)adenine 
(see later).  Since severe duplex destabilization can be expected, nucleoside building block 3 
was designed and synthesized to partially restore duplex stability by increasing the stacking 
interactions.  In a final stage of the work nucleoside analogue 4 was evaluated (see chapter 4).   
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Figure 27: Stucture of the used nucleoside analogues 
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2 Cross-linking with first generation furan modified nucleosides 
2.1 Previous work 
 
The very first experiments with building block 1 introduced above were conducted in our lab 
in 2004.  Part of this work was published in Chemical Communications.3  Different 
nucleosides were synthesized with a furan unit attached to the sugar unit of a uridine via a 
short alkyl chain.  The connection to the sugar ring was made by an amide bond (Figure 28). 
 
NH
O
ON
O
HN
OH
H
HO
O
O
NH
O
ON
O
HNOH
H
HO
O
O
1a 1b  
Figure 28: Structure of the first generation furan-modified cross-linkers 
Upon oxidation of the nucleoside with N-bromosuccinimide (NBS), the furan ring opened to 
the 4-oxo-enal derivative 77 which can react with benzylamine with formation of an imine 78 
(Scheme 14).  However this imine was not isolated, its existence was only proven by ESI-MS.  
If an excess of NBS was added overoxidation to the corresponding carboxylic acid was 
observed. 
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Scheme 14: Reaction of a furan containing nucleoside with benzylamine 
Incorporation of the nucleosides inside a DNA duplex allowed testing of the hypothesis 
whether covalent bond formation could take place with the exocyclic amino functions of the 
nucleobases in the complementary strand.    
 C
ro
ss
-li
nk
in
g 
w
ith
 fi
rs
t g
en
er
at
io
n 
fu
ra
n 
m
od
ifi
ed
 n
uc
le
os
id
es
 
52 
 
The nucleosides were introduced by standard methods in ON3 where X represents the 
modification 1a or 1b.  Duplex formation of ON3 with ON4 allowed initial testing.  Melting 
experiments, one of the standard procedures to assess the effect of a modification on a DNA 
duplex, showed a destabilization of 4 to 5°C for each of the modifications in this position.  It 
can be expected that introduction of the modification in the centre of a duplex destabilizes 
more as the termini are already destabilized by fraying.121 
 
5'-GCCTGTCAGXG-3'
3'-CGGACAGTCAC-5'
ON3
ON4
duplex ON3+ON4
 
 
The cross-link reaction was conducted in a 10 mM phosphate buffer at pH 7 with 100 mM 
sodium chloride at room temperature.  Cross-link reactions were monitored by RP-HPLC.  
The oxidation conditions were optimized and it was shown that adding a new equivalent of 
NBS every fifteen minutes gave the best results.  After 4 equivalents of NBS, the 
complementary strand had completely disappeared and a new product, eluting at a higher 
retention time had formed (Figure 29).  Upon collection of this peak and subjection to ESI-
MS its mass corresponded to the sum of the masses of the two strands ON3 and ON4.  
However, after oxidation of the furan ring 18 mass units are added to the molecular weight.  
This indicates that the formed bond results in the loss of one water molecule which correlates 
with the formation of an imine bond (cfr Scheme 14, 77).  However no further structural 
evidence was collected at this time. 
 
 
Figure 29: RP-HPLC spectra from the first cross-linking reactions with modification 1a,  
XL= interstrand cross-linked duplex 
Melting temperatures of the cross-linked duplex were not obtained as heating the duplex 
above 70°C always resulted in artefacts in the melting profile which made it impossible to 
interpret the results. 
 
These experiments resulted in a number of questions concerning the nature of the formed 
bond and which residue is involved in cross-linking.  Further information about the duplex 
structure is also desirable in the light of biochemical applications. 
ON4 
ON3 
ON4 
ON3 XL XL 
Before NBS With 1 eq NBS With 4 eq NBS 
After 60 minutes 
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2.2 Structural analysis by NMR 
2.2.1 Duplex structure determination 
 
In order to answer all of these questions, an attempt was made to synthesize a cross-linked 
duplex and analyze it by NMR.  For the preparation of an NMR structure of a DNA duplex 
some prerequisites must be fulfilled: a) The modification should be introduced centrally in the 
duplex as the ends are destabilized by fraying, b) the line width of the signals must be small 
and c) spectral overlap must be minimal as this complicates correct assignment. 
 
Three model duplexes were therefore tested and NOESY spectra were recorded for initial 
evaluation.  As synthesizing modified duplexes is labour intensive the modification is 
replaced for this purpose by a deoxyuridine (U).  A full description of NMR analysis of DNA 
duplexes will be given in paragraph 6.1 (page 159).  Different complementary duplexes were 
tested.  The duplexes based on single strands ON5 and ON6 showed broad NMR signals and 
were therefore not suited for this NMR study. 
 
ON5 5'-CGTCAGUGCAGC-3'
ON6 5'-CTGACGUGATGC-3'
ON7 5'-CTGACGGUGTGC-3'
Each of these single strands is used for duplex 
formation with its complementary strand  
 
The duplex formed with ON7 on the other hand showed a very nice dispersion of its signals 
so it was chosen for the further studies. 
 
2.2.2 Sample preparation 
 
Modified phosphoramidites 79a and 79b were synthesized and incorporated with various 
efficiencies (Table 1). Manual couplings were used for the modified phosporamidites since 
they allow using different activators and allow control of all synthesis parameters.  Sometimes 
the amidite concentration needs to be adjusted as well as the coupling time.  All natural 
nucleosides were incorporated under standard conditions. 
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Figure 30: Structure of the phosphoramidites of 1a respectively 1b 
For the manual couplings 200 µl 0.05 M phosphoramidite solution was activated with 300 µl 
0.5 M pyridinium hydrochloride solution before injection on the column.  This solution was 
injected in small quantities during the coupling time.  Drying the phosphoramidites over 3Å 
molecular sieves enhanced the coupling efficiency as the activated phosphoramidite 
hydrolyzes very fast in the presence of water.  Not all oligonucleotides were synthesized in 
the same lab and with the same batch of phosphoramidite and therefore not all values are 
comparable. 
 
79a    
scale (µmol) additives coupling time (min) coupling yield (%) 
0.2 none 15 90 
0.2 molecular sieves 3Å 10 95 
1 molecular sieves 3Å 10 95 
    
79b    
0.2 none 20 10 
0.2 molecular sieves 3Å 15 17 
0.2 none 20 50 
1 molecular sieves 3Å 10 22 
Table 1: Conditions for synthesis of oligonucleotides modified with 79a and 79b 
Coupling yield was analyzed by collecting the DMT cation after deprotection and analyzing 
the concentration of the deprotection solution.  The poor coupling yields of 79b can be 
explained by the presence of a bulky amide group pointing towards the phosphoramidite, 
thereby hampering attack of the 5’-alcohol of the previous base. 
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After deprotection overnight in aqueous ammonia, the oligonucleotide was precipitated by 
adding 100 µl 3 M sodium acetate and 600 µl ice cold ethanol (-20°C) to the oligonucleotide 
which is dissolved in 50 µl water.  This solution was stored in the freezer for at least 2 hours 
(overnight is standard) before the oligonucleotide could be collected by centrifugation of the 
precipitate.  This was preferably done at low temperature.  The solute was removed and 
depending on the desired purity and further purification procedures this was repeated.  This 
removes most of the salts from the ammonia-deprotection.   
 
 
Figure 31: HPLC profile of a crude oligonucleotide, before purification (above) and after one purification 
with ultracentrifugation filter (below) 
For NMR analysis, the salt concentration is very important as high salt concentrations can 
induce structural changes such as transition from B to Z-type DNA and cause line broadening.  
Therefore the sample needs to be desalted prior to use.  Salt can be removed by 
ultracentrifugation on a size exclusion filter (Pall Microsep 1kDa).  The membrane of the 
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filter allows all molecules with a molecular weight below a certain limit (3 kDa) to pass while 
all larger molecules can be collected on top of the membrane.  During the concentration, the 
counter ions shielding the phosphodiester backbone are also rinsed away.  This renders the 
solution slightly acidic so precautions must be taken for acid labile compounds (see 2.3).  A 
further advantage of these filters is that they remove deletion sequences with MW < 3 kDa 
(~11-mers).  So, all capped oligonucleotide sequences with a molecular weight below the cut 
off will be removed from the solution.  RP-HPLC-profiles before and after (Figure 31) show 
that this is the method of preference since impurities disappear and the recovery rate is 
consistently above 80 % which is more than what in general can be recovered with RP-HPLC-
purification.  The concentrated, desalted modified strand was collected, evaporated and 
diluted into a known volume (in general 500 µl) in order to prepare a stock solution.  The 
final concentration of the oligonucleotide was measured according to the nearest neighbouring 
method.122  For calculation of ε, and subsequently the concentration, for the modified duplex, 
the modified uridine residue was replaced with a thymidine.  A UV spectrum was recorded 
between 300 and 200 nm.  The absorption at 260 nm was used for calculation of the 
oligonucleotide concentration.  The maximum should be between 255 and 265 for single 
strands and duplexes.   
 
In order to cross-link the modified strand with its complement, the strands were mixed in 
equimolar amounts and diluted to 20 µM. The solution was buffered at pH 6.8 with 10 mM 
sodium phosphate buffer containing 100 mM sodium chloride.  This mixture was stirred at 
room temperature.  N-bromosuccinimide was added in portions, one equivalent every 15 
minutes, up to four equivalents.  After addition of the 4th equivalent, the reaction was stirred 
for another 15 minutes before it reached completion.  The workup of the reaction consisted of 
concentrating the mixture with an ultracentrifugation device.  This eliminates excess NBS and 
allows introduction of a new buffer.  A buffer is always used for this purification since the 
imine, which is presumably formed during the cross-linking reaction, is acid labile.  As the 
sample is desalted, often the solution has an acidic pH afterwards.  For the NMR sample, 
deuterated phosphate buffer (10 mM, pH 6.8) was used to rinse the cross-linked duplex. 
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2.2.3 NMR analysis of the native and modified duplex 
 
It was shown above that the duplex derived from ON7 (ON7+ON2) was suitable for further 
NMR study (see 2.2.1).  Based on this knowledge the modified duplex ON1+ON2 was 
designed and synthesized.  The numbering of both duplexes is shown below  
 
Duplex ON7+ON2 ON7 5’-C1  T2   G3 A4 C5 G6 G7 U8 G9 T10G11C12-3’ 
 ON2 3’-G24A23C22T21G20C19C18A17C16A15C14G13-5’ 
  
Duplex ON1+ON2 ON1 5’-C1  T2   G3 A4 C5 G6 G7 1a8 G9 T10G11C12-3’ 
ON2 3’-G24A23C22T21G20C19C18A17C16A15C14G13-5’ 
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Figure 32: NOESY recorded at 25°C of the non-modified duplex ON7+ON2 in D2O. Left: Method for 
serial inter-residue connection on the basis of NOESY-spectra 
NOESY and TOCSY spectra were recorded in deuterated water (with 10 mM phosphate 
buffer pH 6.8 and 100 mM NaCl) before the sample was concentrated and diluted to a 10 % 
D2O / 90 % H2O mixture (same buffer and salt conditions, more details see Materials and 
Methods paragraph 8.1.2) for recording spectra to assign the exchangeable protons with 
similar 2D experiments with water suppression using WATERGATE.123 
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A thorough investigation of the effect of the cross-link upon the duplex structure requires a 
duplex with little dynamics.  As can be seen from Figure 32, a detail of the NOESY spectrum 
of the non-modified duplex ON7 + ON2, there is little overlap in the spectrum so this 
sequence could be analyzed completely.  In this type of spectrum cross-peaks appear where 
two protons are close to each other in space (below 5Å).  This way different parts of a large 
molecule or even of different molecules can be interconnected. 
 
Figure 32 represents a zoom of the region where the NOE-signals from the (aromatic) base 
region to the sugar H1’ position appear.  This is generally considered to be one of the 
fingerprint regions of nucleic acids because it allows connecting the different residues within 
one strand.  As shown in Figure 32 (left) this region shows the NOE-cross-peaks between the 
aromatic proton of a residue (H6 or H8) with its own H1’ proton (e.g. C22H1’-H6).  This H1’ 
proton also gives rise to a NOE-cross-peak to the aromatic proton of the 3’-neighbouring 
nucleotide (e.g. C22H1’-A23H8).  This way one can rapidly identify the aromatic and H1’ 
proton signals identity, if the oligonucleotide sequence is known.  These assignments form the 
basis for assigning the remainder of each nucleotide.  In the case of ON7+ON2 the 
assignment is very straightforward.  All residues can be assigned and all connectivities with 
neighbouring residues are visible.  The only exception is the intra-strand connectivity between 
residue 6 and 7 for which no NOE-cross-peak is present. 
 
When we compare Figure 32 to a NOESY of the arabinose modified sample ON1 + ON2 at 
25°C it becomes immediately clear that the lines are very broad and that there is a lot of 
dynamics in the sample (data not shown).  Upon lowering the temperature to 5°C, the 
NOESY spectrum (Figure 33) has improved but due to spectral overlap no full assignment is 
possible.  Because of this overlap integration of the NOE-cross-peak intensities, to extract 
interproton distances that can be used as input for molecular modeling of the duplex structure, 
is impossible.  Given this, no attempt was made to obtain such an NMR based model for the 
non-modified duplex ON7+ON2 either.  The comparative analysis for both modified and 
unmodified duplexes will be limited to comparison of their chemical shifts.  Relative changes 
in chemical shifts will tell us more about the structural perturbations upon cross-link 
incorporation.   
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Figure 33: NOESY of duplex ON1+ON2, standard conditions 500MHz, 5°C in D2O 
 
Both modified duplex ON7+ON2 and non-modified duplex ON1+ON2 show similar 
chemical shifts and NOE-connectivities for the ends of the duplex (Figure 34).  This indicates 
that effect of the cross-linker is only local.  For the aromatic protons located on residues less 
than two nucleotides from the modification, differences appear.   
 
Figure 34: Absolute values of the differences in chemical shift (∆δ) of the aromatic protons (H6 for T and 
C, H8 for G and A) between ON7+ON2 and ON1+ON2 in ppm.  Black values are deviations in nucleotides 
1-12, red values are deviations in nucleotides 13-24.  When no value is indicated the corresponding 
resonance could not be assigned in one of the duplexes. 
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There is a discontinuity in the assignment in the region of the cross-link; the residues adjacent 
to the modified cross-link residue could not all be assigned.  The resonances of the bases of 
the opposite strand can be assigned but there is a significant chemical shift change in residue 
A17.  This indicates that there is a big environmental change for this residue, but from this 
shift difference alone it is not possible to say that there is a cross-link to this residue.  The 
complete assignment tables can be found in the Materials and Methods section 8.1.4.   
 
Figure 35: TOCSY of duplex ON1+ON2 recorded at 25°C in 10 mM phosphate buffer, no salt, 700 MHz 
 
In the TOCSY spectrum recorded at 25°C without salt, there were two signals in the aromatic 
region who’s resonances were not giving rise to other TOCSY-cross-peaks (Figure 35, A and 
B).  Since the cross-linker is conjugated with a base of the complementary strand, the protons 
on the conjugated part of the linker should have chemical shifts comparable to the resonances 
of the bases.  These resonances were fulfilling this prerequisite, but in TOCSY experiments 
there is still a possibility that these cross-peaks are not indicative of a scalar coupling 
network, but arise due to chemical exchange between two conformations, that is slow on the 
NMR time scale.  Which of these possibilities prevails was determined by recording a 
ROESY (WATERGATE-ROESY in H2O) spectrum.  Here, cross-peaks either arise through 
A 
B 
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the NOE effect or via chemical exchange.  Importantly, the latter have the same sign as the 
diagonal peaks and are opposite in sign to the NOE cross-peaks.  
 
Figure 36: WATERGATE-ROESY of duplexON1+ON2 recorded at 25°C in D2O with 10 mM phosphate 
buffer, no salt, 700MHz. 
The WATERGATE-ROESY recorded at 25°C at 700 MHz (Figure 36) shows cross-peaks at 
the same frequency positions as in the TOCSY spectrum.  However they have the same sign 
as the diagonal (color: orange to blue for higher intensity), unambiguously demonstrating that 
they are exchange cross-peaks.  This means that the protons that are connected by these 
signals are related via slow conformational exchange. 
 
This is explained more in depth with the help of Figure 37.  Here the identity of the putative 
cross-link is represented schematically, as its presence and structure cannot be established 
with absolute certainty.  In both conformations, protons Ha and Hb have different chemical 
shifts.  As a result Ha and Hb each contribute two diagonal peaks in the ROESY spectrum.  
Due to slow conformational exchange (with an exchange time in the ms to s regime), 
magnetization that started on Ha in conformation A can be observed in conformation B, 
leading to a cross-peak at frequency coordinates linking both diagonal peaks contributed for 
Ha by each conformation.  If this exchange were to be fast on the NMR time scale, Ha would 
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contribute a single resonance at a position determined by the weighed average of the chemical 
shifts in the two different conformations.  In this case no exchange cross-peaks can be 
observed (Figure 37). 
 
 
Figure 37: Schematic overview of the ROESY cross-peaks resulting of proton Ha under slow and fast 
exchange 
If the duplex is dissolved in buffer containing 100 mM NaCl these exchange cross-peaks 
disappear.  This implies that one of the conformations adopted by the duplex is probably 
stabilized by the salt so that only conformation A or conformation B is present (Figure 37). 
 
Alternatively, the exchange rate is significantly enhanced, leading to a fast exchange situation.  
In any case, we can conclude that this cross-link induces structural changes to its 
neighbouring base pairs and causes a lot of dynamics inside the duplex.  The main questions 
concerning the exact structure and position of the cross-link remained unanswered. 
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2.3 Further analysis of the cross-link 
 
In the RP-HPLC chromatograms of the cross-link reaction between ON1 and ON2 only one 
new peak could be detected.  As it was not confirmed by NMR whether the cross-link is to the 
complementary adenosine, to one of the neighbouring cytidines or a mixture of these, the 
cross-linked duplex was also analyzed by gel electrophoresis.  A 13 % polyacrylamide gel 
under denaturing conditions showed that initially two species were formed for both the 
arabino- and the ribo- modified cross-linker (Figure 38 A).  The left lane represents the 
arabinose (1a) modified duplex while the right lane represents the ribose (1b) modified 
duplex in both gels.  Five months later the same samples were again subjected to gel-
electrophoresis (Figure 38 B).  Whereas in Figure 38A for lane A two main bands can be 
distinguished at the duplex level, Figure 38B clearly shows three main bands at the duplex 
level both in lane 1a and 1b.  This indicated that cross-linking is reversible and several 
different species can be formed. 
 
5'
C1  
T2   
G3 
A4 
C5 
G6 
G7 
8(1)
G9 
T10
G11
C12
3'
3'
G24
A23
C22
T21
G20
C19
C18
A17
C16
A15
C14
G13
5'                        
Figure 38: Possible position of cross-link formation. A: denaturing PAGE immediately after cross-linking, 
B: denaturing PAGE 5 months after cross-linking. Both gels: left lane: cross-link with 1a, right lane: 
cross-link with 1b 
With this in mind one can start hypothesizing about the nature of the cross-link.  There are 
four possible places where nucleophiles can attack on the 4-oxo-enal derivative (Figure 39).  
The nucleophiles in this case are the endo- and exocyclic nitrogens of the complementary 
bases.  Position 1 and 2 are susceptible to Michael addition but as the aldehyde is more 
reactive these possibilities can be ruled out.   
 
1a        1b  1a       1b 
Single strands 
Cross-linked duplex 
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NH
O
ON
O
O
O
NH
O
O O
1 2
3
4
77  
Figure 39: Possible sites susceptible for attack of nucleophiles 
Addition to position 3 and 4 would lead to initial hemi-aminal formation which can dehydrate 
to form a more stable imine.  The reaction in this case would be reversible.  Addition to 
position 3 is more likely as this is an aldehyde which is more reactive towards nucleophilic 
addition compared to the ketone in position 4 and it is in closer proximity to potential 
nucleophiles in the complementary strand. 
 
N3
N
NH2
O
OO
R
N
N
HN
O
R
O
OH
N
N
N
O
R
O
OH
N
N
N
O
R
OH
O
imine formation
Michael addition
N
N
N
O
R
O
Mass difference: 18
R'
R'
R'
R'
R'
MW = ON6 oxidized(=+18) + ON7
MW = ON6 + ON7
80 82 83
81  
Scheme 15: Different pathways for cross-link formation with 1, R is the remainder of the complementary 
strand, R’ is the remainder of the modified strand. 
In the literature it was found that a second reaction pathway, next to imine formation, could 
take place involving the aldehyde resulting from furan oxidation and a nucleobase.  Addition 
of the exocyclic amine onto the reactive enal leads to a hemi-aminal.  Subsequent attack of N3 
of dC in a Michael addition pathway would lead to an acid stable product (Scheme 15).124  
These two reaction modes are easily distinguished as the first is acid labile and the second not.  
Acid induced degradation would prove the presence of an imine, if no degradation takes place 
the second pathway is followed. 
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In a MALDI-TOF analysis, the product is mixed with an acidic matrix in order to protonate 
the negatively charged backbone.  The pKa of 3-hydroxypicolinic acid is sub-zero125 which 
should be strong enough to cleave potential imine bonds but leave the Michael addition 
product intact.  Further evidence for any of the two reaction pathways can be found in the 
mass difference of the formed products.  Upon imine formation the molecule loses water 
leading to a molecular weight difference of 18 while the subsequent Michael addition 
pathway delivers a product which is the sum of the masses of the two complementary 
oligonucleotides. 
 
Inspection of the MALDI-TOF spectra shows that there is no species with a mass 
corresponding to the sum of the two duplex strands.  Only the mass of the complementary 
strand is retrieved together with unidentified peaks which probably correspond to degradation 
products of the modified strand.   
 
ON1 5'-CTGACGG1aGTGC-3', MW 3798.6, MW oxidized 3814.6
ON2 3'-GACTGCCA CACG-5', MW 3613.6
Duplex ON1+ON2
 
 
Figure 40: MALDI-TOF spectrum of the reduced cross-linked sample 
Imines can be reduced with sodium cyanoborohydride, even in cross-linked 
oligonucleotides.126  Treatment of a sample with the reductans for three hours reveals a new 
RP-HPLC peak.  Subjecting the complete sample to MALDI-TOF analysis shows this time a 
signal for which the mass corresponds to cross-linked duplex formed by reductive amination 
between the oxidized furan and one of the amines in the complementary strand (Figure 40, 
MW = ON1 + ON2 + 2). 
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Since a full NMR structural analysis of the duplex could not be obtained, molecular 
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3 Second generation furan modified oligonucleotides 
3.1 Nucleoside analogues: Why? 
 
In the past a tremendous amount of work has been invested in synthesizing new nucleoside 
analogues.128  Modification of the basic nucleic acid structure can enhance properties that are 
already present in DNA or it can induce new properties.  With the advent of biotechnology 
and biochemistry such new properties can imply a real revolution.  Applications of nucleoside 
analogues can be divided into four categories: 
 
3.1.1 Antiviral properties: 
 
As the metabolic processes by which DNA is processed in vivo became more understood, 
chemists started synthesizing analogues of nucleosides with the expectation that they might 
interfere with these natural pathways and hence have an application as drugs.  Most of the 
nucleosides synthesized for these applications carry substituents on a natural nucleoside 
skeleton.129  Some do have antiviral, anticancer or antibacterial activity and are currently used 
as treatment thereof. 
 
3.1.2 Chemical ethiology: 
 
Chemical ethiology of nucleic acid structure refers to the systematic experimental studies 
aimed at narrowing the diversity of possible answers to the question of why nature chose the 
structure type of ribofuranosyl nucleic acids, rather than some other family of molecular 
structures, as the molecular basis of life’s genetic system.130  To answer this question artificial 
oligonucleotides have to be synthesized and compared with natural nucleic acids with respect 
to those chemical properties that are fundamental to the biological function of DNA and 
RNA.  These functions include the potential for informational base pairing in the Watson-
Crick mode, the capacity for self replication and the capacity to express a chemical 
phenotype.  Analogues that were synthesized for this type of studies include homo-DNA 
(84)131, threofuranosyl nucleic acid (TNA, 85)132 and glycol nucleic acid (GNA, 86) (Figure 
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45).133  All of these modify the sugar part of the oligonucleotides as the Watson-Crick base 
pairing must be conserved. 
 
O
O
Base
O
P
O
O OH
O
O
BaseO
P
O
O OH
84 85
BaseO
O
H
P
O
O OH
86  
Figure 45: Structure of homo-DNA (84), TNA (85) and S-GNA (86) 
In a next phase of this research the question rises how our genetic system will evolve in the 
future.  This question has lead to a quest for designing a third base pair to expand the genetic 
alphabet.  It has been shown that the hydrogen bonds can be altered134 or removed135 without 
complete loss of stability or polymerase recognition.  Therefore efforts have predominantly 
focused on synthesizing hydrophobic nucleobase analogues.136 
 
3.1.3 Antigene/Antisense 
Antigene and antisense strategies are described into more detail in paragraph 1.2.2 and 1.2.3.  
In order to circumvent the problems associated with antigene and antisense strategies, such as 
nuclease resistance and cell permeability, modified nucleoside analogues were introduced, 
often resulting in higher structural complexity as can be seen in Figure 46.  Most prominent 
families in this class are locked nucleic acid (LNA, 5)137, hexitol nucleic acid (HNA, 87)131 
and bicyclo-DNA (88).138 
 
O
 
Figure 46: Structure of locked nucleic acid (5), hexitol nucleic acid (87) and bicyclo-DNA (88) 
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3.1.4 Supramolecular/biological chemistry 
 
This category groups different types of modifications ranging from modifications aimed at 
stabilizing or inducing certain biological structures139 to modifications for applications in 
nanostructures.140  Modifications have been introduced both in the sugar and in the base part. 
 
3.2 Acyclic nucleoside building blocks 
 
As we considered designing and synthesizing a simpler acyclic furan containing building 
block, an overview was made of the state of the art in acyclic nucleosides.  In terms of 
synthesizing a simple furan containing nucleoside, acyclic nucleoside mimics offer an 
attractive solution.  It is known that introducing an acyclic nucleotide in a duplex results in a 
destabilization because the loss of entropy for going from two single oligonucleotides to a 
duplex is larger in a system containing flexible nucleosides than in one containing the natural 
nucleotides.141  This of course would be largely compensated for upon cross-link formation.  
Still it is very important to make a well studied choice as some acyclic nucleoside analogues 
might cause too much destabilization to allow duplex formation.   
 
A major advantage is that acyclic nucleoside analogues are often easily synthesized with high 
atom economy.  Furthermore it is also proven that acyclic nucleosides are resistant to 
nucleases,142 which is a major advantage when considering therapeutic applications.   
 
3.2.1 Flexible nucleic acids (FNA) 
 
Ring open nucleoside analogue 89 and its dinucleotides were already synthesized in 1980 as 
deaminease substrates.143  The oligonucleotides consisting of these nucleotides, termed 
flexible nucleic acids (FNA), were introduced by the group of Benner.141  They reasoned that 
removal of C2 from the ribose sugar would result in an isosteric analogue that can be easily 
synthesized from glycerol (Figure 47).  Their experiments showed a destabilization of 9 to 15 
°C per modified nucleotide in an oligonucleotide duplex.  
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Natural DNA 89  
Figure 47: Structure of natural deoxycytidine and flexible nucleic acid cytosine 
 
3.2.2  (S)-9-(3,4-dihydroxybutyl)adenine 
 
In their search for new antisense constructs, the Herdewijn group reported on (S)-9-(3,4-
dihydroxybutyl)adenine (90).144  Although the nucleoside itself was already reported in the 
early 70’s,145 the incorporation into oligonucleotides was not carried out before 1991.  These 
modifications were incorporated by H-phosphonate chemistry as the phosphoramidites were 
relatively unstable.  The main problem during the oligonucleotide synthesis was that upon 
deprotection of the DMT-group elimination occurred (Figure 48).146 
 
Base
O
O
O
P
O
R O
Base
HO
O
O
N
NN
N
NH2
90 Elimination reaction
O
O
N
NN
N
NH2
X
O
X
91 X=H or oligonucleotide chain
3' 2'4'
 
Figure 48: Structure of butyl-nucleosides and the elimination reaction which is responsable for the low 
yields in DNA synthesis  
The properties of this acyclic derivative are quite interesting as there is only little or no effect 
on the thermodynamic properties and the melting temperature, even when incorporated in the 
middle of a duplex.  The measured decrease in melting temperature was 3 °C per 
modification.  Incorporation of 90 also exhibited the nuclease resistance which is common for 
acyclic nucleosides.  Interesting to note here is that the backbone is shortened with one carbon 
atom compared to natural nucleosides thereby limiting the number of torsion angles. 
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Similar to this approach, the “ribose”-form of this nucleoside, (S)-9-(2,3,4-
trihydroxybutyl)adenine, was also incorporated (Figure 48, 91).147  Because of the presence of 
three hydroxyl groups, attachment from 4’3’ and from 4’2’ were evaluated.  
Incorporation in the middle of a duplex resulted in a destabilization of 5 °C with DNA as 
complement whereas with RNA as complement only a minor decrease in melting temperature 
was observed (up to -1.7 °C). 
 
3.2.3 3(S)-5-dihydroxypentyl- and 4(R)-methoxy-3(S)-5-dyhydroxypentyl 
nucleosides 
 
In order to avoid the elimination reaction discussed for the previous nucleoside an extra 
carbon atom was introduced into the backbone.146  This corresponds to elimination of the 
oxygen from the sugar moiety of a natural nucleoside in the case of 3(S)-5-dihydroxypentyl 
(92) and eliminating the bond between C1 and the oxygen in case of 4(R)-methoxy-3(S),5-
dyhydroxypentyl (93) (Figure 49).  Replacement of one nucleoside by its acyclic analogue 
resulted in a decrease in melting temperature of 6 °C for one modification in the middle of the 
duplex. 
O
O
Base
92 93
O
O
Base
OMe
 
Figure 49: Structure of pentyl-nucleosides 
It was suggested that acyclic nucleosides could be advantageous for use as universal 
nucleosides.  This was explained by the fact that the increased flexibility allows better 
positioning to maximize stabilization by the hydrogen bonds. 
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3.2.4 (R)- and (S)-3’,4’-seco-thymidine 
 
When removing the bond between C3 and C4 of a deoxyribose sugar, the obtained system is 
called 3’,4’-seco-DNA (Figure 50, 94).148   
O
O
O
N
NH
O
O
94  
Figure 50: Structure of seco-thymidine 
The hybridization properties of these nucleosides inside a DNA duplex were relatively poor, a 
decrease of approximately 10 °C for one modification was observed.  When incorporated at 
the 3’-end of an oligonucleotide, seco-units efficiently protected the oligonucleotide against 
exonuclease III degradation. 
 
3.2.5 Peptide nucleic acids 
 
Peptide nucleic acids (PNA, 95) are pseudopeptides with pendant nucleobases (Figure 51).  
They were introduced in 1991 by Peter Nielsen.149  They show excellent sequence 
discrimination and bind very tightly to DNA.  They were also shown to have the ability to 
invade duplexes.  This is attributed to the absence of negative charges in the backbone 
compared to normal DNA.  Of all acyclic oligonucleotide analogues they are the most studied 
due to their extraordinary properties.  Antisense effects of PNA were shown to work in mice 
but the pharmacokinetic profile of PNA is not very favourable for in vivo activity. 
 
 
Figure 51: structure of peptide nucleic acids 
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3.2.6 (N-thymin-1-ylacetyl)-1-arylserinol nucleosides 
 
Inspired by chloramphenicol (Figure 52, 96), a broad spectrum antibiotic, a series of 
nucleoside derivatives was synthesized by the group of Ganesh.150  They reasoned that the 
reduced solubility of PNA could be increased by maintaining the phosphodiester backbone.  
The result can be seen in Figure 52.  The aromatic substituent in the backbone was thought to 
restrict conformational flexibility of the acyclic chain. 
* N
H
*
O
O
PHO O
O
O
HN
N
O
O
Ar
97
OH
N
H
Cl Cl
O
N+
-O
O
OH
96  
Figure 52: Structure of the antibiotic chloramphenicol and its derived nucleoside 
Upon incorporation in the middle of a duplex, one modification caused a destabilization of 
9 °C.  At the termini these modifications were less destabilizing.  It was proven by CD that 
base stacking is not altered because of the acyclic backbone. 
 
3.2.7 Glycol nucleic acid (GNA) 
 
One of the most discussed acyclic nucleoside analogues of the last years is glycol nucleic acid 
(GNA, 86).  Upon removal of the CH2O-group of Eschenmoser’s TNA (85) a simple glycol 
nucleic acid can be obtained by a very short synthesis.  GNA will be discussed in more detail 
later. 
 
Figure 53: Structure of glycol nucleic acids 
Earlier this backbone had already proven its use in oligonucleotides.  Intercalating nucleic 
acids (INA, 98) were synthesized for stabilisation of duplex structures.151  Also there, the ease 
of synthesis of this type of derivatives was seen as a major advantage. 
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3.3 New furan-modified oligonucleotides 
 
In view of the short and efficient routes developed for some of the acyclic building blocks, we 
decided to introduce a furan moiety in one of the systems discussed above. 
 
3.3.1 Proposed structures for the second generation nucleoside 
analogues 
 
From all acyclic analogues that were considered PNA is probably the most interesting 
candidate for furan attachment, but as the synthesis of PNA-oligomers requires specific 
equipment and expertise this was not considered.  The second most promising analogue is 
(S)-9-(3,4-dihydroxybutyl)adenine as this is the least DNA destabilizing modification.  The 
furan unit would be used as base-replacement.  Therefore nucleoside 2 was proposed. 
 
O
HO
HO
2
O
O
HO
HO
3  
Figure 54: Structure of the proposed nucleoside analogues 
In order to increase stability through enhanced stacking, an extra phenyl unit would be 
desirable.  A recent method for introduction of a phenyl unit on an acyclic backbone was 
published by Fillichev et al..152  They took the glycol nucleic acid backbone133 and modified it 
with bromobenzyliodide.  This was incorporated into a duplex and the iodide was substituted 
through Sonogashira coupling.  The versatility and simplicity of this approach inspired us for 
coupling a furan unit to the benzene unit resulting in (R)-3-(4-furan-2-yl-benzoyloxy)-
propane-1,2-diol 3.   
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3.3.2 Nucleoside analogue 1: 2-(S)-4-Furan-2-yl-butane-1,2-diol 
A. Modeling 
 
Before synthesizing a modification in the lab it is always usefull to see what the effect of a 
modification on a duplex is in silico.   
 
Figure 55: Frame of MD simulation with modification 2 (2 depicted in yellow) 
Previous modeling studies (see paragraph 2.4) suggested that cross-linking with modification 
1 was not selective because of its mobility in the major groove.  As suggested there, keeping 
the furan unit stacked inside the duplex could increase selectivity.  Modeling studies of the 
reference duplex incorporating nucleoside 2 show in MD simulations of 1 ns that the furan 
unit is indeed stacking inside the DNA duplex during the simulation.  A frame of the 
simulation is shown in Figure 55.  Modified residue 2 is depicted in yellow. 
 
Duplex ON8+ON5 ON8 5’-CTG ACG G2G TGC-3’ 
ON2 3’-GAC TGC CAC ACG-5’ 
 
At the beginning of the simulation the furan unit is not stacking inside the helix, but during 
the simulation it moves into stack for a part of the time.  This result is surprising as the furan 
moiety is only a small aromatic ring.   
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B. Retrosynthesis 
 
The retrosynthesis of key intermediate 99 is outlined in Scheme 16.  There are two convenient 
routes towards this intermediate, one via a Wittig strategy (route A) and a second which 
involves only SN2 substitutions (route B). 
O
O
O
O
O
O
O
O
O Br
O
O
O
O
Ph3P
O
O
O
OH
HO
O
O OH
E/Z
99
Br
100
101 102
103 104
105 51
106
Route A Route B
O
HO
HO
2
 
Scheme 16: Retrosynthesis of nucleoside 2 
The Wittig strategy starts from (S)-solketal 103 and furfuryl-alcohol 104, both commercially 
available.  (S)-solketal can be oxidized by chrome (VI) oxidation to the corresponding (S)-2,3-
(O-isopropylidene)-glyceraldehyde 101.153  This can be coupled via a Wittig reaction with 
furfuryltriphenylphosphonium bromide 102, which is easily accessible by bromination of 
furfuryl alcohol followed by substitution of the bromide by a triphenylphosphonium group.154  
This reaction would yield a mixture of E/Z 4-(2-Furan-2-yl-vinyl)-2,2-dimethyl-
(1,3)dioxolane (100). Both forms can be reduced with a simple reduction with Palladium on 
activated carbon. 
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The second strategy starts from the commercially available (S)-(+)-3,4-O-
isopropylidenedioxybutan-1-ol (106).  Tosylation of the alcohol followed by bromination 
yields a secondary bromine (105) that can be easily substituted with lithiated furan to yield 
compound 2 after deprotection. 
 
C. Synthesis of nucleoside building block 1: 
C.1 Route A 
 
We started out with this procedure because the rigidity of the non-hydrogenated compounds 
could provide us two extra interesting building blocks for incorporation in duplexes.  In this 
way the influence of the double bond on the stability of the duplex and on the selectivity of 
the cross-linking reactions can be studied.  The synthesis is outlined in Scheme 17.   
O
O
OH
O
O
O
(a)
O
O
O
(a) PCC (2 eq), CH2Cl2, 0°C to rt, 20 h. (b) 102 (1 eq), BuLi 0.95 eq, THF, -78°C than -
20°C followed by 0°C, 2.5 h, 14% over 2 steps
(b)
100101103
 
Scheme 17: Synthesis according to the Wittig-strategy 
The most common literature procedure for oxidation of solketal uses pyridinium 
chlorochromate (Cr VI) as oxidant.153  NaOAc can be added to the reaction mixture to 
neutralize possible present traces acid.  Molecular sieves can also be added as they are slightly 
basic and also capture traces water.  Molecular sieves are further known to enhance the 
velocity of the reaction, the highest increase in reaction rate is observed for 3Å molecular 
sieves.155  A problem related to 101 is its volatility which increases the risk of losing large 
quantities while evaporating.  It is equally known to polymerize, racemize and form 
hydrates.156 
 
Scheme 18: Synthesis of furfuryltriphenylphosphonium bromide 
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Furfuryltriphenylphosphonium bromide 102 could be synthesized more successfully.  Starting 
with furfuryl alcohol 104, reaction with phosphorus tribromide yields furfuryl bromide 107.154  
Triphenylphosphine was next added and the mixture was refluxed.  This resulted in 
furfuryltriphenylphosphonium bromide (102) crystals upon cooling the reaction mixture.  The 
compound could be used in the next reaction step without purification. 
 
The first step in the Wittig reaction itself is the in-situ generation of the phosphorylid.  This 
was carried out by deprotonating the furfuryltriphenylphosphonium bromide with 
n-buthyllitium which resulted in a bright orange product.  Aldehyde 101 was added and after 
purification compound 100 was obtained in 14 % yield.  In spite of repeating the reaction 
several times no better yields were obtained.  This repeated low yield was ascribed to the low 
purity of the aldehyde.  We therefore decided to abandon this route. 
 
C.2 Route B 
 
O
O
O
O
O
O
OOH OTs
O
O Br
(a) pTsCl (1.15 eq), pyridine, rt, 2.5 h, 91 %. (b) LiBr (5 eq), DMF, 60°C, 1 h. 
(c) furan (2 eq), BuLi (1.8 eq), -78°C, 15 min, 2 h at rt, than bromide overnight, 
rt, 62% over 2 steps.
(a) (b)
(c)
106 105
99
108
 
Scheme 19: Synthesis of 4-(2-Furan-2-yl-ethyl)-2,2-dimethyl-[1,3]dioxolane (99) 
The second strategy started from (S)-(+)-3,4-O-isopropylidenedioxybutan-1-ol (106) which is 
commercially available.  It could be easily tosylated in pyridine and no further purification is 
necessary.  As the literature procedures all describe halogen substitution, the tosylate 108 was 
not directly substituted.157,158,159,160   
 
We chose bromide 105 as halogenated intermediate.  The bromide itself was quite volatile (bp 
96-100 °C at 26mm Hg), therefore care should be taken during solvent removal.  The 
bromination reaction was purified by flash chromatography.  In order to get the bromide as 
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dry as possible a co-evaporation with tetrahydrofuran (azeotrope boils at 65°C with 5 % water 
and 95 % THF) was performed three times.   
 
Two equivalents of furyllithium were used in the reaction to ensure complete conversion of 
the bromide.  Furyllithium was prepared by deprotonating furan with n-butyllithium.  At low 
temperatures this forms a white precipitate which disappears when heating to room 
temperature.  After flash chromatography 99 was obtained in 56 % yield over three steps. 
 
C.3 Synthesis of the phosphoramidite 
 
O
O
O O
HO
HO O
DMTO
HO
ODMT
O
O
P
O
N CN
(a) HCl, THF, 0°C, 3h, 89%.(b) DMTCl, Pyridine, 0°C, 1.25h, 66%.(c) 
(iPr2N)(NCCH2CH2O)PCl, DIPEA,CH2Cl2, rt, 2h,79%
99 2 109
6
(a) (b)
(c)
 
Scheme 20: Synthesis of the phosphoramidite of 2 
Deprotection was performed according to different literature procedures, but attention had to 
be paid to the lability of the furan ring under strong acidic conditions.  Deprotection in 80 % 
acetic acid152 gave rise to side products that were difficult to separate and the yield of the 
reaction was not satisfactory.  We therefore opted for another procedure which uses 2 M 
hydrogen chloride in 50 % tetrahydrofuran.  Although at room temperature this led to furan 
degradation, no furan hydrolysis was observed at 0 °C. 
 
Subsequently, DMT protection of the primary alcohol in 2 had to be achieved. The main 
problem of this reaction is that a mixture of mono- and ditritylated compounds was always 
obtained.  The selectivity could be increased by working at lower temperature and using no 
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excess of dimethoxytritylchloride.  The reaction time was also decreased compared to the 
literature procedure to prevent di-dimethoxytritylation. 
 
By NMR-analysis it could be confirmed that the dimethoxytrityl group was positioned on the 
primary alcohol.  The 1H spectrum of 109 in deuterated chloroform shows a (broad) doublet 
signal for the remaining OH. This means that the alcohol hydrogen only couples to one 
hydrogen, confirming its identity as a secondary alcohol. 
 
Phosphoramidite 6 could be prepared by standard methods133 using β-cyanoethyl 
chlorophosphoramidite.  The DMT-protected nucleoside should be very dry since the 
phosphoramidite reagent hydrolyses fast in contact with humidity.  To prevent humidity from 
entering the reaction mixture, the reaction was prepared under argon atmosphere.  The 
reaction yields two diasereomers around phosphor in a one to one ratio.  This can be seen in 
the phosphorous spectrum as two peaks with the same intensity resonating around 150 ppm. 
 
C.4 Attempts for an alternative preparation of diol 2 
 
Because the synthesis of the bromide 105 (Scheme 19) is hampered by its volatility, an 
alternative strategy was investigated.  The volatility of the bromide can be reduced by 
changing the part that is not incorporated into the final skeleton, the protecting group of the 
diol.  Alternatives for this acetonide can be found in literature from the group of Ley.  They 
have developed a method which uses diacetals as 1,2-diol protecting groups.161  The highest 
reported yield with the building block needed for strategy 2 is obtained with phenantrene-
9,10-quinone (Figure 56, 110) which is reacted with catalytic amounts of camphorsulphonic 
acid and trimethylorthoformate under methanol reflux.162  The resulting phenantrene-9,10-
diacetals however are extremely difficult to deprotect.  Dissolving-metal reduction in liquid 
ammonia or protic acid catalyzed hydrolysis didn’t result in deprotection of the alcohols.   
 
 
Figure 56: Phenantrene-9,10-quinone 
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Alternatively it was proven that butane-2,3-dione was effective as protecting agent and 
deprotection could be achieved in high yields for certain alcohols with a mixture of TFA and 
water.  Depending on the catalyst used different types of adducts can be formed.  Scheme 21 
shows this for the R-isomer of the triol corresponding previously used (S)-(+)-3,4-O-
isopropylidenedioxybutan-1-ol 106.  With camphorsulphonic acid a bridged cyclic product is 
formed (113) while under acid catalyzed conditions with boron trifluoride etherate the alcohol 
on position 4 stays unprotected (Scheme 21).  These adducts have a higher molecular weight 
so most probably the volatility issues will be solved.  If this strategy would be used, 
optimization might be necessary for the deprotection step as 90% TFA in water might be too 
aggressive for the furan ring. 
 
HO
OH
OH
O
O
O
O OH
O
O
O
O
BF3.OEt2, CH(OMe)3
MeOH, reflux, 12 h, 64%
CSA, CH(OMe)3
MeOH, reflux, 12 h, 65%
111
112
113
 
Scheme 21: Protection scheme of 111 with different catalysts 
The other steps, tosylation followed by bromination remain unchanged as well as the 
substitution of the bromide with furyllithium.  The substitution of these derivates is not 
published so the optimized methods from the previous synthesis were used.  The complete 
synthesis is outlined in Scheme 22. 
HO
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O
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O
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Scheme 22: Alternative synthesis route to nucleoside 2 with different protecting groups 
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In our hands the protection step of the (S)-diol (ent-111) yields a lower conversion compared 
to the literature procedure for the (R)-diol although this step was not repeated.  Tosylation of 
the free alcohol gave only moderate yields compared to the previous synthesis route.  This 
step was repeated twice with similar yields.  The tosylate was smoothly converted to the 
bromide 115 and the latter could be substituted with furyllithium.  The yield of this last 
reaction step is with 27 % very low.  These two lower yields are likely due to the presence of 
the very sterically hindered sugar ring.  Overall, this synthesis route results in much lower 
yields and it requires an extra step starting from commercially products.  Therefore the 
synthesis was not scaled to larger quantities for the further reaction steps.   
 
D. Oligonucleotide synthesis and purification 
 
Building block 2 was then incorporated into oligonucleotide strands by automated DNA 
synthesis.  As phosporamidite 6 is an oil, it was dried in solution with molecular sieves.  4,5-
Dicyanoimidazole163 in acetonitrile, also dried over molecular sieves, was added as activator.  
The coupling of the modified nucleoside was performed manually with a prolonged coupling 
time of 10 minutes.  The coupling yields under these conditions were estimated to be more 
than 99 %.  Coupling to different bases did not result in observed differences in coupling 
efficiency.  DMT-groups were left on the terminal 5’ position in order to allow purification 
via sep-pak filtration. 
 
The synthesized sequences are shown in Table 2.  The sequence ON8 was chosen because it 
was already used in the study with the previous building block and the other sequences were 
chosen by changing each time the neighbours of the modification.  This would allow analysis 
of the selectivity in different contexts. 
 
label Sequence Calculated mass (Da) Measured [M+1] (m/z) 
ON8 5’-CTG ACG G2G TGC-3’ 3589.63 3589.44 
ON9 5’-CTG ACG C2C TGC-3’ 3509.54 3509.86 
ON10 5’-CTG ACG A2A TGC-3’ 3557.56 3557.53 
ON11 5’-CTG ACG T2T TGC-3’ 3539.62 3540.51 
Table 2: Sequences synthesized with nucleoside 2 for duplex cross-linking 
All oligonucleotides were cleaved from solid support by treatment with aqueous ammonia (28 
%) at 55 °C overnight.  The resulting solution was flushed over an activated C18 sep-pak 
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filter for three times.  Due to the apolarity of the DMT-group, all oligonucleotides bearing a 
DMT-group will be retained by the solid support but not the sequences with only terminal 
hydroxyl groups.   
 
A subsequent washing step with aqueous ammonia solution (2.5 %) removes protecting group 
waste and residual sequences with terminal free hydroxyl groups from the solid support.  This 
is followed by a rinsing step with water before the DMT-protecting group can be cleaved with 
a 1.5 % trifluoroacetic acid solution in water.  This is followed by a last washing step to 
neutralize the solid support and to remove the DMT cations before collecting the 
oligonucleotide with a 20 % acetonitrile solution in water. 
 
Purities of the oligonucleotides were checked and if necessary they were purified with RP-
HPLC.  The purification of ON11 is illustrated in Figure 57.  Often after sep-pak, minor 
impurities can still be present because the coupling yields during DNA synthesis are not 
100%.  These resulting shorter sequences can be easily separated from the target strand by 
HPLC (retention time 12.7 min).   
 
In the first experiments a Phenomenex Jupiter C18 300Å was used but this column has a 
limited lifetime as the large pores collapse due to the high pressure from the RP-HPLC.  
Phenomenex launched a new type of column in 2007 that was specially designed for 
separation of oligonucleotides and is called Clarity.  The support is made from TWIN, a 
composite silica support, with a C18 phase attached to it and the pore size is only 110Å.  In 
our hands it gives better separations compared to the Jupiter columns and it has a slightly 
longer lifetime. 
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Figure 57: Purification of ON11 on a Jupiter column: RP-HPLC spectrum after sep-pak (above) and  
RP-HPLC spectrum after RP-HPLC purification (below) 
Purifications of the synthesized oligonucleotides were carried out on an analytical column.  
For these purifications it is important to look not only at the most sensitive wavelength for the 
oligonucleotides (260 nm) but also to the less sensitive ones: certain RP-HPLC purifications 
are hampered by the presence of peaks eluting close to the desired product.  Sometimes the 
obtained resolution after optimalisation is not enough to obtain complete separation.  For 
example the zoom region of a preparative injection with poor separation is shown in Figure 
58.  It is of a modified 15-mer oligonucleotide that was not used during this PhD.  It reveals a 
large peak that saturates the detector completely, hence it is not possible to see if this is one or 
more products. 
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Figure 58: RP-HPLC spectrum recorded at 260 nm of a modified 15-mer oligonucleotide,  
preparative injection, approximately 0.5mg product 
This is however recorded at the most sensitive wavelength.  The detector is saturated but not 
the column.  In this case the amount of oligonucleotide is around 0.5 mg for a 250 x 4.6mm 
column.  There are two solutions to this problem: or the flow cell of the detector is changed to 
a larger one or the spectrum can be recorded at a different wavelength where the detection is 
less sensitive.  As an example the same HPLC-spectrum recorded at 310 nm reveals two very 
close eluting peaks that can be separated under these conditions, although not perfectly, 
whereas at 260 nm this was not possible.   
 
 
Figure 59: RP-HPLC spectrum recorded at 310 nm of a modified 15-mer oligonucleotide 
Changing the flow cell to a semi-preparative flow cell has the same effect, it reduces the 
intensity of the peaks but this time by taking only a fraction of the product flow that comes 
from the column. 
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After RP-HPLC purification, the oligonucleotides are ready for use.  The identity of the 
oligonucleotides was confirmed by mass-spectrometry, no conversion from the furan ring to a 
pyrrole was observed in contrast to certain examples in literature.164 
 
3.3.3 Nucleoside analogue 3: 2-(S)-3-(4-Furan-2-yl-benzyloxy)-propane-
1,2-diol 
A. Modeling 
 
As discussed before, the nucleoside analogue 3 was also considered.   The larger conjugated 
aromatic system should show a stronger stacking interaction with the neighbouring bases.  
This interaction is supposed to compensate part of the destabilisation caused by the acyclic 
backbone and the absence of hydrogen bonding.  Another interesting aspect of this building 
block is that the total linker length is longer than the first nucleoside.  With this modification 
it could be possible to extend the cross-link method to triplex cross-linking. 
 
 
Figure 60: Frame of a MD simulation with modified building block 3 (3 depicted in yellow) 
The second analogue that was proposed was also modeled in the same oligonucleotide 
sequence as previous modification.  Where the previous building block was only stacking 
inside the duplex for part of the simulation time, this modification moves in stack and does 
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not go out of stack thereafter.  It pushes the complementary adenine base away as can be seen 
in Figure 60 (modified building block depicted in yellow).  For this building block we 
therefore can expect even better selectivity than the previous one 
 
B. Retrosynthesis 
 
When looking at the target nucleoside building block, phosphoramidite 7, we see some 
evident disconnection possibilities.  The disconnections are shown in figure 1.   
 
In very few steps the skeleton of the molecule can be synthesized from three commercial 
products: (S)-solketal (103), 4-bromobenzylbromide (117) and furan, which is derivatized to 
furylzincchloride (118) in situ.  The final two steps needed to prepare the molecule for 
incorporation in oligonucleotides are dimethoxytrityl protection and synthesis of the 
phophoramidite.   
 
O
O
O
O
P
ON
N
O O
7  
Figure 61: Disconnections for synthesis of molecule 7 
The first step involves SN2 substitution of the benzylic bromide with solketal.  Subsequent 
Negishi cross-coupling of the aromatic bromide with furylzinc chloride completes the 
skeleton.  The last two steps are standard reactions published for similar compounds. 
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Br
O
O
ODMT
O
O
P
O
N
N
OH
O
O
Br
ZnCl
7
103
117
118
 
Figure 62: Retrosynthesis of molecule 7 
 
C. Synthesis of nucleoside building block 3 
 
The total synthesis is outlined in Scheme 23.  The first step involves an SN2 reaction where 
the free alcohol function of (S)-solketal attacks the benzylic bromide.  The formed water is 
removed from the solution by azeotropic distillation with toluene. 
CH2
O
O O
OH
Br
Br
O O
O
Br
DMTO
O O
O
O
DMTO
O
NC
+
R =
a b
c dHO e
103 117 119 120
 
Scheme 23: Synthesis of phosphoramidite 7 
The next step is a metal-catalyzed Negishi cross-coupling reaction.  The Negishi cross-
coupling was chosen because it gave the highest reported yield for furan cross-couplings.165  
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Alternatively a Suzuki cross-coupling could be performed with the very stable 2-furanboronic 
acid.  The first step involves the deprotonation of furan by BuLi.  Upon ZnCl2 addition the 
lithium is replaced by ZnCl.  This furylzincchloride is used in the reaction with formation of 
compound 120.  A large excess of furylzincchloride was used since equimolar amounts 
resulted in very low conversion which was attributed to the sensitivity of furylzincchloride to 
moisture.  
 
The first step in the catalytic cycle (Figure 63) involves an oxidative addition (Pd0 to Pd2+) 
where Palladium exchanges two ligands for the benzene ring on one side and the bromine on 
the other side.  In the subsequent transmetallation the bromide is replaced with a furan-group.  
This is followed by an isomerisation step so the two molecules to be coupled have the correct 
orientation for the reductive elimination (Pd2+ to Pd0) which releases the newly formed 
molecule. 
PdL4
[0]
Pd
L
L
Br119
O ZnCl
ZnClBr
transmetallation
oxidative addition
[II]
Pd
L
L
119
O[II]
cis/trans
isomerization
Pd
L
119
L
O[II]
O
O
O
O
reductive
elimination
120
PdL4
[0]
tetrakis(triphenylphosphine) Pd[P(C6H5)3]4
119
 
Figure 63: Reaction mechanism for the Negishi-cross-coupling 
In a next step the hydroxyl groups are deprotected in acidic medium in accordance with the 
synthesis of the previous building block.   
 
During the protection of the primary alcohol with dimethoxytrityl chloride a problem of 
regioselectivity is observed as there is only a small difference in reactivity between the 
primary and secondary alcohol.  This results in formation of doubly dimethoxytritylated 
product even when not all starting material is consumed.  The highest selectivity could be 
obtained with a slight excess of the diol at low temperature. 
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The final step is the synthesis of the phosphoramidite 7.  In the case of similar glycerol 
nucleic acid modifications the standard β-cyanoethyl chlorophosphoramidite does not result in 
formation of the phosphoramidite.166  The less reactive β-cyanoethyl N,N,N’,N’-
tetraisopropylphosphoramidite is used because of the mildness and chemoselectivity of this 
phosphitylation reaction.  Diisopropylammonium tetrazolide is used to activate this reagent 
before the 3’-alcohol can attack on the central phosphorous atom with formation of 7.  
 
D. Oligonucleotide synthesis and purification 
 
Incorporation into oligonucleotides and purification was carried out in accordance with the 
methods described for the previous nucleoside.  The stability of the phosphoramidite in 
acetonitrile with molecular sieves was tested and no decrease in reactivity was observed over 
a one day time period.  The sequences incorporating modification 3 are represented in Table 
3.  In general oligonucleotides containing modification 3 showed an increase in RP-HPLC 
retention time compared to modification 2.  This is ascribed to the increased apolarity of the 
modification. 
 
label Sequence Calculated mass (Da) Measured [M+1] (m/z) 
ON12 5’-CTG ACG G3G TGC-3’ 3681.66 3682.7 
ON13 5’-CTG ACG C3C TGC-3’ 3601.64 3602.2 
ON14 5’-CTG ACG A3A TGC-3’ 3649.67 3650.6 
ON15 5’-CTG ACG T3T TGC-3’ 3631.64 3632.8 
Table 3: Sequences synthesized with nucleoside 3 for duplex cross-linking. 
 
  
 3.4
3.4.1
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One of the standard methods for evaluating the influence of a modification on the duplex 
structure 
temperature of a sample containing equimolar amounts of both oligonucleotides 
increased.  If the UV absorbance of the sample changes during this experiment it reflects a 
conformational change of the molecules in solution.
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both strands 
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is lower than the sum of its two composing strands
the duplex is smaller than the sum of the extinction coefficien
this it can be seen that a
until no more duplex species are present.  The point where fifty percent of the strands are 
present in duplex form is called the m
calculating the first derivative of the melting profile as the first derivative is 
point.
 
 
   i i ti   t  l  
  li l ti  
 t i  i t it r fl ts  
   t r.   
 t  t  t  tr  r  
  i ti  i  
 Evaluation of the 
 
 
Figure 
Cross
Melting temperatures
and stability
64
hybridize to
-link experiments with building block 
: Schematic representation of a melting temperature experimen
 is by measuring its melting temperature.  In this experiment the 
s more duplex becomes single stranded, the absorbance will increase 
 form a duplex.  The absorbance of this duplex is zero under 
furan
for
  
 a DNA duplex is shown in 
 
-modified 
elting temperature.  It is most commonly found by 
nucleoside
167
 and hence 
  
the molecular absorbance of the duplex 
Figure 
2
ts of the single strands.  
 
the extinction coefficient ε of 
building blocks
 
64
t for duplex DNA
 
.  At low temperature 
maximal
is gradually 
 
 
 
From 
at this 
in a 
Se
co
nd
 g
en
er
at
io
n 
fu
ra
n 
m
od
ifi
ed
 o
lig
on
uc
le
ot
id
es
 
94
 
Se
co
nd
 g
en
er
at
io
n 
fu
ra
n 
m
od
ifi
ed
 o
lig
on
uc
le
ot
id
es
 
Se
co
nd
 g
en
er
at
io
n 
fu
ra
n 
m
od
ifi
ed
 o
lig
on
uc
le
ot
id
es
 
Se
co
nd
 g
en
er
at
io
n 
fu
ra
n 
m
od
ifi
ed
 o
lig
on
uc
le
ot
id
es
 
 
 Se
co
nd
 g
en
er
at
io
n 
fu
ra
n 
m
od
ifi
ed
 o
lig
on
uc
le
ot
id
es
 
95 
 
Absorbance of oligonucleotides is maximal between 255 nm and 265 nm for non-modified 
duplexes.  Measuring at the highest absorbance results in the highest sensitivity and therefore 
DNA duplexes are measured at 260 nm. 
 
A stock solution of the synthesized oligonucleotides was prepared in H2O.  After 
concentration determination by UV, the required volumes of each strand were mixed in 
equimolar amounts.  The samples were further diluted with a 100 mM phosphate buffer at pH 
7 and with a 1 M NaCl stock solution.  The volume is adjusted in order to obtain a final 
oligonucleotide concentration of 2 µM in 10mM phosphate buffer at pH 7 with 100 mM 
NaCl.  Once inside the cuvettes, the samples were heated until 95 °C and slowly annealed 
until 25 °C or lower if necessary.  The cooling rate was 0.3 °C/minute.  When the lowest 
temperature point was reached the measuring of the melting curve was started with a heating 
slope of 0.3 °C/minute.  The profile recorded in this step is always used for calculation of the 
melting temperature.  As a reference, the sample is also cooled again to the starting 
temperature.  The melting temperature results are presented in Table 4.  The strands in the left 
column represent the modified strands with X representing the first base of the pairs in the top 
row.  The second bases of each pair are the bases located opposite of the X in the 
complementary strand.  No mismatches were introduced in the strands. 
 
Complement to modification 2*A T*A 2*C G*C 2*T A*T 2*G C*G 
5’-CTGACG GXGTGC-3’ 40,1 56,7 39,6 59,3 36,1 53,1 38,9 62,4 
5’-CTGACG CXC TGC-3’ 30,5 53,7 24,9 61,6 32,5 56,3 32,4 58,7 
5’-CTGACG AXATGC-3’ 30,9 48,1 24,0 52,0 30,0 49,7 29,3 53,4 
5’-CTGACG TXT TGC-3’ 29,2 49,7 23,1 53,5 27,3 47,2 26,5 51,7 
Table 4: Melting temperatures in °C, residues in bold are located in the modified strand 
As expected, introduction of the modified building block 2 severely destabilizes the duplex, 
however much more than the 3 °C earlier reported for studies describing the use of a similar 
building block with acyclic backbone and an adenine base.146  This destabilization can be 
attributed to the reduced stacking and the elimination of several hydrogen bonds.  The 
destabilizations are shown in Table 5.  These destabilizations are relative to the corresponding 
matched duplex so it might not surprise that replacement of a guanosine residue by our 
modification destabilizes more than replacement of an adenosine as the replacement involves 
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removal of three respectively two hydrogen bonds (columns 3 versus 4).  This analogy is also 
seen for replacement of a cytidine versus replacement of a thymine (columns 5 versus 2).   
 
Complement to modification A C T G 
5’-CTG ACG G2G TGC-3’ -16,6 -19,7 -17,0 -23,5 
5’-CTG ACG C2C TGC-3’ -23,2 -36,7 -23,8 -26,3 
5’-CTG ACG A2A TGC-3’ -17,2 -28,0 -19,7 -24,1 
5’-CTG ACG T2T TGC-3’ -20,5 -30,4 -19,9 -25,2 
Table 5: Destabilisations in °C with regard to the fully matched duplex  
 
B. Cross-linking experiments with a complementary adenine base 
 
From the first generation building blocks it is known that when the context is G1G*CAC the 
cross-linking is not selective to A.  Therefore it is a good starting point for evaluating the new 
building block.  The first sequence studied was: 
 
duplex ON8+ON2 ON8  5’-CTG ACG G2G TGC-3’ 
ON2 3’-GAC TGC CAC ACG-5’ 
 
Both strands were mixed in equimolar amounts in 10 mM sodium phosphate buffer at pH 7 
with 100 mM sodium chloride.  The mixture was heated to 95 °C and the duplex was 
annealed slowly to 20 °C, the temperature at which the cross-link reactions were conducted. 
C2
O OR Br
O
HH
O
R
O
N
O
O
Br
O
O
 
Scheme 24: Oxidation mechanism of furan by NBS 
For oxidation of the furan ring N-bromosuccinimide (NBS) is used.  The 2-position of furan is 
most susceptible for electrophilic bromination as the resulting cation is the most stable.  The 
brominated intermediate is susceptible for nucleophilic attack by water which causes ring 
opening of the furan.  The result is an unsaturated 4-oxo-enal derivative (Scheme 24, 124).  
The reaction mixture before addition of oxidizing agent was analyzed by RP-HPLC and 
looked as follows: 
 Se
co
nd
 g
en
er
at
io
n 
fu
ra
n 
m
od
ifi
ed
 o
lig
on
uc
le
ot
id
es
 
97 
 
 
Figure 65: RP-HPLC spectrum of ON8+ON2 before oxidation (A) and after oxidation (B) 
Based on the spectra of the single strands the first eluting peak was assigned to the non-
modified strand ON2 and the later eluting peak to the modified strand, ON8.  To start the 
reaction, one equivalent of NBS was added in a small volume, 3 µl in general, to avoid 
influence of dilution.  After fifteen minutes the reaction was checked by taking a small aliquot 
of reaction mixture and subjecting it to RP-HPLC.  As can be seen from Figure 65 B the 
intensities of both ON8 and ON2 have decreased and a new peak that elutes later is formed. 
 
The modified strand completely disappeared and a small amount of complementary strand is 
still present.  To identify the new peaks, the reaction mixture was purified by RP-HPLC, the 
different fractions were collected and evaporated by vacuum centrifugation.  The dry fractions 
were dissolved in milliQ water and subjected to MALDI-TOF analysis.  Analysis of the 
spectra showed that the peak eluting before ON2 with a retention time of 11.4 minutes 
corresponds to oxidized modified ON8.  The peak eluting at 11.7 minutes was confirmed to 
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be ON2.  The broad signal at 13 minutes corresponds to a mixture of the oxidized and the 
non-modified strand together with cross-linked duplex.  The presence of this cross-linked 
product can be attributed to the major component in the HPLC spectrum, which is cross-
linked duplex and is eluting just behind (cfr signal at 13.4 min Figure 65).   
 
Figure 66: MALDI-spectrum of cross-linked duplex (peak eluting at 13.4 min in Figure 65 B) and zoom 
region of the cross-linked mass. 
MALDI-TOF analysis reveals that for the peak eluting at 13.4 minutes the mass corresponds 
to the mass of ON2 plus the mass of the oxidized form of ON8 (7210.0, Figure 66).  The 
masses clustered around 3616 are single stranded oligonucleotides and their degradation 
products.  Since the MALDI matrix is very acidic, which is even enhanced by the addition of 
DOWEX beads during the sample preparation, a part of the cross-linked duplex degrades.  As 
these single strands are much smaller they ionize much easier thereby giving rise to peaks 
with very high abundances in the mass spectra which not necessarily represent large 
quantities.  
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C. Cross-linking experiments with a complementary thymine base 
 
Cross-link formation does not tell anything about selectivity, so to test if the cross-link is 
really to the complementary adenosine rather than its neighboring cytidines, the adenine base 
was replaced with thymine, a residue that does not have an exocyclic amine.  The duplex 
looks in that case like: 
 
Duplex ON16+ON8 ON16 3’-GAC TGC CTC ACG-5’ 
ON8  5’-CTG ACG G2G TGC-3’ 
 
The reaction conditions were exactly the same as in the previous reaction.  The RP-HPLC 
chromatogram before addition of NBS shows two nicely separated peaks.  Again the first 
peak is the non-modified strand, ON16, and the second peak is ON8. 
 
 
Figure 67: RP-HPLC spectrum of ON8+ON16 before oxidation (A) and after oxidation with 2 equivalents 
NBS (B), ON8-ON16 represents cross-linked duplex 
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Full conversion of the modified strand required two equivalents of NBS, each added with a 
fifteen minute time interval.  Next to a large amount of ON16 still present (retention time 11.8 
min.), two main new products were formed, one eluting before the non-modified strand and 
one eluting after the modified strand.  MALDI-TOF-analysis confirmed that the first eluting 
peak corresponds to oxidized and overoxidized ON8 and the peak with a retention time of 
13.3 minutes contains cross-linked duplex.  This is however a very small amount of cross-
linked product.  We suggest that the overoxidized product corresponds most probably to a 
product where furan is opened and the aldehyde further oxidized to a carboxylic acid (Figure 
68, 125).   
O
O
O O
OH
125
ON8 overoxidized: Calcd. 3621.6; found 3620.4 
Figure 68: Suggested structure of the overoxidation adduct eluting at 11.5 minutes 
From this experiment it is quite likely that when cross-linking in a G2G.CAC context, the 
cross-link is almost exclusively formed with the complementary adenine base. 
 
D. Cross-linking experiments with a complementary cytosine base 
 
The reactivity of furan metabolites such as cis-1,4-butene-dial towards natural nucleosides is 
reported to be dC>>dG>dA105 at pH 7 so it would be interesting to see how the more reactive 
residues behave.  A cross-link experiment with a C opposing to the modification is shown in 
Figure 69.  The duplex sequence in that case is: 
 
Duplex ON8+ON17 
ON8 5’-CTG ACG G2G TGC-3’ 
 
ON17 3’-GAC TGC CCC ACG-5’ 
 
After addition of two equivalents NBS the modified strand ON8 has completely disappeared.  
Again there is a large amount of cross-link observed (13.3 minutes) but also a leftover of non-
modified strand (11.7 minutes).  This experiment proves that cross-link formation is not only 
possible to A but also to complementary C. 
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Figure 69: RP-HPLC spectrum of ON8+ON17 before oxidation (A) and after oxidation  
with 3 equivalents NBS (B), ON8-ON17 represents cross-linked duplex 
 
E. Cross-linking experiments with a complementary guanine base 
 
The spectrum after oxidizing a G-containing duplex (ON8+ON18) with 3 equivalents NBS 
show no cross-linking, only the oxidized modified strand (Figure 70, retention time 13.1 
minutes) and the non-modified strand are present (ON18, Figure 70, retention time 
13.3 minutes) 
 
duplex ON18+ON8 ON18 3’-GAC TGC CGC ACG-5’ 
ON8 5’-CTG ACG G2G TGC-3’ 
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As guanine has an exocyclic amine in the minor groove which is known to react with furan, 
this leads to the conclusion that the oxidized furan is presumably not located in the minor 
groove of the duplex. 
 
 
Figure 70: spectrum of ON8+ON18 before oxidation (A) and after oxidation with 4 equivalents NBS (B) 
This last experiment also shows that cross-linking is very much dependent on the local 
structure: a T as complement allows limited cross-linking to a neighbouring C but a G as 
complement does not allow cross-linking to an adjacent C.  
 
F. Varying the neighbouring bases 
 
In a next phase, the bases next to the modification were changed.  This changes the duplex 
context surrounding the cross-linker and might affect the cross-link selectivity.  The 
complementary strands were always fully matched and the bases positioned opposite the 
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modification were varied to check cross-link selectivity.  The results of the cross-linking 
experiments based on RP-HPLC analysis are summarized in Table 6. 
 
  Base complementary to the cross-linker 2 
 Sequence A C T G 
ON8 5’-CTG ACG G2G TGC-3’ + + - - 
ON9 5’-CTG ACG C2C TGC-3’ + + - - 
ON10 5’-CTG ACG A2A TGC-3’ + + - - 
ON11 5’-CTG ACG T2T TGC-3’ + + - - 
Table 6: += excellent cross-linking, -no significant cross-linking 
The cross-link reaction shows selectivity to adenosine and cytidine while no/very poor cross-
linking is observed to thymine and guanosine.  All masses of cross-linked duplexes were 
verified by MALDI-TOF and corresponded to the sum of the masses of non-modified + 
oxidized modified strand.   
 
G. Cross-link yields 
 
As the main drawback of most published cross-link methods is the low yield this is a critical 
point to evaluate.  Most methods do not surpass 30 % purified yield.  The highest reported 
conversion is 80 % but this is not an isolated yield of a product ready to use in biochemical 
studies.76  
 
The yields reported here are based on concentrations determined by UV measurement of the 
cross-linked duplexes after the samples were isolated by RP-HPLC.  After RP-HPLC 
purification the masses of the cross-linked product were always confirmed by MALDI-TOF.  
For this purpose approximately 10 % of the sample is used.  The yields were determined from 
reactions on a scale of at least 10 nmol so accurate determination of the yield was possible 
 
Cross-link to A C 
5’-CTG ACG G2G TGC-3’ 34 % 23 % 
5’-CTG ACG C2C TGC-3’ 28 % 44 % 
5’-CTG ACG A2A TGC-3’ 40 % 42 % 
5’-CTG ACG T2T TGC-3’ 49 % 73 % 
Table 7: Isolated cross-link yields 
Isolated yields here are almost all above the highest reported yields.  Cross-linking occurring 
when the modified nucleoside 2 is located between two A.T base pairs resulted in higher 
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yields than when located between two G.C base pairs.  To date we have no explanation for 
this behaviour.  The highest cross-link yield is 73 % which is the highest purified cross-link 
yield reported in literature.  The cross-link yields might be higher upon changing the 
stoichiometry of the duplex: more modified strand might be able to completely consume the 
non-modified strand.  
 
H. Stability of the cross-linked duplexes 
 
As seen before, duplex stability is easily assessed by measuring the melting temperature of the 
duplex.  For a cross-linked duplex it is expected that the stability is raised significantly 
because the covalent bond inhibits strand separation. 
 
The sample preparation for determining the melting temperature is slightly different to 
previous examples as the cross-link reaction is not reversible.  When heating until the duplex 
dissociates the cross-link will break and upon cooling the cross-link will not form again.  This 
implies that the melting temperature can only be recorded once per sample.  Thus oxygen 
bubbles, which are normally removed upon heating to 95 °C, can be formed during analysis 
thereby disturbing the spectra and complicating analysis.  Dissolved oxygen can be removed 
by bubbling a small flow of nitrogen through the cuvette for two minutes.  The salt and buffer 
conditions are the same as used in the previous melting experiments to allow direct 
comparison. 
 
 
Figure 71: Melting temperature experiments with reference duplex (triangles), modified duplex (squares)  
and cross-linked duplex (tilted squares) 
0
0,1
0,2
0,3
0,4
0,5
0,6
0,7
0,8
0,9
1
15 35 55 75 95
N
o
rm
a
li
s
e
d
 a
b
s
o
rb
a
n
c
e
Temperature (°C)
Melting temperatures
GXG*CAC XL
GXG*CAC
GTG*CAC
 Se
co
nd
 g
en
er
at
io
n 
fu
ra
n 
m
od
ifi
ed
 o
lig
on
uc
le
ot
id
es
 
105 
 
Previous analysis showed that the modified duplex (red line Figure 71) is quite strongly 
destabilized compared to the non-modified duplex (green line Figure 71).  The melting profile 
of the cross-linked duplex, purified from the reaction mixture by RP-HPLC, is represented by 
the blue line in Figure 71.  Where the introduction of the modified building block leads to a 
destabilization of 16 °C, the cross-linking reaction increases the stability with more than 28 
°C.  This steep increase is seen for all cross-linked duplexes (Table 8). 
 
cross-linked duplexes cross-linked to A cross-linked to C 
5’-CTG ACG G2G TGC-3’ >84 °C 80,0 °C 
5’-CTG ACG C2C TGC-3’ >84 °C >84 °C 
5’-CTG ACG A2A TGC-3’ >84 °C 71,5 °C 
5’-CTG ACG T2T TGC-3’ 79,5 °C 79,0 °C 
Table 8: Melting temperatures of the cross-linked duplexes 
Melting temperatures for half of the samples is higher than what is possible to determine.  At 
95 °C the plateau representing the single strands (Figure 64) is not reached for these duplexes 
and calculation of the first derivative is not possible.  Alternative calculation methods for 
melting temperature determination are not possible either in this case.167 
 
Figure 72: Melting temperature experiments with cross-linked duplex (squares) and  
cross-linked sample after heating to 95°C (triangles) 
The melting curves of the duplex after heating to 95 °C show again a much lower melting, in 
this case 44.2 °C (Figure 72 triangles).  This melting temperature is still slightly higher than 
the non cross-linked modified duplex.  In order to find an explanation for this some samples 
were purified by RP-HPLC but none of the resulting peaks could be identified by MALDI-
TOF.  
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I. Gel-electrophoresis experiments 
 
With the first generation of building blocks the presence of multiple cross-linked species was 
revealed by gel-electrophoresis.  In gel-electrophoresis molecules can be separated based on 
their specific shape and charge rather than on polarity as in RP-HPLC. 
 
The experiments were temperature controlled at 40 °C and used a 20 % polyacrylamide gel.  
The gel was run under denaturing conditions as it was saturated with 7 M urea and the buffer 
system was a 1xTris-Boric acid-EDTA buffer at pH 8.3.  Samples were loaded onto the gel 
with a formamide containing loading buffer as this is also known to denature DNA duplexes. 
  
Figure 73: 20% denaturating PAGE at 60°C for all tested duplexes with modification 2 (X=1),  
XL= cross-link, ss=single strand 
The results of the gel-electrophoresis confirm the results obtained by RP-HPLC for most of 
the duplexes.  However in the case where the modification is located between two cytidines 
and opposite a thymine residue (lane 10), a small amount of cross-link is observed where this 
is not the case on RP-HPLC.   
 
As this product wasn’t observed on RP-HPLC it was impossible to isolate it for mass analysis 
and subsequent enzymatic degradation to confirm the position of cross-link formation.  It is 
known that cross-link formation cannot occur towards thymine so one of the neighbouring 
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guanosine residues must be involved in the cross-link.  Hence replacement of these 
guanosines with inosine one at a time should result in one of the cases in cross-link and in the 
other case no cross-link should be observed.  Inosine has the same structure as guanine but the 
exocyclic amino-group on is removed (Figure 74). 
 
NH
N
N
O
NH2
N
O
OH
HO
NH
N
N
O
N
O
OH
HO
Deoxy-guanine (dG) Deoxy-inosine (dI)  
Figure 74: structure of dG and dI 
Cross-linking experiments where ON9 was combined with ON20 or ON21 showed no cross-
link formation.  Only with the original ON19 strand cross-link was observed.   
 
duplex 
ON9+ON19 
ON9  5’-CTG ACG C2C TGC-3’ duplex 
ON9+ON21 
ON9  5’-CTG ACG C2C TGC-3’ 
ON19 3’-GAC TGC GTG ACG-5’ 
 
ON21 3’-GAC TGC ITG  ACG-5’ 
 
duplex 
ON9+ON20 
ON9  5’-CTG ACG C2C TGC-3’ 
ON20 3’-GAC TGC GTI  ACG-5’ 
 
 
 
Figure 75: Denaturing PAGE experiment for determination of the cross-link  
selectivity with C2C.GTG (X=2) 
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From this it can be concluded that cross-linking is very much dependent on local structure and 
a small distortion of the duplex structure can result in the loss of cross-linking potential.  In 
these two inosine cases replacement of only one amino-group is enough to lose the ability to 
form cross-link.  C.I pairs are known to be compatible with a small minor groove while C.G 
pairs are not as their bifurcated amino-hydrogen bonds do not accommodate within a small 
minor groove.168 
 
J. Enzymatic degradation of the cross-linked duplexes 
 
Previous experiments showed a clear connection between local structure and cross-link 
formation.  Therefore the assumption that observed cross-linking in a G2G*CAC context is 
certainly to A if no cross-link is observed with G2G*CTC is no longer justified.  Hence a 
different method for determination of the cross-link selectivity is necessary. 
 
One of the existing methods would be tandem ESI-MS-MS where the duplex is ionized in a 
mass spectrometer and subsequent fragmentation could allow determination of the position of 
the cross-link.  This is however not possible with these large duplexes as the current 
generation electron-spray mass spectrometers (ESI-MS) do not have enough energy for 
producing relevant fragmentations in such large molecules.  Production of a ladder followed 
by analysis with gel-electrophoresis169 was not considered as the mixture of the produced 
fragments might be too complex to allow easy analysis.   
 
3' 5'
EXO III SVP
 
Figure 76: Action of exonuclease III (EXO III) and snake venom phosphodiesterase (SVP) on a DNA 
duplex 
For oligonucleotide sequencing the most practical method in our case proved to be MS 
detection of enzymatic digestion products.170  The two enzymes commonly used for 
enzymatic digestion of cross-linked duplexes are snake venom phosphodiesterase (SVP) or 
phosphodiesterase I, a 5’ exonuclease that cleaves phosphodiester bonds from a DNA duplex 
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starting from the 5’ terminus of each strand, and exonuclease III (EXO III), which hydrolyses 
the phosphodiester bonds starting from the 3’ terminus releasing 5’-monophosphates. 
 
Exonuclease III has been used to assess the selectivity of several cross-linkers171 as well as 
phosphodiesterase I.172  Exonuclease III was chosen because it was available in the lab.  It is 
very user friendly as it comes in solution and the reaction buffer is also supplied.  One unit of 
the enzyme catalyzes the release of one nmol acid soluble nucleotide in 30 minutes at 37 °C.   
 
From this it was calculated that for two nanomols crude reaction mixture approximately 20 
units EXO III at 37 °C would be necessary if the enzyme digests both strands until the cross-
link in thirty minutes.  Immediately after the reaction, the mixture was injected into the RP-
HPLC for fraction collection.  MALDI-analysis of the fractions showed truncated duplexes 
that weren’t digested long enough in order for the enzyme to reach the cross-link.  Therefore 
the reaction conditions were adjusted: longer reaction times of 50 minutes and smaller 
amounts (0.6 nmol) of purified cross-linked samples with 200 units EXO III resulted in the 
presence of three major peaks, in the case of ON8+ON2, in the region where the 
oligonucleotide products are expected (Figure 77).  Fractions were collected from all peaks, 
evaporated under reduced pressure and analyzed by MALDI-TOF.  The peaks eluting in the 
beginning of the spectrum (~5 minutes) were supposed to correspond to the nucleoside 5’-
phosphates. 
 
 
Figure 77: RP-HPLC chromatogram of the enzymatic degradation of ON8+ON2 
For analysis of the products an excel sheet was made with all possible masses of the products 
resulting from 3’-digestion of a known duplex structure.   
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The small peak at 11.3 minutes retention time was composed of a mixture of single strand 
digests (Figure 78, ON2-7bases, ON2-6 bases, ON2-5 bases, details: see materials and 
methods section).  These are side products from the digestion of contaminant single strands.   
 
 
Figure 78: MALDI-spectrum of the peak eluting at 11.3 minutes. 
The next small peak just before the largest fraction corresponds also to digested single strand, 
it is the complementary strand ON2 which has lost four bases from its 3’-terminal (found: 
2379.2, calcd.: 2378.4, , 3’-GC CAC ACG-5’, Figure 79) 
 
 
Figure 79: MALDI-spectrum of the peak eluting at 11.7 minutes 
The first major peak at 11.9 minutes was again a mixture of different products (Figure 81), 
but some of these were adducts from cross-linked duplexes.  The m/z of 2683.3 corresponds 
to the non-modified strand ON2-3 bases (calcd 2682.5, 3’-TGC CAC ACG-5’) and 
2988.3 corresponds to oxidized ON8-2 bases (calcd 2987.5, 5’-CTG ACG G 2(oxidized) G 
T-3’). 
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126  
Figure 80: Proposed structure of the product eluting at 12.0 with a m/z of 3300.6 
The next two, smaller peaks in the MS spectrum are the most interesting, the product 
corresponding with m/z 3301.4 is represented in Figure 80 (calcd. 3300.6) and m/z 3605.3 
corresponds to a similar structure with one base extra on the 3’-end of the modified strand 
(calcd. 3607.6).  In this case the enzyme is blocked by the presence of the acyclic residue in 
the modified strand, two bases from the modification the duplex structure is too distorted to 
be digested by the enzyme.   
 
Figure 81: MALDI-spectrum of the peak eluting at 11.9 minutes 
On the side of the complementary strand ON2 the enzyme is not stopped by the cross-link and 
“eats” over the residue.  This releases a short single strand of four nucleotide units (5’-GCAT-
3’), the leftover of the non-modified strand which is too short to be recognized by the enzyme.  
This tetranucleotide elutes with a retention time around nine minutes and could be identified 
in several other cross-linked duplexes.  This fragment gives a first indication that cross-
linking takes place to the complementary adenosine and not to its neighbouring bases as was 
the case with the first generation of cross-linkers.   
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Figure 82: Maldi spectrum of the peak eluting at 12.3 minutes(A) and zoom region of the spectrum 
 
The MALDI-TOF spectrum of the peak with a retention time of 12.3 minutes (Figure 82 A) is 
a mixture of two products, probably due to overlap with the peak eluting at 12.4 minutes.  The 
zoom region of the spectrum, represented in Figure 82 B, shows 4441.3 as m/z value of the 
molecular ion.  The further observed m/z value 4459.3 also corresponds to a molecular ion.  
The difference is 18, indicating the loss of water.  This is confirmed by the presence of a 
cluster of peaks corresponding to a m/z value of 4463.2, the sodium adduct of the first 
molecular ion.   
 
Figure 83: Mechanism of cross-link formation and dehydration of the first formed adduct. 
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A possible structure corresponding to m/z 4441.3 is represented by the compound in Figure 
84 (calcd 4440.8).  The product corresponding to m/z 4459.3 has the same nucleotide 
composition but the hydrated cross-link is present (Calcd. 4458.8).  The structure of these 
products can be explained by the acid catalyzed elimination of water with formation of a 
bicyclic aromatic system (Figure 83).  This type of reaction is observed in literature at pH 
below 6.1107 so most probably these adducts are formed upon concentrating the fractions from 
the RP-HPLC.  The triethylamine of the TEAA buffer will evaporate first (boiling point 
89°C) leaving the acetic acid (boiling point 118°C) in the sample which can cause the acid 
catalyzed elimination. 
O
PO OH
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H
GT-3'
O
O
P OHO
O
HO
O
O
N
N N
N
N
5'-CTG ACG G
CACG-5'ON8 -2 bases
ON7 - 7 bases
130
calcd.:4440.8, found: 4441.3  
Figure 84: Structure of the product eluting at 12.4 minutes 
Finally the MALDI-spectrum of the product that elutes at 12.4 minutes (Figure 85) shows an 
m/z value of 4441.3 which corresponds with the compound represented in Figure 84 (calcd 
4440.8).   
 
Figure 85: MALDI-spectrum of the peak eluting at 12.4 minutes 
If the 5’-tail is still present, fragments of different molecular weight will be obtained for 
different cross-links within one duplex (see Figure 86 B, C, D for cross-linking to respectively 
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the 3’-neighbouring C, the complementary C and the 5’-neighbouring C).  In the case of a 
G2G*CCC context only this type of fragments can prove the selectivity of the cross-link 
reaction.  As illustrated in Figure 86, cross-linking to the complementary or neighbouring C’s 
gives rise to fragment A if the non-modified strand is completely degraded.  
CTGACGG1GT
CCACG-5'
CTGACGG1GT
CCCACG-5'
CTGACGG1GT
CACG-5'
CTGACGG1GT
C
A B C D
 
Figure 86: Fragments originating from different cross-links resulting in identical molecular weights. 
All cross-linked duplexes were analyzed in a similar digestion setup and it was confirmed for 
all duplex contexts that cross-linking occurs only towards the complementary base and not to 
the neighbouring bases 
 
K. Structure of the cross-link 
 
So far no real attempt was made to identify the exact structure of the cross-link.  In a recent 
method described by Schärer,71 a cross-linked dinucleotide was synthesized and the retention 
time of this molecule on RP-HPLC was compared with a digest of the cross-linked duplex.  In 
this digestion reaction three enzymes were used: exonuclease III, snake venom 
phosphodiesterase and calf intestine phosphatase.  The former two enzymes were discussed 
above; the latter enzyme removes phosphate groups from the mononucleotides produced by 
the other enzymes.  This is necessary for direct comparison of the retention times on RP-
HPLC.   
 
Results from enzymatic digestion with EXO III show that the modified duplex structure is too 
distorted two base pairs away from the modification to be recognized by the EXO III enzyme.  
Hence it is not possible to digest the cross-linked duplex up to the stage of the dinucleotide as 
could be expected from literature examples.142  Therefore it was decided to try and confirm 
the cross-link structure by reacting two mononucleosides, a modified and a non-modified one, 
with each other.  As in this case there is no template DNA molecule bringing the two relevant 
nucleotides together, the expected yields are low.  The ideal conditions for oxidation of furan 
in organic solvents were shown to be the use of NBS at -20 °C in a mixture of THF-acetone-
 water.
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Figure 87 shows the RP-HPLC chromatogram of the crude reaction mixture.  The signal at 
retention time 4 minutes corresponds to dC while the analysis of the peak at retention time 10 
minutes shows the corresponding product to have a molecular weight in agreement with 
cross-linked dinucleoside 8/131.  As can be seen from this reaction chromatogram the 
conversion to cross-linked dinucleotide is quite low as predicted above. 
 
Isolation of the product peak resulted in clean RP-HPLC and MS spectra (Figure 88).  The 
small shift in retention time is due to minor changes in the mobile phases as the spectra were 
recorded on different data.  The signal at m/z 440 corresponds to the protonated (M+1) cross-
linked product and m/z 324 corresponds to a compound where the glycosidic bond has been 
cleaved and where only the cytidine base is attached to oxidized the cross-link residue (calcd 
323). 
 
 
Figure 88: RP-HPLC and ESI-MS spectrum of purified dinucleotide 
The structure was further characterized by NMR.  Spectra were recorded in deuterated 
acetone at 500 MHz for hydrogen and at 125 MHz for carbon.  The obtained 1H NMR 
spectrum was compared with literature data103 for the earlier characterized natural adduct of 
cis-butene-dial and dC (57 and 58).  The open form 8 and the ring closed form 131 are 
apparently present both as a mixture of diastereomers.  Although complicated, the 1H NMR 
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spectrum clearly displays all characteristic peaks, confirming the proposed structure.  In this 
way it has been proven that this type of structure can indeed be formed upon reaction of 
cytidine with the oxidized cross-link residue.   
 
Similar reaction with deoxyadenosine was not performed as the reaction with nucleoside 3 
and dA showed that the formed adducts are unstable (see later).  It was not possible in that 
case to isolate the product but the mass-spectrum confirmed a similar type of adduct 
formation as with dC.  In the initial report where Dedon103 elucidated the structure of the 
adducts formed between cis-butene-dial and dC it was also reported that adducts of cis-
butene-dial adducts with adenine were not stable. 
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Figure 89: 
1
H NMR spectrum of the cross-linked dinucleotide 8/131 in acetone-d6 recorded at 500 MHz 
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L. Conclusion 
 
Experiments have shown that the new type of building block for cross-linking is capable of 
forming a strong and selective cross-link between two complementary strands in a duplex.  
The cross-link reaction is selective for the complementary adenine and cytosine bases.  This 
selectivity was confirmed by enzymatic digestion with exonuclease III.   
 
No cross-linking to the neighbouring bases was observed except when a complementary 
thymidine is flanked by two guanosines.  It could however not be determined to which of the 
two neighbouring guanosines cross-linking occurs and what type of adduct is formed in that 
case.   
 
The formed cross-link enhances the thermal stability of the duplex significantly in contrast to 
the non cross-linked modification which causes a strong destabilization of the duplex. 
 
The exact structure of the cross-link was characterized and found to resemble the natural 
adducts formed by reaction of furan metabolites with deoxycytidine.   
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3.4.2 Cross-link experiments with building block 3 
 
Similar to the duplexes incorporating building block 2, duplexes with building block 3 were 
evaluated with the same techniques to probe the effect of the extra phenyl unit on the cross-
link.  The used experimental setups were identical to the conditions used for 2 unless 
otherwise specified. 
 
A. Melting temperatures 
 
The extra phenyl unit is introduced in order to compensate for part of the destabilization 
introduced by the acyclic backbone and by the removal of the hydrogen bonds with the 
complementary base.  This stabilization is supposed to originate from increased stacking of 
the conjugated furan unit as compared to the furan unit alone as was seen from the molecular 
dynamics simulation. 
 
Complement to modification 3*A T*A 3*C G*C 3*T A*T 3*G C*G 
5’-CTG ACG GXG TGC-3’ 45,2 56,7 48,9 59,3 45,1 53,1 45,6 62,4 
5’-CTG ACG CXC TGC-3’ 41,9 53,7 41,3 61,6 47,6 56,3 46,2 58,7 
5’-CTG ACG AXA TGC-3’ 36,9 48,1 38,3 52 38,4 49,7 37,9 53,4 
5’-CTG ACG TXT TGC-3’ 35 49,7 35,6 53,5 34,5 47,2 36,4 51,7 
Table 9: Melting temperatures of the duplexes modified with nucleoside 3 (in °C). 
The results of the UV-melting experiments are shown in Table 9.  X represents the bold base 
in each column.  The complementary strand was fully matched and the base complementing 
the bold base of each column is the second base.  From these results it can be seen that there is 
still a decrease in melting temperature but this time less pronounced.  The phenyl containing 
furan building block destabilizes between 5 and 16 degrees less than the furan building block 
without phenyl group (Table 4). 
 
Complement to modification 3 A C T G 
5’-CTG ACG G3G TGC-3’ -11,5 -10,4 -8.0 -16,8 
5’-CTG ACG C3C TGC-3’ -11,8 -20,3 -8,7 -12,5 
5’-CTG ACG A3A TGC-3’ -11,2 -13,7 -11,3 -15,5 
5’-CTG ACG T3T TGC-3’ -14,7 -17,9 -12,7 -15,3 
Table 10: Destabilisations (in °C) with modification 3 compared to the fully matched duplexes 
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B. Cross-linking to A 
 
For the first experiment the duplex context was not changed compared to previous 
modifications.  The duplex looked as follows: 
 
duplex ON12+ON2 ON12 5’-CTG ACG G3G TGC-3’    ON2  3’-GAC TGC CAC ACG-5’ 
 
In the RP-HPLC analysis the non-modified peak eluted again before the modification (Figure 
90 A) although the difference in retention time is slightly higher than before.  Chromatograms 
for the study of this modification were all recorded on a Phenomenex Clarity reversed phase 
column. 
 
 
 
Figure 90: RP-HPLC chromatogram of ON12+ON2 before addition of NBS (A) and after addition of 4 
equivalents of NBS (B), ON12-ON2 designates the cross-linked duplex. 
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The cross-link formation in this case requires higher amounts of oxidizing agent.  Four 
equivalents of NBS were needed whereas the same sequence with modification 2 only needed 
one equivalent of NBS for full conversion.  The RP-HPLC chromatogram after complete 
oxidation of the modified strand is shown in Figure 90 B. 
 
It was confirmed that the peak at 12.9 minutes corresponded to the complementary strand 
(ON2) and the peak at 14.6 minutes to the cross-linked product (ON12 - ON2).  The MALDI 
spectrum showed two molecular ions in the region above m/z 7000, one corresponding to the 
sum of the molecular weight of oxidized modified strand and complementary strand and one 
corresponding to the dehydration product of the latter.  The highest intensity in the molecular 
weight spectrum corresponds to the dehydrated product where this is not the case when 
incorporating building block 2.   
 
MALDI-analysis further revealed the presence of a new type of adduct.   The small amount of 
product eluting at 15.6 minutes was shown to have a molecular weight corresponding to the 
modified strand ON12 carrying a bromine.  As this brominated single strand was present in 
all cross-link experiments from this series, the position of the bromine was determined. 
 
C. Localisation of the bromine in the modified strand 
 
In collaboration with the laboratory of Prof. Dr. Stefan Schürch tandem ESI-MS-MS 
fragmentations were performed on these purified brominated single strands.   
 
This method relies on ionization of the sample, selecting one ion and performing a 
fragmentation on this ion.  The method is optimized for fragmentation on the phosphodiester 
bonds so it is possible to obtain information on the molecular weight of each individual 
residue.  From these experiments it could be confirmed that bromination takes place on the 
modified residue and not on other sites that are susceptible for bromination with NBS.  The 
most susceptible place for bromination in the modified residue is C2 (Scheme 26). 
 
An explanation for this reactivity was found in literature.173  After the bromination of furan, 
which is the first step in this reaction, there are two possible reaction pathways for the system 
(Scheme 26).  If the attack of water on the 5-position is fast enough, the bromide will leave 
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the molecule and a 4-oxo-enal derivative is produced (pathway b).  However, if the 
abstraction of the proton on C2 of the furan ring is faster than the attack of water, a 
brominated furan ring (133) is formed which cannot react any further (pathway a). 
 
C5 C2
O O
BrR
H
Base
O
HH
R Br
OR
O
a
b
a
b
O
O
O
NBS
 H2O
R
O
132
133
134  
Scheme 26: Mechanism of bromination 
This side reaction is not observed with the previous building blocks so it is presumably due to 
the presence of the conjugated phenyl unit.  When the bromine adds to the furan ring the 
resulting positive charge can delocalize to the neighbouring benzene ring.  This stabilizes the 
carbocation and might favour abstraction of the hydrogen on C2. 
 
The brominated cross-linked product which is present in some cases was not analyzed by MS-
MS as these systems are too large to undergo efficient fragmentation.  It is suggested, based 
on enzymatic degradation experiments, that this bromination takes place on guanosine 
residues near the termini of the duplex (see later).   
 
D. Cross-link selectivity 
 
A full series of modified duplexes was also constructed incorporating modified building block 
3.  As deduced from the HPLC profiles the selectivity of the cross-link reaction with this 
modification is identical to the previous building block 2.  The phenyl unit does not seem to 
have an influence on the cross-link selectivity.   
 
  Base complementary to the cross-linker 3 
 Sequence A C T G 
ON12 5’-CTG ACG G3G TGC-3’ + + - - 
ON13 5’-CTG ACG C3C TGC-3’ + + - - 
ON14 5’-CTG ACG A3A TGC-3’ + + - - 
ON15 5’-CTG ACG T3T TGC-3’ + + - - 
table 11: += excellent cross-linking, -no significant cross-linking 
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There was a general observation in all the duplexes that in order to completely oxidize the 
modified strand more equivalents of NBS were needed compared to oxidation of strands 
containing 2.  In many cases four equivalents NBS were needed for complete consumption of 
the modified strand, where modification with 2 only required two or three equivalents on 
average.   
 
The explanation for this higher amount of NBS can be found by comparing the electronic 
nature of the different building blocks.  The HOMO orbital of the phenylfuran system has 
lower energy compared to furan due to its conjugation.  As a result the energy gap between 
the HOMO of the furan and the LUMO of the electrophilic bromine atom is larger and hence 
the reaction is more difficult.  This is compensated for by addition of more equivalents NBS.    
 
The same cross-link selectivity as with 2, cross-link formation only to A and C, was 
confirmed by gel-electrophoresis.  In all cases a more intense cross-link spot was seen for 
cross-linking to complementary C’s than A’s (Figure 91 lanes 2, 7, 12 and 17 versus 4, 9, 14, 
19).   
  
Figure 91: Denaturing 20% PAGE experiment with all cross-link possibilities tested for modification 3 
Enzymatic degradations were performed with EXO III.  The selectivity from these 
experiments showed that in all cases except one, only cross-link to the complementary base 
was observed (for analysis and structures: see Materials and Methods).  If a complementary C 
is flanked by two other C’s, cross-linking is observed to the complementary C and its 3’-
neighbouring C.  Again the enzyme stopped cleaving at two bases from the modified residue 
XL 
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in the modified strand so the duplex distortion is probably similar as with the other acyclic 
modified building block 2.     
 
In the complementary strand the enzyme could cleave the base before and after the cross-
linked residue releasing its 5’-tail.  These four bases were also characterized and showed in 
some cases bromination.  This bromination is most probably due to the higher amounts of 
NBS present in the reaction medium.  From the presence of these fragments it was suggested 
that brominations of the cross-linked duplex take place on guanosines close to the termini of 
the duplex as guanine bases are known to be easily brominated by NBS. 
 
The bromination issues, both G and furan bromination, might be solved if a different 
oxidizing agent is used such as cytochrome P450, singlet oxygen or hydrogen peroxide.  
Further research is needed in this direction. 
 
E. Cross-link yield 
 
The isolated cross-link yields are much lower than using modified building block 3.  The 
cross-linked duplexes however showed similar stability as no degradation was observed after 
several months at -20 °C. 
 
Cross-link to A C 
5’-CTG ACG G3G TGC-3’ 10 % 13 % 
5’-CTG ACG C3C TGC-3’ 28 % 15 % 
5’-CTG ACG A3A TGC-3’ 21 % 18 % 
5’-CTG ACG T3T TGC-3’ 29 % 27 % 
Table 12: Isolated cross-link yields of 10 nmol reactions 
The reduced yields can be partially attributed to the bromination side reaction (Scheme 26).  
The strands that were brominated are not available anymore for cross-linking and as this 
brominated species easily represented 10 % or more from the total amount of product in this 
case, high cross-link yields cannot be obtained using the NBS oxidation. 
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F. Thermal stability of the cross-linked duplexes 
 
The cross-linked duplexes were analyzed by UV-denaturation experiments to determine the 
stability of the cross-link.  Melting temperatures are shown in Table 13.  The inherent lower 
stability of the adducts from cis-butene-dial with adenosine is well reflected in the melting 
temperatures.  The duplexes with cross-link to A have a melting temperature which is at least 
12 °C lower than their cytidine counterparts. 
 
cross-linked duplexes cross-linked to A cross-linked to C 
5’-CTG ACG G3G TGC-3’ 70,4 83,2 
5’-CTG ACG C3C TGC-3’ 70,0 >84 °C 
5’-CTG ACG A3A TGC-3’ 71,4 >84 °C 
5’-CTG ACG T3T TGC-3’ 67,8 80,1 
Table 13: Melting temperatures in °C of cross-linked duplexes modified with 2 
This observation contrasts with that for nucleoside 2 where duplexes cross-linked to A are 
more thermally stable than those cross-linked to C.  Apparently the electronic nature of the 
covalent bond is strongly influenced by the phenyl unit as it has the ability to alter cross-link 
effectiveness (Table 12) as well as cross-link stability (Table 13). 
 
G. Structure of the cross-link 
 
Similar to the method described in 3.4.1(K) modified building block 3, bearing a phenyl unit, 
was oxidized with NBS in an aqueous solution with THF and acetone and dC was added.  The 
resulting structure is a similar adduct as was formed in the previous case.  The main 
difference here is that the yield is lower because of the bromination side reaction which also 
takes place on the single nucleoside level.  This side-product was easily removed by column 
chromatography, the resulting RP-HPLC and molecular weight spectra are shown in Figure 
92. 
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Figure 92: RP-HPLC and ESI-MS spectrum of the purified dinucleoside X+C 
The structure was confirmed by COSY and NOESY NMR as the spectral overlap in 1H-
spectra was high (Figure 93).  The presence of two diastereomers could be derived from by 
the two signals corresponding to proton 9.   
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Figure 93: 
1
H spectrum of the cross-link in MeOH at 500 MHz 
For this modified building block oxidation was also performed in the presence of 
deoxyadenosine.  A product with a molecular weight consistent with oxidation followed by 
similar adduct formation could be observed via ESI-MS but the compound could not be 
isolated for further characterization.  This is in agreement with literature data reporting on the 
lower stability of deoxyadenosine adducts as compared to deoxycytidine adducts.  The half 
life time of the natural deoxyadenosine adducts is only a fraction of the stability presented by 
the deoxycytidine adducts.105 
 
Figure 95 shows the RP-HPLC profile from the crude reaction mixture with dA.  Some 
conversion is visible (peak eluting at 10.4 minutes) but these adducts were not stable during 
purification.  The molecular weight spectrum corresponding to this peak does not show the 
molecular weight of the complete product but it contains the molecular weight of the cross-
linked molecule which has lost acetone, the signal at m/z 497.1 (Figure 94). 
OH
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NN
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N
HO
 
Figure 94: Structure of a cross-linked fragment eluting at 10.4 minutes 
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Figure 95: RP-HPLC of the crude reaction mixture of 120 + dA (A) and  
ESI-MS spectrum of the peak eluting at 10.4 minutes (B) 
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H. Conclusion 
 
The second modified building block 3 was smoothly incorporated into DNA duplexes and 
upon oxidation it was possible to form cross-links.  The cross-link selectivity was shown to be 
similar to the first furan containing nucleoside analogue 2 as it forms cross-links to A and C.  
No cross-linking was observed to neighbouring nucleotides except for cross-linking with 
G3G*CCC where the cytidine on the 3’-side of the complement also reacted. 
 
The modification destabilizes the DNA duplex less than the previous nucleoside because of its 
enhanced stacking possibilities.  Upon cross-link formation thermal stabilities are similar to 
the former cross-linked duplexes.  It could however be clearly demonstrated that in this case 
cross-linking to dC gives rise to more stable adducts compared to cross-linking to dA 
reflecting the stability of the natural adducts with furan metabolites. 
 
The cross-link reaction is forming a stable type of adduct that probably is produced by hemi-
aminal formation followed by 1,4-addition to the unsaturated ketone.  
 
The major drawback in the case of the new phenyl containing building block is the formation 
of brominated side products which reduce cross-link yields.  A solution to this might be found 
in the use of alternative oxidizing agents. 
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4 Third generation furan modified oligonucleotides 
4.1 Routes towards aryl-modified sugars 
 
As it was shown that both acyclic nucleoside analogues 2 and 3 have a strong duplex 
destabilizing effect before oxidation, it would be profitable if the furan unit could be 
introduced in a way that destabilizes the duplex less.  An obvious choice is to make use of a 
natural cyclic deoxyribose moiety, thereby restricting backbone flexibility and hopefully 
restoring some of the stability. 
 
In literature several methods are described for introduction of aromatic rings on sugar units.  
These nucleosides are called C-nucleosides as they replace the labile glycosidic C-N bond by 
an extremely stable C-C bond. 
 
4.1.1 SN2 substitution of Hoffer’s chlorosugar 
 
In the large series of artificial nucleosides developed by the group of Kool, one of the 
methods relies on direct substitution of the α-chloro-atom in Hoffer’s chlorosugar (135)174 by 
aromatic arylgrignards.175  Their yields are somewhat low (around 20%) but only the β-
anomer is found in the reaction mixture which avoids difficult separations of α- and β-sugars.  
The low yields are due to the α,β-elimination of the chloride under the basic reaction 
conditions and to a smaller extent to the reaction of the Grignard reagents with the protecting 
group esters. 
O
 
Figure 96: Hoffer’s chlorosugar 
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The yields of this reaction can be increased by substitution of the chlorosugar using 
organometallics different from the Grignard reagents.  Diarylcadmium and diarylzinc 
compounds resulted in the highest yields, for one case even up to 60% of the β-anomer was 
isolated.176  The only drawback was that also the α-anomer was formed in that case.  This 
could be explained by the partial formation of a carbocation SN1 intermediate which then 
reacts with the organometallics with low diastereoselectivity.  The undesired α-anomer can be 
epimerized with a mixture of trifluoroacetic acid and benzenesulfonic acid but complete 
conversion is impossible in practice.177  Nowadays the cadmium assisted route is the most 
commonly used method for introduction of aryl substituents on the anomeric position in 
deoxyribose sugars. 
 
The group of Hocek optimized the substitution of the chlorine atom using the mono-Grignard 
adduct of paradibromobenzene and obtained similar yields as in the toxic cadmium procedure.  
The resulting bromide could be used as attachment platform for various aryl groups by Stille, 
Suzuki-Miyaura or Negishi cross-coupling.178  
 
4.1.2 Addition to 2-deoxyribonolactone 
 
Aryl C-nucleosides can also be prepared by addition of an aryllithium compound to 2-deoxy-
D-ribono-1,4-lactone179 which is protected with the Markiewicz disiloxane.180  Initial attack of 
the aryllithium yields a tertiary alcohol which can be reductively removed with triethylsilane 
and borontrifluoride etherate (Figure 97). The obtained yields were in the range of 20 to 50% 
and both α- and β-anomers were produced.   
O
O
Si
O
(Pri) Si O(Pri) SiAr
 
Figure 97: Reaction scheme for the deoxyribonolactone strategy  
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4.1.3 Friedel-Crafts alkylation 
 
The reaction of unsubstituted aromates with Hoffer’s chlorosugar under Lewis acid catalyzed 
conditions is also a published route to β-deoxyribose sugars.181  BF3.OEt2 or AgBF4 were used 
as Lewis acid.  The major advantage of this method is that no arylhalogens are needed but 
cheaper, simple aromatics can be used.  However it also limits the substitution patterns of the 
aromatic units as substituents will influence the alkylation.  Another problem associated with 
Friedel-Crafts alkylation is that often overreaction occurs which might explain why the 
reported yields are lower than with previous methods. 
 
4.2 A new cyclic furan containing building block 
 
As the acyclic nucleoside bearing a benzene ring (3) is destabilizing the oligonucleotide 
duplex least, the benzene unit would preferably be conserved in the next generation 
nucleoside building blocks.  The bromination side reaction will also be present in this case but 
in view of the possibility for alternative oxidation methods this can be regarded as a less 
important criterion. 
O
OH
HO
O
4  
Figure 98: Structure of the proposed third generation furan modified nucleoside 
As the platform provided by the method of Hocek already incorporates a benzene ring it is 
perfectly suited for our purpose.  Nucleoside analogue 4 was therefore proposed.  It is 
possible to synthesize this molecule starting from Hoffer’s chlorosugar in two steps: 
attachment of the paradibromobenzene ring followed by cross-coupling with the furan unit 
(Figure 99). 
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Figure 99: retro synthesis of the third generation nucleoside 
Hoffer’s chlorosugar is commercially available from Sigma-Aldrich (CAS 4330-21-6) but is 
prepared in three steps from deoxyribose without purification and at a fraction of the price. 
 
4.3 Synthesis 
 
The synthesis started with the preparation of Hoffer’s chlorosugar (Scheme 27).  Starting 
from 2-deoxy-D-ribose (140) the anomeric position could be acetylated with acetylchloride in 
methanol.182  Next, the remaining alcohols could be protected with p-toluoyl chloride in 
pyridine.183  In the work-up of this step the obtained oil must be crystallized in diethyl ether.  
The smallest glass filter present in the lab (nr 4) was not small enough so part of the crystals 
went through which explains the relatively low yield (48% over 3 steps).  The last step is the 
replacement of the acetate by a chlorine group.  This is done by bubbling HCl gas through an 
acetic acid solution containing the nucleoside and acetylchloride.182  The resulting precipitate 
is the chlorinated sugar 135 that can be used without further purification.  As at this time the 
target nucleoside 4 was donated as a generous gift by prof. Dr. Michal Hocek, the chlorosugar 
was not further used.   
 
HO
ToluylO
HO
ToluylO
H
HO
H
HO
 
Scheme 27: Synthesis scheme of Hoffer’s chlorosugar 
The final steps for preparation of the nucleoside for DNA synthesis still had to be performed.  
DMT protection and subsequent phosphoramidite formation of the nucleoside under standard 
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conditions was possible (Scheme 28) but the yields were somewhat lower than expected: 66% 
yield for the DMT protection and 59% for the phosphoramidite preparation.   
 
O
O
DMTO
O
O
OH
DMTO
O
PO
N
NC
O
OH
HO
O
4 143 144
(a)DMTCl (1.5 eq), pyridine, 0°C to rt, 66%; (b) (iPr2N)(NCCH2CH2O)PCl (2.5 eq), DIPEA, CH2Cl2, rt, 59%.
(a) (b)
 
Scheme 28: Preparation of the phosphoramidite of nucleoside 4 
The DMT-protection reaction suffered from overreaction as the 3’-hydroxylgroup could also 
be dimethoxytritylated.  Since the present amounts of nucleoside were small, the reaction was 
not optimized as was done in previous overreaction cases.  Future preparations should use 
shorter reaction times at 0°C.  The low yield for phosphoramidite preparation could not be 
explained as no problems were encountered during the synthesis and purification. 
 
Incorporation into oligonucleotides was possible, again using dicyanoimidazole as activator 
and using manual couplings of ten minutes.  Coupling yields with modified building block 4 
are much lower compared to the acyclic building blocks.  They were estimated not to exceed 
80% based on the trityl group release.  Further extension of the chain from the modified 
building block was not hampered and synthesis could be continued with 99% coupling yields.  
The synthesized sequences are shown in Table 14. 
 
ON22 5'-CTG ACG G4G TGC-3'
 
Table 14: Sequences with modified residue 4 
Purification was done with SEP-PAK and RP-HPLC before use in further experiments.  
Concentrations were measured at 260 nm and extinction coefficients were calculated 
according to the nearest neighbour method with replacement of the modification by an 
adenosine.   
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4.4 Melting temperatures 
 
The melting temperature results are presented in Table 15.  The strands in the left column 
represent the modified strands with X representing the first base of the pairs in the top row.  
The second bases of each pair are the bases located opposite of the X in the complementary 
strand.  No mismatches were introduced in the strands.  As expected, the melting temperatures 
still showed a destabilization compared to the non-modified reference duplexes because of the 
absence of hydrogen bonding (Table 15).  In contrast to what was expected the destabilization 
caused by nucleoside 4 is not lower than the one caused by acyclic counterpart 3 as shown in 
Figure 100. 
 
Complement to modification 4*A T*A 4*C G*C 4*T A*T 4*G C*G 
5’-CTG ACG GXG TGC-3’ 44,4 56,7 47,1 59,3 40,1 53,1 45,3 62,4 
5’-CTG ACG CXC TGC-3’ 40,4 53,7 39,9 61,6 41,4 56,3 43,4 58,7 
5’-CTG ACG AXA TGC-3’ 36,7 48,1 35,4 52 34 49,7 37,8 53,4 
5’-CTG ACG TXT TGC-3’ 34,7 49,7 32,6 53,5 33,8 47,2 37,2 51,7 
Table 15: Melting temperatures recorded at 260 nm, 3 µM duplex concentration,  
10 mM phosphate buffer pH 7 and 100 mM NaCl 
This is a remarkable observation as the sugar ring reduces conformational flexibility of the 
building block within the oligonucleotide which should lead to an enhanced preorganization 
and hence an increase in stability.   
 
Figure 100: Comparative graph of melting temperatures with oligonucleotides modified with 2, 3 or 4. 
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An explanation of this phenomenon can be found by taking into account the reduced 
flexibility inside the helix.  Apparently the sugar unit prevents the polyaromatic system from 
finding the ideal conformation that stabilizes the duplex most.  Due to this reduced stacking 
the melting temperature is lowered reflecting the decrease in stabilization.  The enhanced 
rigidity and preorganisation of the backbone does not compensate for this reduced stability.   
 
4.5 Initial cross-linking experiments 
 
The cross-linking experiments were performed with 20 µM duplex concentration buffered at 
pH 7 with 10 mM phosphate buffer and 100 mM sodium chloride.  NBS was added with 
fifteen minutes time intervals.  For the first tests the following duplex was used: 
  
Duplex ON22+ON2 ON22 5’-CTG ACG G4G TGC-3’ 
ON2   3’-GAC TGC CAC ACG-5’ 
  
Complete oxidation of the modified strand required three equivalents NBS in this case and led 
to the RP-HPLC chromatogram shown in Figure 101 B.  Collecting the RP-HPLC peaks and 
subsequent MALDI-TOF analysis allowed assignment of the three major peaks.  The product 
with a retention time of 14.0 minutes is unmodified ON2, the middle peak at 16.3 minutes 
corresponds to cross-linked product and the last peak, eluting at 17.2 minutes is again 
brominated modified strand as was observed with the oligonucleotides modified with 3. 
 
As the aromatic unit remained unchanged compared to the oligonucleotides modified with 3, 
the bromination was also assumed to take place at the furan unit and not at random guanosine 
residues.  The analysis of the cross-link peak resulted in the conclusion that the pathway 
leading to the natural adducts of cis-butene-dial with nucleobases was most probably 
followed.  The molecular weights corresponded also here to the sum of the oxidized modified 
strand and the non-modified complement.   
 
 Th
ird
 g
en
er
at
io
n 
fu
ra
n 
m
od
ifi
ed
 o
lig
on
uc
le
ot
id
es
 
137 
 
 
Figure 101: RP-HPLC profile of ON22 + ON2 before addition of NBS (A) and after addition of 4 
equivalents oxidant, ON7-ON22 represents the cross-linked duplex 
 
Enzymatic digestion with exonuclease III was used to confirm the location of the cross-link.  
The conditions were identical to those used in the previous chapter but the resulting RP-
HPLC chromatogram didn’t look as clean as before.  Further not all peaks of the enzymatic 
degradation could be ionized in the MALDI as the present amounts were apparently too small.  
Only the peaks at 12.2, 12.7, 13.2 and 13.7 minutes resulted in recognizable fragments 
(Figure 102).   
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Figure 102: RP-HPLC chromatogram of the enzymatic degradation from the cross-linked product 
between ON22 and ON2. 
The first peak (12.2 minutes) contained a mixture of single strand fragments, both from ON22 
and ON2.  The second (12.7 minutes) and third peak (13.3 minutes) contained fragments with 
the same molecular weight.  It was found that they contained cross-link of the modified strand 
to a cytidine residue which is neighbouring the complementary adenosine.  In this case the 
modified strand had lost 2 or 3 bases from its 3’-terminus which leaves two resp. one base on 
the 3’-side of the modification (Figure 103).  The peak eluting at 13.7 minutes shows a 
dehydrated cross-link species where the cross-link is to the complementary adenosine.   
 
5'-CTG ACG G3G T-3'   or 5'-CTG ACG G3G -3'
C C  
Figure 103: Structure of the products eluting at 12.7 and 13.3 minutes. 
The enzymatic digestions with this cross-linked duplex resulted in a different outcome than 
those cross-linked with 2 or 3.  Presence of cross-links to both A and to C of the 
complementary strand was observed.  In case of the modified strand alone the enzyme 
recognizes the cyclic modified building block and digests over the modification.  In a cross-
linked context however the modified building block is seen as unnatural as the enzyme action 
is blocked in the modified strand by the presence of the cross-link. 
 
The structural influence of the cross-link on the duplex is most probably lower compared to 
nucleosides 2 and 3 as the enzyme can digest the modified strand up to one nucleotide from 
the modification where the acyclic nucleotides probably distort the duplex more so the 
enzyme can only digest up to two nucleosides from the modification. 
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The presence of two types of cross-link, both to complementary A and to neighbouring C, is a 
major drawback when using this nucleoside in cross-link experiments.  As the degradation of 
the complementary strand is quite fast no fragments were found that could actually confirm 
the position of the cross-link: to the 5’-neighbouring C or the 3’-neighbouring C.  No further 
experiments were possible to confirm the exact location of the cross-link in the time frame of 
this PhD. 
 
4.6 Cross-linking selectivity 
 
Full context analysis for cross-linking using this cyclic modified building block was 
performed as described for the previous acyclic nucleosides.  Gel-electrophoresis was used for 
selectivity analysis as this allows easy assessment of cross-link formation.   
  
Figure 104: Gel-electrophoresis (20% denaturing PAGE) with the modification between 3 G.C pairs 
Complete conversion of the modified strand required three to five equivalents of NBS, similar 
or slightly higher to what was needed with nucleoside 2.  This is completely within 
expectations as the substituent on the furan unit is still an aromatic ring. 
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Two distinct sets of results were obtained for the cross-link selectivity.  When the 
modification was flanked by two C’s or two G’s, cross-linking was observed in case a C or an 
A was present as complement (Lanes 2, 4, 7, 9, Figure 104).  In the other case, where two A.T 
pairs were flanking the modification, cross-linking only took place with cytidine as 
complement and not with adenosine as complement (Lanes 4 and 9 versus lanes 2 and 7, 
Figure 105).  This shows again a very strong dependence on local structure.  Therefore 
experiments with different base-pairs adjacent to the modification would be interesting, 
especially with this modification. 
 
  Base complementary to the cross-linker X 
 Sequence A C T G 
ON22 5’-CTG ACG G4G TGC-3’ + + +/- +/- 
ON23 5’-CTG ACG C4C TGC-3’ + + - - 
ON24 5’-CTG ACG A4A TGC-3’ - + - - 
ON25 5’-CTG ACG T4T TGC-3’ - + - - 
Table 16: Cross-link selectivity based on gel electrophoresis with the third generation furan containing 
nucleosides, + good cross-link formation, - no cross-link formation, +/- poor cross-link formation 
The presence of cross-link to neighbouring C in paragraph 4.5 is confirmed by the presence of 
small amounts of slower migrating product in the case of a complementary T (Figure 104 
boxed signal).   
 
Figure 105: Gel-electrophoresis (20% denaturing PAGE) with the modification between 3 A.T pairs 
XL 
SS 
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Enzymatic digestion was further used to localize the position of the cross-link.  The enzymatic 
digestion was always performed on 0.6 nmol except for ON23+ON41 (C4C.GAG) as 10 
nmol reaction only led to 0.3 nmol purified cross-link. The reaction time was shortened in this 
case to 35 minutes and the reaction volumes were also adjusted (40 µl with 4µl 10X reaction 
buffer).  Because the cross-link is not inhibiting the enzyme, the tail from the complementary 
strand which is attached to the cross-linked base is always removed.  As seen in Figure 106, 
one fragment obtained from enzymatic degradation can be the result of 3 different types of 
cross-link in this one case.  So not only is this building block less selective, it is also more 
difficult to analyze its formed adducts. 
 
CTGACGG4GT
CCCACG-5'
CTGACGG4GT
CCCACG-5'
CTGACGG4GT
CCCACG-5'
CTGACGG4GT
C
A B C D  
Figure 106: Possible cross-linked products obtained from enzymatic digestion 
For almost all cases it was proven that cross-linking takes place to the complementary base.  
Only for the case with CCC as complement (ON22+ON17, see Materials and Methods) it was 
not possible to confirm that cross-linking was not occurring to the neighbouring bases because 
of the reason shown in Figure 106.  As explained before the cross-linking to A flanked by two 
C’s was not selective (ON22+ON2). 
 
As the structure of the furan unit was not changed compared to nucleoside analogue 3 the 
reaction pathway was suggested to be the same as with nucleosides 2 and 3 (Figure 83). 
Observations from MALDI-TOF, the stability of the cross-link and the presence of the 
dehydration reaction were consistent with this reaction pathway.  Hence the structure of the 
resulting cross-link is suggested to be similar to molecule 9. 
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4.7 Cross-link yields 
 
The cross-link yields with this modified building block are very low.  The highest purified 
yield is 21% which is not bad compared to the published alternatives but compared to the 
other nucleosides that were used during this study they represent the lowest yield. 
 
Cross-link to A C 
5’-CTG ACG G4G TGC-3’ 18% 17% 
5’-CTG ACG C4C TGC-3’ 3% 8% 
5’-CTG ACG A4A TGC-3’ no XL 21% 
5’-CTG ACG T4T TGC-3’ no XL 19% 
Table 17: Cross-link yields with modification 4,  
The highest yields are observed when the modification is flanked by two A.T base pairs, the 
neighbours which also result in the highest cross-link selectivity.  Cross-linking is most 
efficient with C reflecting the natural reactivity of cis-butene-dial with the nucleobases.  This 
observation is in contrast to what was observed for nucleoside analogue 3 so the electronic 
properties of furan, or better its oxidized form, are not the determining factor for cross-
linking.  Probably the steric properties of the duplex and the conformational behavior of the 
nucleosides within the duplex are influencing cross-link selectivity and yield. 
 
4.8 Thermal stabilities of the cross-linked duplexes 
 
Only the duplexes that cross-linked with a yield over 10% were analyzed by thermal 
denaturation.  The denaturation profiles (see Materials and Methods) showed increased 
stability of the duplex after cross-link formation.  The melting temperatures are high for all 
duplexes.  The difference in melting temperature between the cross-linked duplex to A and to 
C is relatively small, but as the sample of cross-link to A also contains cross-link to C it 
would be incorrect to draw stability conclusions from these.  These samples could be stored 
for over 6 months at -20°C without significant degradation.   
Cross-link to A C 
5’-CTG ACG G4G TGC-3’ 78.0 >84.0 
5’-CTG ACG A1a TGC-3’ no XL 80.7 
5’-CTG ACG T4T TGC-3’ no XL 81.6 
Figure 107: Melting temperatures for the cross-linked duplexes in 10 mM phosphate buffer at pH 7  
with 100 mM NaCl (in °C)  
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4.9 Conclusion: Comparison between the different furan containing 
building blocks 
4.9.1 Synthesis 
 
Different furan containing nucleoside building blocks were synthesized and evaluated for 
their cross-linking capacity.  The syntheses of these three nucleoside building blocks (Figure 
108) are all straightforward and easy scalable.  All three nucleosides therefore fulfill the 
requirement of fast and easy building block accessibility.  Especially the nucleosides 
containing a phenylfuran unit are easily synthesized and allow straightforward synthesis of 
analogues such as ortho- or metha- substituted benzene rings or hetero-aromatic ring systems 
bearing a furan.  The phosphoramidite of modified nucleoside 3 can be synthesized on a 1g 
scale in one week and is the easiest to synthesize. 
O
OH
HO
O
4
O
O
O
OH
HO
OH
HO
2 3  
Figure 108: Structure of the novel nucleoside analogues 
4.9.2 Cross-link selectivity 
 
The analysis of the cross-link selectivity was performed using several complementary 
methods.   
 
A. Gel-electrophoresis, RP-HPLC and MALDI analysis 
 
Both acyclic nucleosides 2 and 3 show identical selectivity, they cross-link to A and C.  One 
exception to this rule is the cross-link observed with CXC.GTG which could not isolated 
because of its very low cross-link efficiency.  
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Incorporation of nucleoside analogue 4 led to a different selectivity.  Cross-link to C is 
observed in all cases while the modification was only able to cross-link to a complementary A 
if the modification is flanked by two G.C (or C.G) pairs.  This reflects a strong dependence of 
the cross-link reaction on the local structure of the duplex.  Reaction with a GXG.CYC with 
Y being any natural base resulted in cross-link formation in all cases.  With Y= T or G only 
very small amounts of cross-link were formed but these were high enough to be detected by 
gel-electrophoresis.   
 
The results from gel-electrophoresis were confirmed by RP-HPLC where, in case of cross-
linking, a new sharp peak was formed for the cross-link product.  MALDI-analysis from each 
of these peaks confirmed the cross-link formation  
 
MALDI also revealed the presence of a bromination product of the modified strand containing 
modified building blocks 3 or 4.  It was confirmed that bromination took place on the furan 
C2.  This side reaction is attributed to a more stable carbocation resulting from Br+ addition 
because it is stabilized more by delocalization in case of the phenylfuran derivatives.     
 
B. Enzymatic degradation studies 
 
Enzymatic degradation with EXO III was used to confirm the exact position of the cross-link.  
The acyclic nucleosides 2 and 3 generated a different set of products than nucleoside 4 as the 
acyclic building block changes the structure of the duplex more severely which results in a 
stronger inhibition of the enzyme action.  The results are shown in Table 18. 
 
X= modification 2 3 4 
Y= base complementary to X A C A C A C 
5’-CTG ACG GXG TGC-3’ A C A 3’CC AC? C? 
5’-CTG ACG CXC TGC-3’ A C A C A C 
5’-CTG ACG AXA TGC-3’ A C A C - C 
5’-CTG ACG TXT TGC-3’ A C A C - C 
Table 18: Cross-link selectivity as confirmed by enzymatic degradation: A or C: cross-link to 
complementary A resp C.  3’C indicates cross-link to the 3’C neighbouring of the complement. “?” 
indicates that the position of the cross-link to C was not determined 
For nucleoside analogue 2 the cross-link reaction only takes place to the complementary A or 
C.  No adducts corresponding to cross-link with neighbouring bases of this complement were 
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detected.  This was confirmed by enzymatic degradation studies.  Nucleoside analogue 3 has 
similar selectivity with one exception where cross-link formation was observed not only to the 
complementary C but its 3’ neighbouring C. 
 
Nucleoside building block 4 showed different digestion patterns as the modified strand is 
digested much faster.  Apparently the duplex structure resembles the natural duplex structure 
more strongly and hence is digested faster.  In the G4G.CAC context both fragments of the 
modified strand cross-linked to A as well as cross-linked to one of the neighbouring C’s are 
produced.  It was not determined to which of the neighbours cross-linking proceeded.  With 
three opposed cytidine residues it was not possible to determine to which C cross-linking took 
place.  
 
4.9.3 Stability 
 
The thermal stability of the modified, non cross-linked duplexes is lowered in all cases.  
Figure 109 represents the full series of modified duplexes.   
 
Figure 109: Melting temperatures for the modified, non cross-linked duplexes (2µM) in 10 mM phosphate 
buffer at pH 7 with 100 mM NaCl (in °C) 
From each three bars the first represents modification with 2, the second with 3 and the third 
with 4.  Modification 2 is most destabilizing while modifications 3 and 4 have similar 
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destabilization patterns.  The key to this reduced destabilization is the phenyl unit which 
enlarges the stacking surface and hence the stability.   
 
The thermal stability of the cross-linked duplexes is shown in Table 19.  The discrepancy 
between the high thermal stabilities for cross-link to A with modification 2 and the high 
thermal stabilities for cross-link to C with modification 3 seems to result from the presence of 
the phenyl unit.   
 
X= nucleoside analogue 2 3 4 
complement of X = A C A C A C 
5’-CTG ACG GXG TGC-3’ >84°C 80,0°C 70,4°C 83,2°C 78.0°C >84.0°C 
5’-CTG ACG CXC TGC-3’ >84°C >84°C 70,0°C >84°C nm nm 
5’-CTG ACG AXA TGC-3’ >84°C 71,5°C 71,4°C >84°C no XL 80.7°C 
5’-CTG ACG TXT TGC-3’ 79,5°C 79,0°C 67,8°C 80,1°C no XL 81.6°C 
Table 19 Melting temperatures of the cross-linked duplexes (2µM) in 10 mM phosphate buffer  
at pH 7 with 100 mM NaCl (in °C).  nm: not measured 
All of the cross-linked duplexes were stable for several months at -20°C and no difference 
was observed between cross-link to A or to C in contrast to the stabilities of the cis-butene-
dial adducts with the natural nucleoside analogues.  This is attributed to the presence of the 
duplex structure which enhances the stability of the formed adducts. 
 
4.9.4 Cross-link yields 
 
Table 20 summarizes the cross-link yields after purification for all duplexes.  The presence of 
the phenyl ring reduces the yield of cross-link formation often with a factor two or even three.  
The bromination reaction alone does not consume enough modified strand to fully explain the 
decrease in cross-link yield.   
 
All cross-link yields were determined after removal of a sample (10 to 20%) for MALDI 
analysis so the yields should be slightly higher in theory.  The yield of 73% is the highest 
reported isolated yield to date for a pure isolated specifically cross-linked duplex.  As only 
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one equivalent of modified strand was used it might be possible to increase the yields by 
adding extra equivalents of modified strand. 
 
X= nucleoside analogue 2 3 4 
complement of X = A C A C A C 
5’-CTG ACG GXG TGC-3’ 34% 23% 10% 13% 18% 17% 
5’-CTG ACG CXC TGC-3’ 28% 44% 28% 15% 3% 8% 
5’-CTG ACG AXA TGC-3’ 40% 42% 21% 18% no XL 21% 
5’-CTG ACG TXT TGC-3’ 49% 73% 29% 27% no XL 19% 
Table 20: Isolated cross-link yields of all cross-linked duplexes 
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5 Triplex cross-linking 
 
The occurrence of triplexes and their importance in antigene strategy has been discussed in 
paragraph 1.2.3.  In this chapter we will give an overview of our attempts to expand the 
developed strategy towards cross-linking in a triplex context.  In this chapter we have focused 
on the parallel or pyrimidine triplex motif which is the most studied triplex form. 
 
5.1 Conditions for triplex formation 
 
In a triplex, three polyanionic chains are combined.  In order to form triplexes divalent 
cations, such as Mg2+ should be added to compensate part of the repulsion of the polyanionic 
backbones. Based on NMR experiments it was shown that the closed state of the triplex is 
also stabilized by the presence of Mg2+.184  A further requirement for parallel triplex 
formation is the protonation of dC in the triplex forming oligonucleotide (TFO).  Therefore 
experiments involving triplexes are usually carried out at pH 5.  This need for low pH can be 
relieved by modifying the structure of the TFO.  Not only insertion of heteroatoms in the 
backbone185 can enhance stabilization but also sugar-modifications186 and base 
modifications187 have the ability to enhance triplex formation.  Often these methods rely on 
incorporation of amino groups which are protonated at physiological pH which gives rise to a 
positive charge inside or in the neighbourhood of the triplex which reduces electrostatic 
repulsion.  Triplex formation is also promoted by incorporation of intercalators and this often 
leads to triplex formation at physiological pH.152 
 
5.2 How to detect triplexes? 
5.2.1 Analysis of thermal melting curves 
 
As described earlier (see 3.4.1 A) the Tm can be defined as the melting temperature or the 
temperature of mid-transition in a UV-melting experiment.  For triplex DNA structures two 
transitions will appear (Figure 110).  The transition at higher temperature will correspond to 
the duplex to single strand conversion while the transition at lower temperature corresponds 
with the triplex to duplex transformation.167  In this latter step, the TFO will be released from 
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the major groove.  As this unstacking increases the extinction coefficient ε of all strands 
together (duplex + TFO) this can also bTemperature (°Ce monitored by UV at 260 nm.  
However at 295 nm it is also possible to monitor the triplex to duplex transition: at pH 5, 30% 
of the cytidines are protonated.188  These protonated cytidines show absorbance at 295 nm.  
For triplex formation the number of protonated cytidines will increase and hence it will be 
possible to monitor triplex melting by a decrease in UV absorbance at 295 nm.  The major 
advantage of this wavelength is that the duplex to single strand transition is not seen so if the 
melting temperatures of duplex and triplex are close together the transition of triplex to 
duplex can be monitored alone. 
 
Figure 110: Typical profile of a triplex UV-melting experiment recorded at 260 nm 
As for the preparation of triplex samples special attention must be paid to the inherent slow 
kinetics of triplex formation: DNA triplexes form 100 to 1000 times slower compared to 
DNA duplexes.189  Therefore duplexes are usually annealed first and after their equilibration 
the TFO should be added.  To ensure complete equilibrium conditions the samples are best 
left overnight before starting experiments. 
 
5.2.2 Gel-mobility shift assay 
 
When studying triplex formation it is very important to verify whether cross-linking takes 
place in a triplex and not by strand displacement in a duplex.  Gel-electrophoresis under 
native conditions is an ideal tool to verify this.  Separation with gel-electrophoresis is based 
on structure and charge of the molecules.  When a TFO binds a duplex, the global structure 
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becomes larger and the complex will migrate slower through the gel compared to the duplex 
species.  Hence a new band will occur when running the gel under native conditions.  These 
native conditions imply that the gel should be run at pH 5 in the presence of Mg2+ ions and 
glycerol should be used as loading buffer instead of the formamide loading buffer for 
denaturing gels.  The percentage of acrylamide in the gel is decreased to 14% as the triplex 
species are much larger and therefore require a less dense gel for ideal separation.  This type 
of experiment is typically conducted at 4°C to ensure the binding of the triplex forming strand 
to the duplex.   
 
For the verification of cross-linking, denaturing gels should still be used.  If a cross-link is 
formed a slower moving band will be produced whereas the absence of cross-linking will only 
result in bands corresponding to single stranded oligonucleotides.   
 
5.3 Triplex cross-linking methods 
 
Some strategies for triplex cross-linking have been described before in chapter 2 such as 
photo-induced cross-linking (paragraph 1.3.2 (B)) and 2-amino-6-vinylpurines (paragraph 
1.3.2 (E)).  The main goal of these triplex cross-linking experiments is delivery of a DNA 
damaging agent to a specific sequence190, site specific dsDNA cleavage which can be enzyme 
assisted191 or completely synthetic (“synthetic restriction enzymes”),192 or for the study of 
nucleotide excision repair.193  As these applications as well as their methods for cross-linking 
were already discussed before they will not be repeated here.  
 
One point worth mentioning here is that TFO’s can be used for detecting specific duplex 
DNA sequences.  Double stranded DNA immobilized on a DNA microarray can be used to 
detect single stranded oligonucleotides which have a marker attached to them.194  Triplex 
formation is very much dependent on environmental factors such as salt concentration and 
temperature.  As this complicates analysis these stability problems might be bypassed by 
cross-linking the modified TFO (e.g. by introducing the cross-linker as a cap) into its duplex 
DNA.   
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5.4 Cross-linking with a modification in the middle of a DNA triplex 
5.4.1 Sequence selection 
 
The pyrimidine or parallel motif needs a polypyrimidine TFO to target a 
polypurine:polypyrimidine tract.  For the sequence selection one must take care that no four 
consecutive guanosine residues are incorporated as these can form quadruplexes which are 
extremely stable and hence complicate analysis.  This quadruplex formation as side reaction 
also causes problems for the synthesis of this type of strand: if quadruplex is already formed 
during DNA synthesis, it hampers the next phosphoramidite coupling.  Further problems arise 
during purification of this sequence: quadruplex formation leads to substantial losses of 
oligonucleotide during the SEP-PAK procedure.  Taking these considerations into account, 
the following sequences were chosen as a model triplex: 
 
Duplex ON26+ON27 
ON26  5’-GCG CGA GAA GGA GAG AAA GCC GG-3’ 
 
ON27 3’-CGC GCT CTT  CCT CTC TTT CGG CC-5’ 
TFO 
 
           5’-CT CTT CCX CTC TTT C-3’ 
        X=T: ON28, X=3: ON29 
 
X represents a thymidine residue in the non-modified reference (ON28) triplex while in cases 
of cross-linking it represents nucleoside analogue 3 (ON29).  In first instance the melting 
temperature of the reference duplex is measured.  In Figure 111 the line with the circles 
represents the melting curve of the duplex showing a melting temperature of 75°C.   
 
When the non-modified TFO ON32 is added and the melting transition is measured under the 
same circumstances a second transition is observed. At 62°C a second melting transition can 
be observed for the triplex to duplex transition.  When one of the thymidine residues is 
replaced with building block 3 this second transition shifts for about 20°C to a lower 
temperature, still resulting in a stable triplex with a melting temperature of 42°C.  This means 
that at room temperature and even at body temperature the triplex incorporating the furan 
modified building block is stable.   
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Figure 111: Melting temperature of the reference duplex (rounds), non-modified triplex (squares)  
and the modified triplex (triangles) 
 
5.4.2 Cross-linking using building block 3 
 
Cross-linking experiments were conducted under conditions favourable for triplex formation, 
acetate buffer at pH 5, 2 mM MgCl2 and 100 mM NaCl.  The duplexes were first annealed 
from 95°C to 20°C after which the TFO’s were added.  To ensure the equilibrium is shifted 
towards triplex formation 1.5 equivalents of the TFO are added in all experiments.  The 
samples were equilibrated for at least 90 minutes at 20°C before cross-linking was tested.  
Oxidation of the furan modification was performed in a similar fashion as for duplex 
experiments.  One equivalent of NBS in 3 µl aqueous solution was added every fifteen 
minutes.  The oxidation reaction was monitored by RP-HPLC.  The column temperature for 
triplex experiments was raised from the usual 50°C to 60°C.  Due to the high stability of the 
triplex and duplex it is not possible to separate the three strands on RP-HLPC at lower 
temperature and hence it would not be possible to monitor the oxidation reaction of the 
modified strand at lower temperature.  A representative RP-HPLC chromatogram can be seen 
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in Figure 112.  Cross-linking was tested both at 25°C and at 37°C.  In both cases more than 4 
equivalents of NBS were needed to completely oxidize the modified strand. 
 
 
Figure 112: RP-HPLC chromatogram of the triplex cross-link reaction at 25°C before addition of NBS(A) 
and after addition of 4 equivalents of NBS (B) 
RP-HPLC analysis showed no cross-linking as no sharp new peaks were formed except for an 
expected peak for brominated modified strand (retention time 16.2 min).  To rule out 
formation of cross-linked species that degrade under the conditions used at the RP-HPLC, 
cross-linking should also be analyzed by gel-electrophoresis.  In Figure 113 a cross-link 
experiment at 25°C is shown.  The first two lanes each represent a single strand of the duplex, 
the third lane shows the duplex strands together, migrating with the same velocity in a 
denaturing gel.  Lane 4 corresponds to the mixture of duplex with TFO to which four 
equivalents NBS were added at 25°C, each with a fifteen minute time interval.  As can be 
seen from this figure no cross-linking is present as no new band is produced. 
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Figure 113: Denaturing PAGE (14%) of the triplex cross-linking experiment with ON26+ON27+ON29 
In a context where the modified building block in the TFO is facing an A.T basepair, no 
cross-linking seems to occur.  It was therefore decided to try and probe if cross-link formation 
was possible in a G.C-3 context.  Therefore a duplex consisting of ON30+ON31 was 
annealed and mixed with modified strand ON29.   
 
Duplex ON30+ON31 
 ON30 5’-GCG CGA GAA GGG GAG AAA GCC GG-3’ 
 
ON31 3’-CGC GCT CTT  CCC CTC TTT CGG CC-5’ 
 
 
 
Figure 114: Denaturing PAGE (14%) of the triplex cross-linking experiment with ON30+ON31+ON29 
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The problem associated with this specific duplex is that ON30 contains four guanosines in a 
row (see above).  In the gel-electrophoresis experiments this leads to formation of a band 
corresponding to a quadruplex as can be seen in Figure 114.  No cross-linking was observed 
in this case either.   
 
From these experiments it can be concluded that no cross-linking takes place when the furan 
modification is incorporated in the middle of a TFO.  Both in an A.T-3 or G.C-3 context no 
cross-link formation could be detected. 
 
5.5 Cross-linking at the terminus of a DNA triplex 
 
To probe if cross-link formation was possible with the modification at a different position 
inside a TFO, the modified building block 3 was immobilized on controlled pore glass in 
order to be used as first nucleoside in DNA synthesis.  For that purpose a succinate derivative 
of the DMT-protected modified building block was proposed using succinate anhydride in 
dichloromethane (Figure 115, 145).  The reaction needs no purification and the product can be 
used immediately for coupling to the solid phase. 
O
O
HO
DMTO
O
O
O
DMTO
O
O
OH
OO O
Et3N, CH2Cl2, rt, 4h
145121  
Figure 115: Synthesis of the succinate derivative of nucleoside 121 
Coupling to the solid support was achieved using diisopropylcarbodiimide (DIC, 145) and 
hydroxybenzotriazole (HOBT, 149) for coupling to amino-alkyl modified solid support.  
Protonation of DIC by the carboxylic acid proton sensitizes the central carbon for nucleophilic 
attack by the carboxyanion. The obtained isoureum derivative 148 is decomposed upon 
addition-elimination reaction with HOBT.  This results in a very reactive OBT ester 151 
which is ideal for amide bond formation with aminoalkylated CPG (Figure 116). 
 
 Tr
ip
le
x 
cr
os
s-
lin
ki
ng
 
156 
 
N C N
R OH
O
N C N
H
R O
O
+ N C N
H
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N
O
O
R
+
NH2
H
N R
O
146 147 148
149
150151152  
Figure 116: Formation of the amide bond between the aminopropyl-CPG  
and the succinate ester of the nucleoside (=R) 
The residual amine groups on the CPG were capped using a mixture of acetic acid, 1-
methylimidazole and lutidine.  After thorough drying of the support it was ready for DNA 
synthesis.  In this way oligonucleotides with modified building block 3 as 3’ cap can be easily 
obtained. 
 
These 3’-modified oligonucleotides were purified in a similar fashion as previous modified 
oligonucleotides.  The retention times of these modified strands were significantly higher 
compared to the internally modified oligonucleotides.  This is due to the effect of the apolar 
modification which is much more solvent exposed at this position.  The following sequences 
were synthesized: 
TFO ON32 5’-CTC TTC CTC TCT T3-3’ 
   TFO ON33 5’-CTC TTC CTC TCT TT3-3’ 
 
With strand ON32 a G.C-3 base pair context will be studied while ON33 leads to an A.T-3 
context.  In this way it is possible to test if there is a difference for cross-linking to A or C as 
was often observed for duplexes.   
 
The thermal stabilities of the triplexes before oxidation are shown in Figure 117.  The triplex 
with ON33 only decreases the triplex to duplex transition with 3°C with respect to the non-
modified triplex.  Compared to the internally modified TFO this destabilization is negligible.   
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Figure 117: UV thermal denaturation experiments with modified triplexes recorded at 260 nm in a 
solution buffered at pH 5 with 10 mM NaOAc, 100mM NaCl and 2mM MgCl2.  
The cross-linking experiment was conducted as before, again monitoring oxidation with RP-
HPLC and verification of cross-linking was done with denaturing gel-electrophoresis.  This 
time cross-linking was visible with the duplex as a slower migrating band appeared when 
cross-linking both at 25 and 37°C.   
 
As seen in Figure 118 the fully matched triplex gives rise to cross-link with both A and C.  
When introducing three mismatches in the middle of the duplex (duplex ON34+ON35, 
sequence see next page) compared to the modified strand no cross-link formation can be 
observed in gel electrophoresis experiments. 
 
Duplex ON26+ON27 
ON26  5’-GCG CGA GAA GGA GAG AAA GCC GG-3’ 
 
 
ON27 3’-CGC GCT CTT  CCT CTC TTT CGG CC-5’ 
 
Duplex ON34+ON35 
ON34 5’-GCG CGA GAA GAG AAG AAA GCC GG-3’ 
 
 ON35 3’-CGC GCT CTT  CTC TTC TTT CGG CC-5’ 
 
TFO ON32 5’-CTC TTC CTC TCT T3-3’ 
 
TFO   ON33 5’-CTC TTC CTC TCT TT3-3’ 
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Figure 118: Denaturing gel (14%) of cross-linking experiments at 25°C  
with modification 3 as 3’ terminal cap 
 
5.6 Conclusions for triplex cross-linking 
 
Nucleoside building block 3 was incorporated into different triplex forming oligonucleotides.  
It was tested if cross-link formation from this third strand was possible to one of the duplex 
strands.  When the modification was located in the middle of the TFO the thermal stability of 
the triplex was decreased substantially, but it still resulted in stable triplexes at body 
temperature.  Upon oxidation of the furan moiety no cross-link formation was observed.  A 
terminally located building block 3 resulted in a negligible loss in thermal stability.  Cross-
linking in this case was possible both in a G.C-2 context as in a A.T-2 context.  Introduction 
of 3 mismatches in the middle of the TFO resulted in no cross-link formation. 
 
These last results are very promising, but further mismatch studies should be performed.  One 
of the major advantages of this approach is that a terminal residue does not influence the rest 
of the triplex structure.  The introduction of a modification without the need of a labile 
phosphoramidite makes this approach widely applicable.  
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6 Base pair lifetimes of LNA modified oligonucleotides 
6.1 The importance of LNA 
 
As described in chapter 2, in a first phase of this work it was attempted to characterize the 
exact structure of the covalent bond within the cross-linked duplex.  As the specific 
knowledge for this type of study was not present in the lab, this research was initiated during 
a stay abroad in the Nucleic Acid centre in Denmark. 
 
Locked nucleic acid (LNA195, Figure 119) is a RNA mimic that is characterized by a furanose 
structure that is locked in the C3’-endo conformation or north conformation.196,137a  This is 
achieved by connecting the 2’ oxygen of a ribose sugar to C4’ via a methylene bridge.  LNA 
has an unprecedented affinity towards DNA and RNA.  The increase in melting temperature is 
dependent on the number of LNA incorporations and the sequence but the stabilization is 
between 1 and 8°C/modification for DNA duplexes and between 2 and 10°C/modification for 
RNA duplexes.197  Replacement of the bridging oxygen with N198 or S199 resulted in similar 
stabilizations.  Replacement of this oxygen by a carbon resulted in a decrease in melting 
temperature of 2.3°C per modification200 indicating that the heteroatom in position 2’ is a 
necessary structural feature.   
O
OO
O
N
NH
O
O
O
O
O
O
N
NH
O
O
5 5  
Figure 119: Two different views of LNA 
As LNA and analogues can be incorporated into oligonucleotides by the standard 
phosphoramidite approach they offer an easy platform for fine tuning hybridization properties 
of virtually any oligonucleotide.  They are very easy to handle and have a good solubility in 
water.   
 
Different crystal and NMR structures of LNA containing oligonucleotides have 
appeared.201,202,203  These studies show that LNA’s have a structural effect on the 
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neighbouring nucleosides.  Neighbouring sugar puckers are also converted into N-type sugars, 
especially the 3’ neighbouring nucleotides exhibit this effect.  The A-character of a DNA 
duplex increases as the number of LNA’s increases.  The optimum for increase in 
thermostability is observed for <50% LNA nucleotides, which corresponds with the structural 
saturation also observed around this limit (i.e. more modifications do not induce further 
structural changes in the neighbouring nucleosides).  LNA/DNA hybrids show structural 
features of a RNA/DNA duplex while LNA/RNA duplexes are structurally similar to 
RNA/RNA duplexes.  LNA was further shown to form triplexes,204 quadruplexes205 and i-
motif206 structures. 
 
LNA mismatch discrimination is equal or superior to that of native oligonucleotide duplexes.  
Because of this, they are used for detection of single nucleotide polymorphisms (SNP’s), even 
with sequences as short as 8 nucleotides.207  Other diagnostic applications can be found in 
miRNA detection in cells: as these miRNA’s are very small they are difficult to trace.  
Fluorescent LNA probes can be used to quantify the miRNA in cells.208  This can be 
generalized to in situ detection of RNA by hybridization with complementary LNA probes, 
the so called RNA capture probes.  They allow the study of the expression level and 
localization of RNA within eukaryotic cells.209  The only drawback that must be taken into 
account for these assays is that the LNA strand should not contain self-complementary 
segments because of the high affinity of LNA for other LNA’s. 
 
Because of its interesting properties LNA’s have been extensively tested for therapeutic 
applications.  LNA has been shown to enhance serum stability: three terminal LNA units are 
enough to cause resistance towards enzymatic degradation.210  LNA itself cannot activate 
RNase H but gapmers with LNA’s at the termini can.210  Further antisense strategies that can 
be applied with LNA include steric block,211 siLNA,212 and alternative splicing213 which are 
all due to its high affinity for RNA.  A last application worth mentioning is that incorporation 
of LNA into a catalytically active DNA molecule (LNAzyme) enhances RNA cleavage.214  
Because of the polyanionic backbone LNA can be delivered in cells by the standard protocols 
using cationic transfection agents.215,216  Some LNA-based drug candidates have already 
entered clinical trials although no extensive report was found in literature.  One antisense 
LNA oligonucleotide has entered phase I/II clinical trials for use against chronic lymphocytic 
leukemia.217 
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Because of these many applications it would be very useful to know how LNA behaves in a 
(DNA) duplex.  One of the internal motions, base flipping, can be monitored by NMR.  Study 
of this mechanism would allow correlating the particular LNA behaviour to motions at atomic 
level.  As certain torsion angles in LNA are structurally constrained, this study might give 
insight into the importance of certain torsion angles and would therefore enhance the 
understanding of the behaviour of DNA and LNA. 
 
6.2 Structure determination with NMR 
6.2.1 Introduction 
 
Several techniques can be used to probe the structure of large biomolecules such as DNA and 
RNA but only two can provide information at the atomic level: X-ray diffraction and NMR.  
X-ray diffraction offers the advantage that very large molecules can be studied way above the 
limit of what is possible by NMR.  But the major problem here is that crystals must be formed 
and if there are crystals they are not necessarily the crystal of a biologically relevant 
conformation.  Also crystal packing forces might affect the resulting structure.  Therefore X-
ray crystallography sometimes fails to provide the necessary information for solving certain 
biological mechanisms. 
 
NMR can be seen as complementary to crystallography: where the structures cannot be 
crystallized valuable information can often be obtained by NMR from small parts of the full 
molecule.  NMR can also yield information about the dynamics of the molecule in solution 
whereas X-ray studies solid structures so all dynamics is frozen.  The largest oligonucleotide 
structures studied by NMR are in the range of 70 nucleotides, but these large structures can 
only be solved with site specifically labeled oligonucleotides.   
 
A challenge associated with X-ray diffraction of oligonucleotides is that oligonucleotides 
often contain regions with enhanced flexibility which often results in very difficult 
crystallization.  These structures are particularly suited for NMR analysis, on condition that 
the flexibility is not too high either.  Another particular problem with X-ray of nucleic acids is 
that nucleic acids have a large surface/volume ratio and therefore the crystal packing forces 
are more important compared to for example proteins. 
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Of course NMR also has drawbacks.  One of the problems for studying oligonucleotides is 
that the proton signals are all resonating in the same small region often leading to spectral 
overlap that complicates analysis and limits the size of the studied molecules.  NMR can only 
provide structural data from short distances: J-couplings give information from torsion angles 
about single chemical bonds and NOE cross-peaks only arise for distances smaller than 5Ǻ.  
A more recent development, residual dipolar couplings (RDC’s), aids to solve this problem by 
providing information from the relative orientation of different parts of the molecule to each 
other.218 
 
6.2.2 IUPAC numbering of the natural nucleosides  
 
The nomenclature published by IUPAC/IUB is used for assignment of the resonances (Figure 
120).219 
Base
O
H2"OH
H2'H3'
H1'H4'
HO H5'
"H5
N1
C2
N3
C4
C5
C6
N9
C8
N7
NH2
N1
C2
N3
C4
C5
C6
N9
C8
N7
O
NH2
N3
C2
N1
C6
C5
C4
NH2
O
N3
C2
N1
C6
C5
C4
O
O
H3C
N3
C2
N1
C6
C5
C4
O
O
H
H
HH
H H
H
H
2'-deoxy-bèta-D-Ribose Adenine, A Guanine, G
Cytosine, C Thymine, T Uracil, U  
Figure 120: Nomenclature, structure and standard atom numbering of β-D-ribose  
and the nucleobases used during this work 
 
6.2.3 Structural information by NMR 
 
Various types of structural information can be obtained from homonuclear NMR-experiments.  
The most important are J-couplings as discussed before, resonance position, which give 
information about the chemical environment and NOE’s that yield inter-atom distances 
smaller than 5Ǻ.  RDC’s can provide information about the relative orientation of the 
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different parts of a molecule and finally also information about the dynamics of structures can 
be obtained.  Information about the global structure, for example A or B-type DNA, can be 
obtained from CD spectra. This global structure is correlated to the sugar-pucker.  The 
deoxyribose sugar puckering can be either N-type of S-type (Figure 121).  The former is 
standard for A-type DNA while the latter is the normal conformation for B-type DNA.  In 
practice the sugar puckering often is in an equilibrium between different conformations and 
this is reported as a certain percentage N or S.  J-couplings can be used to analyze the sugar 
conformation of the nucleotides.   
 
Base
O
C'5
C'1
C'2
C'3
C'4
Base
O
C'5
C'1
C'2
C'3
C'4
C'3 endo, N-type C'2 endo, S-type  
Figure 121: In-plane view of the conformation of N- and S-type sugar puckering 
The conformation of individual nucleosides can only be obtained by analysis of the 
J-couplings with the Karplus equation.220,221  However it is not always easy to extract this 
information from DQF-COSY spectra as the linewidth of the signals is finite and the digital 
resolution is often limited.  From a certain molecular model it is however possible to simulate 
the COSY cross-peaks with good results which allows easy comparison between the obtained 
and calculated spectrum. 
 
The chemical shifts are determined by the chemical environment of the relevant atom.222   Of 
course this environment is determined by the nucleotide sequence and this latter is also 
responsible for local conformation.  The resonance position of some signals is determined by 
the nature of the nucleotide they are part of while others are more dependent on the 
neighbouring nucleotides.  For example the chemical shift for H5 of dC and the methyl group 
of dT are mainly determined by the neighbouring nucleoside that is on the 5’-side while the 
chemical shift of the H1’ resonance is dependent on the nature of the 3’ neighbouring 
nucleoside.  The rest of the proton signals are dependent on the nature of the nucleotide they 
are part of and on the local geometry of the duplex. 
 
NOE connectivities as well as experiments to probe dynamics will be discussed in the next 
paragraph in more detail.  
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6.2.4 Assignment strategy 
 
The assignment strategy can be divided into two parts: the residue specific assignment and the 
sequential assignment.  The strategy presented here is specific for right-handed B-DNA 
duplexes. 
 
The residue specific assignment relies on COSY and TOCSY spectra: for each residue the 1H 
signals of the sugar-ring can be assigned based on the (DQF-) COSY spectrum.  The COSY 
experiment relies on 3J-couplings between signals.  If the coupling between two spins is large 
enough it will allow a through bond transfer of magnetization and a cross-peak will appear in 
the 2D spectrum.  This translates in cross-peaks between H1’ and H2’/” but also from H2’/” to 
H3’ and so on.  The COSY spectra can also be used for connecting nucleobase signals: H5 and 
H6 of dC and dU give intense cross-peaks in the aromatic region and the methyl group of 
thymine or methylated dC give also a cross-peak to their neighbouring H6 proton (4J-
coupling).   
 
The TOCSY spectrum can be used to verify if the COSY assignments are correct, especially 
in case of overlap this can be necessary.  In TOCSY (TOtal Correlation SpectroscopY) 
experiments magnetization can be transferred through all protons that have a 3J-coupling 
between them.  So with this type of experiment it is possible to see cross-peaks from H1’ to 
H2’ but also from H1’ to H3’ and H4’ etc. 
 
Once the intra-residue connectivity’s based on J-couplings are solved, the next assignment 
phase can be started: the sequential assignment.  It is possible to assign the sequence through 
bond by hetero-correlation experiments: a correlation can be made from H5’ or H5” to the 
neighbouring phosphorus and from this phosphorus again to the H3’ of the next residue, in 
theory.  In practice this is only possible for small molecules as the 31P resonances are often 
poorly resolved and the 1H-31P couplings are small.223  This explains why DNA duplexes rely 
on NOE connectivities for sequential assignment. 
 
The general assignment strategy starts from one specific residue whose signals can be easily 
assigned such as a terminal residue or a thymidine.  From the aromatic resonances of this 
residue the NOE connectivities will allow to link the intra-residue protons as well as inter 
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residue (H6/8 to H1’ and H6/8 to H2’/” being the most important).  By combining this NOE 
information with TOCSY and COSY spectra a full assignment can be made of the duplex. 
 
The connections can be divided in different groups forming cross-peaks at distinct regions in 
the NOESY spectrum.  The most important inter-residue signals are shown in Figure 122.  As 
the aromatic H6 spins resonate above 6 ppm and H1’ around or below 6 ppm their cross-peaks 
correspond to the colored zone in Figure 122.  As the 5’-terminal H6 (or H8 for purines) has 
only one cross-peak to a H1’, its own, this is an ideal starting point for interconnecting all 
residues from a specific strand.   
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Figure 122: NOE connectivities between the aromatic spins and H1’ 
In theory it is possible from analysis of this region together with the COSY and TOCSY 
spectra to assign all non-exchangeable protons from the duplex.  The only complication is the 
presence of H5-H6 cross-peaks arising in the same region but they are easily distinguished as 
they are the most intense signals for anti-nucleosides: they are 2.45Ǻ from each other while 
H1’ is approximately 3.7Ǻ away from the aromatic H6/H8 spin both inter- as intra-residue.224  
If syn-nucleosides are present they will also show very intense cross-peaks for H6/8 to H1’ so 
based on these peaks it can be determined whether the glycosidic bond is syn or anti. 
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Figure 123: NOE connectivities between the aromatic spins and H3’ and H2’ or H2” 
The cross-peaks between the aromatic protons and the sugar H2’/” and H3’ (Figure 123) can 
be used to confirm the assignments made with COSY and to confirm the assignments of the 
sequential nucleotides.  The cross-peak intensity can also give information about the torsion 
angle around the glycosidic bond χ.  Although these intensities (and thus distances) depend 
only weakly on the sugar puckering, a combined used of these distances makes it possible to 
determine the percentage of N- or S-pucker as alternative for J-coupling based methods even 
though the uncertainty is larger.225  One exception to this rule is the H3’ to H6/H8 signal 
which is very intense for N-type sugars.  Therefore it allows easy detection of N-type sugars. 
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Figure 124: NOE connectivities between the aromatic spins and the dT methyl group. 
 
The last set of cross-peaks shows the proximity of the thymine methyl group to its intra-
residue H6 and to the aromatic proton of its 5’-neighbouring base.  No correlations with the 
aromatic protons of the 3’-flanking base are seen.  As this is in a spectral region with very few 
signals these cross-peaks with dT are also ideal starting points for the assignment.  The other 
regions present in the NOE-spectrum can be used to confirm the identity of the already 
assigned signals 
 
H4’ and H5’ are not always assigned as they are in a spectral crowded region (around 1 ppm).  
The limited number of NOE-cross-peaks to H4’ renders analysis very difficult.  One 
possibility to assign H4’ is by the presence of H1’ to H4’ cross-peaks in the TOCSY spectrum 
as to H5’/” these are not observed. 
 
After assignment of all non-exchangeable protons, the exchangeable protons should be 
assigned.  These supply the most intense interstrand cross-peaks.  The spectra to visualize 
these must be recorded in water, as they cannot be detected in D2O due to H/D exchange.  As 
some deuterium must be present in the sample to lock the sample a mixture of 90% H2O and 
10% D2O is used.  The WATERGATE255 solvent suppression can be used in combination 
with a NOESY pulse scheme to yield the desired cross-relaxation peaks. 
 
Non hydrogen-bonded imino-protons resonate somewhere around 10ppm.  If they become 
hydrogen bonded they shift downfield: thymine imino-protons shift most downfield ending 
around a chemical shift between 13 and 14.5 ppm while the guanine imino-protons end up 
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resonating between 11.5 and 13.5 ppm.  In general the imino-proton signals are quite sharp, in 
contrast to the amino-protons that are broadened due to chemical exchange with the solvent.  
Cross-peaks are normally visible between the T imino-resonance and the amino- and H2 
signal of A (latter distance: 2.8Ǻ) and in case of a G.C pair between the imino-proton of G 
and the amino-protons of C. 
 
The position of amino-proton resonances involved in Watson-Crick base pairing is between 
6.5 and 9 ppm.  In general they are not chemically equivalent and one of the two hydrogen 
atoms is resonating upfield from the other so there is no fast (on the NMR time scale) 
conformational exchange.  The signal resonating downfield is the internally, hydrogen bonded 
amino-proton while the amino-proton exposed to the solvent will show a more upfield shift.  
Cytidine amino-protons are easily assigned as they exchange the slowest of all amino-protons.  
Adenine amino-protons are more difficult to assign as they exchange faster and guanine 
amino-protons are exchanging so fast that they are rarely observed. 
 
As the planes defining one base pair are only separated by 3.5Ǻ, often intra-strand NOE’s can 
be seen.  This is for example the case for the amino-protons of A or C if they are flanked by 
another A or C.  When two bases with imino-protons are flanking each other often intra-
strand imino-imino cross-peaks are observed and in case of GA or AG context inter-strand 
cross-peaks of the imino-protons between the G and T can be observed too.  The imino- and 
amino-protons at the termini are exchanging faster with water and therefore these are often 
not possible to assign.  In general this exchange can be slowed down by lowering the 
temperature of the sample which often leads to better spectra of the exchangeable protons. 
 
A full overview of the sequential intra- and interstrand proton-proton distances for all possible 
base combinations can be found elsewhere.226 
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6.3 The study of exchangeable protons in nucleic acids 
6.3.1 Importance 
 
Base pairing is an important feature of nucleic acids: the hydrogen bonding of the nucleobases 
protects them and their genetic information and it plays a key role in the function and 
structure of large biological structures such as tRNA.  The base pairs are subject to various 
fluctuations which have certain biological relevance.  Base pair opening can be seen as the 
destruction of Watson-Crick hydrogen bonding within a base pair and movement of at least 
one base out of the helical stack.  It is a key step in recognition by different enzymatic 
processes such as nucleotide excision repair227, and it makes reactive sites on the base 
accessible for chemical attack.228  Another feature of these fluctuations is that they are 
supposed to be the first step in a larger disruption of the helix necessary for both replication 
and transcription.   
 
During this opening, the reactive groups on the base become accessible for reaction such as 
methylation or exchange of protons.  The protons that can exchange in DNA are the imino-
protons of dG and dT and the amino-protons of dA, dC and dG, all of which are involved in 
hydrogen bonding.  The imino-protons are used to determine the dynamics of opening as they 
are least solvent exposed and therefore they are supposed to exchange mainly when the base 
pair is open.  The first step in this exchange process involves the disruption of the hydrogen 
bonds of a base-pair which is followed by flipping out of one of the two bases.  Once flipped 
out, the imino proton of this base or of its complement, can exchange.  As the whole process 
is catalyzed by proton acceptors this means that the rate limiting step can be catalyzed.  Only 
the second step, the chemical exchange, can be catalyzed by proton acceptors so it is the rate 
limiting step.  It was shown that no exchange is possible from the closed state as exchange in 
absence of catalyst is much slower than exchange from the single nucleoside. 
 
6.3.2 Imino-exchange theory 
 
The method used in this study is the inversion recovery method which is used to determine T1 
of the imino-protons.  The imino-proton exchange is catalyzed by general base catalysis248 
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and hence catalysts can be used to monitor the kinetics of base pair opening.  A general 
scheme for exchanging of imino protons in a DNA duplex is given in Scheme 29. 
(NH)cl (NH*)cl (NH*)op (NH)op
ktrc
kcl
kop
ktro
 
Scheme 29: Imino-proton exchange scheme in a DNA duplex 
kcl and kop represent the closing and opening rate of the base pair while ktrc and ktro represent 
the proton transfer rates in closed respectively open state.  The disappearance of the asterisk 
indicates the exchange has taken place.  From this reaction scheme the following rate 
equations can be obtained: 
(1)  
(2)  
The solution to these differential equations is229: 
(3) .	..
	.
 
With kex representing the exchange rate that is the inverse of the exchange time τex.  This 
exchange time corresponds to the time where the concentration of a protonated imino function 
has dropped to 1/e of the initial value.230  By inverting equation (3), one gets: 
(4) 	
  	   	 
 
Where β= ktrc/ktro.  As exchange cannot occur from the closed state231,232, β is zero (so a three 
state system is obtained) and the equation can be simplified to: 
(5) 	
   
 
 
With Kd=kop/kcl.  If an external catalyst is added and this catalyst acts similarly on the open 
state as on the isolated nucleoside, ktro would be equal to ki (=1/τi).  This is not always the 
case as a bulky catalyst may have hindered access to the open base pair or differences may 
arise due to the electrostatic interaction between a charged catalyst and the polyelectrolyte.  
Therefore a correction factor α was introduced which correlates ki with ktro: ktro=α ki.250  For 
NH3, the catalyst used in this study, the value of α can be considered close to one.  This 
transfer rate from the monomer ki is given by:233 
(6) 		 
With kcoll the collision frequency between the donor, in this case the nucleoside, and the 
acceptor, which is the added base.  The factor (1+10(pKnu-pKbase))-1 represents the fraction of 
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collisions that is effective for transfer.  ki was determined experimentally to 
2.10-8.[Base].s-1.M-1 for both T and G. 234 
 
The base concentration is proportional to the total amount of buffer added and is also in 
relationship with the pH of the sample.  It is very important to note here that pKbase is 
temperature dependent235: 
(7) 	 
 
Upon substituting ki in (5) equation (8) is obtained: 
(8) 

 
 
As the base concentration is explicit in ki the plot of the exchange time in function of the 
inverse catalyst concentration will be a straight line whose extrapolation to infinite catalyst 
concentration ( yields the base pair lifetime τop.  From the slope of this chart the 
apparent dissociation constant, αKd, can be determined.  Some publications have the catalyst 
concentration explicit in the second term in equation (8).236,237  This relies on two different 
definitions: they divide ki by the base concentration (so ki=π∆/[Base], ∆ represents here the 
linewidth of the imino proton of a free monomer) and to compensate this factor they re-
introduce the base concentration in ktro=α [Base] ki.  Of course the result is the same but 
attention must be paid not to mix up the different theories.   
 
The exchange time at a defined base concentration can be measured by the following 
equation: 
(9) 
  
 
With Trec the longitudinal relaxation time (or T1) in the presence of a specific base 
concentration and Taac the longitudinal relaxation time in absence of catalyst.  This latter 
factor accounts for differences in relaxation rate that are not originating from external 
catalysis addition.  This relaxation time is measured in the presence of the high salt 
concentration which is present in the catalyst sample [Buffertotal]-[Base].  This correction 
factor is needed as high salt concentrations, resulting from the conjugated acid of the catalyst, 
induce changes in dipolar relaxation due to changes in correlation time.236  The correlation 
time is a measure for the time it takes for a molecule to rotate around its axis in solution; 
hence this suggests aggregation of the duplex as larger molecules rotate slower.  As a 
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consequence spin diffusion is enhanced and the longitudinal relaxation will become faster 
resulting in an underestimation of the exchange times and an overestimation of the 
dissociation constant.251 
 
From the dissociation constant at different temperatures it is possible to extract 
thermodynamical parameters according to the van ’t Hoff equation (with R the gas constant 
and T the temperature in K): 
(10) 
°

°
 
The activation Gibbs free energy can be calculated via Eyring’s absolute reaction rate 
theory238 on the basis of the exchange times (τop=1/kop): 
(11) 
°
 
In this equation k is the Boltzmann constant, h is the Planck constant and κ is the transmission 
coefficient of the activated state which is assumed to be 1.  This transmission coefficient is a 
coefficient taking into account the fraction of bases returning to closed state when they have 
already crossed the activation energy but the flipping process itself did not happen. 
 
6.3.3 Methods 
A. Non-NMR methods 
 
In general these techniques are not accurate as they can only measure an average over 
different protons in a sample.  They rely on the exchange with light and heavy or tritiated 
water or chemical probes such as mercury239 or formaldehyde.240  The main advantage of the 
hydrogen exchange experiments is that they are not perturbing the structure. 
 
For example the approach from Engelander tritiated different DNA duplexes after which the 
duplexes were immobilized on a sephadex column.241  Once on the column the tritium begins 
to exchange with the light water present in the column and in the column effluent the tritium 
can be measured.  The plot from measured tritium versus time gives an indication of the rate 
of proton exchange under given conditions.  But of course this is an average over all base 
pairs.  They erroneously concluded that the imino-protons exchange very fast, every time the 
base-pair opens exchange occurs, as they found the exchange was insensitive to chemical 
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catalysist.  With NMR experiments it was found that the concentrations used in these studies 
were too low to catalyze the exchange efficiently. 
 
A different methodology, used quite often, is the stopped flow kinetic studies with UV.242  
The exchange of nucleotide hydrogen for deuterium generates a shift in the UV spectrum.  A 
stock solution of oligonucleotide was quickly mixed inside the spectrophotometer with a 
deuterium oxide solution.  By monitoring the change in transmittance, which is usually in the 
range of 10 %, one can obtain a measure for the exchange mechanism.  This is of course again 
a rough method and similar results were obtained as with the previous method.  This method 
was also used to study DNA-LNA hybrids.243 
 
A different spectroscopic technique is based on resonance Raman spectroscopy.244  Its 
advantage compared to previous methods is that the observed differences between deuterated 
and non-deuterated bases are more significant and that it also allows selective monitoring the 
exchange of C or G by excitation at the appropriate wavelength.245 
 
B. NMR methods 
 
Different NMR-methods can be used for determination of the kinetics and thermodynamics of 
exchange processes within DNA.  Depending on the timescale on which the exchange process 
takes place, one should use different NMR techniques.  Exchange times between 1 minute and 
1 seconds as well as those below 1 ms are not routinely accessible by NMR.  Long exchange 
times can be measured by proton-deuterium exchange experiments in a similar fashion as the 
stopped flow kinetic experiments but NMR offers the advantage that it allows site specific 
exchange measurement.  All of the following methods rely on the assumption that no 
exchange takes place from the closed state of a base pair. 
 
Real time experiments, similar to the deuterium experiments in previous section, can be used 
with NMR for probing base-pair opening.246  The oligonucleotide is dissolved in protonated 
buffer and fast mixing is achieved by introduction of a Teflon capillary with deuterated 
solution into the NMR tube.  At time zero the solution is mixed together by a syringe 
connected to the capillary.  0.4 minutes after mixing the measurement can be started so the 
minimal exchange time that can be measured with this method is one minute.247  The time it 
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takes for the imino-signal to disappear completely is the exchange time under those 
conditions.  This method is only suited for exchange processes that are very slow such as 
imino-protons in quadruplexes. 
 
The first paper describing the current model describing duplex base-pairing was published in 
1985 by Leroy and co-workers.248  They used saturation transfer from water to label 
magnetically the exchangeable protons.  The line broadening of the NMR signal upon 
addition of catalyst is a measure for the exchange time: the faster the imino- and amino-
protons exchange rate is the broader the signal will become.  The exchange times correlate to 
the increase of full-linewidth at half maximum (∆) by the relation: 1/τex=π∆.  Exchange times 
in the range of 1 to 100 ms are accessible by this method.249  The base pair lifetimes can be 
obtained by plotting the inverse exchange times versus the inverse catalyst concentration and 
interpolating the exchange time to infinite catalyst concentration.  This last situation 
corresponds to the opening limited exchange mechanism: exchange occurs every time the 
base pair opens because of the high catalyst concentration. 
 
The standard method currently used for determination of exchange times relies on the 
determination of T1 of the exchangeable protons.250  The T1 or longitudinal relaxation time of 
imino protons has two contributions: the cross-relaxation with a second proton, such as an 
amino-proton, and chemical exchange.  The first is independent of catalysis whereas the 
second is dependent only on catalysis.  However if the second -cross-relaxing- proton is also 
exchanging faster because of the catalyst, there could be an indirect effect of the catalysis on 
this cross-relaxation, but it was proven that this contribution is negligible.  Therefore the 
exchange time can be obtained by (τex)-1= (T1cat)-1-(T10)-1.  T1cat is the relaxation time with 
catalyst and T10 is the relaxation time without catalyst.  This latter relaxation time is measured 
with the salt concentration which is also present in the sample with catalyst (as conjugated 
acid of the catalyst).  If this difference in salt concentration is neglected it might cause 
underestimation of the base pair lifetime as salt can enhance the relaxation.251  By plotting the 
exchange times against the inverse concentration of added catalyst and extrapolating the 
exchange time to infinite catalyst concentration the base pair lifetime will be obtained if the 
measurements are done under conditions where the exchange is catalyst dependent (see 
below).  This way exchange times between 10 and 600 ms are accessible. 
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Dissociation constants could also be obtained by measuring the changes in imino chemical 
shift at different temperatures.121  These differences are only significant for the terminal base 
pairs as these have large dissociation constants, so this method is only suited for the study of 
end fraying.  The imino chemical shift from the closed base pair δc will be significantly 
different than the shift from the open base pair δo.  As a result the observed chemical shift of 
this proton is the population average of the chemical shift it adopts in each of the two states 
present.  From this, the dissociation constant from the terminal two base pairs can be 
calculated with (δc – δ)/(δ – δo)=Kdiss.  However this requires knowledge of the imino 
chemical shifts of the open and closed states.  These are approximated by the chemical shift of 
the mononucleotide respectively the chemical shift in the duplex at very low temperature 
where the equilibrium is almost completely shifted to closed state. 
 
In the same publication the dissociation constant was also determined by the apparent pK shift 
of the imino proton, traced by the titration of the aromatic proton chemical shift.  The 
midtransition point inside a duplex pK(app) is changed compared to the isolated nucleoside 
pKi.  From this it is possible to calculate the equilibrium constant at the point of mid-titration 
Kd with the equation 10pK(app)-pKi = (1+1/Kd).  The dissociation constant itself is pH dependent 
and was shown to correspond with: Kdiss= Kd(1+10pH-pKi).  There is a quite large uncertainty 
for this measurement due to the crudeness of the model.  A more in depth discussion of the 
theory behind this model can be found in reference 121. 
 
6.3.4 NMR experiments 
 
The experiments used for determination of the exchange times with and without catalyst are 
inversion recovery experiments.  The standard pulse sequence for an inversion recovery 
experiment is shown in Figure 125.  At time zero the bulk magnetization is located on the 
positive z-axis.  A 180° pulse is applied to transfer the magnetization to the –z axis.  The 
magnetization will in time return to its equilibrium position along the +z axis.  This process is 
called longitudinal relaxation.  Also transverse relaxation exists; it is the loss of magnetization 
in the xy plane and can be used to determine T2.   
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τ
180° 90°
z
-z
y
FID (t1)
 
Figure 125: Pulse sequence of the inversion recovery experiment used to measure the longitudinal 
relaxation, below: evolution of the longitudinal magnetization 
As the bulk magnetization returns to equilibrium the net magnetization on the z axis increases 
(or decreases on the –z-axis) with the time.  However the magnetization along the Z-axis is 
not observable.  Therefore if one wants to measure how far the z-magnetization has relaxed a 
second pulse is necessary to transform the z-magnetization into observable magnetization.  
This second pulse, applied on the x-axis, will rotate the z-magnetization (+ or -) from the z to 
the -y-axis.  As this net longitudinal magnetization is in the xy-plane it can be observed by 
recording its free induction decay (FID).   If the time τ between the two pulses is very small 
the resulting signal will be negative and quite large.  Upon increasing τ the resulting signal 
will shrink to zero and will finally become positive.  The intensity of the resulting resonance 
I(t), is a function of the longitudinal relaxation time T1 and the recovery delay τ.  T1 can then 
be obtained by fitting the intensities from varying delays τ to equation (12).  
(12) 

 
In this equation I(0) represents the resonance intensity immediately after inversion and I(∞) 
the peak intensity after full recovery. 
 
This experiment is however a simplified version of what was used in practice.  Some changes 
had to be introduced to make this sequence applicable for these imino-exchange experiments.  
The 180° pulse has to be selective as only the imino-protons of the spectrum need to be 
inverted.  If not the relaxation rate of the imino-protons would not only be dependent on the 
chemical exchange with catalyst, but also on the relaxation rate of the bulk solvent, water.    
Selective excitation of a spectral region can be performed with selective (“shaped”) pulses 
and ISNOB-5 (Inversion Selective excitatioN fOr Biochemical applications) is used here.252 
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Further modifications of the pulse sequence imply solvent signal suppression: as the samples 
are recorded in 90% 1H2O the magnetization of water needs to be suppressed.  The intensity 
of the water resonance is at least 100000 times larger than the intensity of the imino-signals in 
a normal sample.  The ratio between these falls outside the dynamic range of the analog to 
digital converter (16 bit) so only the water signal would be observed.  Jump-and-return253 (JR) 
is preferred for this type of experiments over methods such as presaturation254 and 
WATERGATE.255  The major advantages of JR are that this sequence does not alter the 
solvent magnetization, it has the shortest excitation time of all, it gives good sensitivity and it 
does not result in a linear phase shift.   
 
The JR sequence253 consists of two on resonance (i.e. on the water signal) hard 90° pulses that 
are oppositely phased and separated from each other by a delay ∆.  The first pulse (90x) 
moves all magnetization from the +z axis to the y axis.  During the waiting time ∆, the spins 
can dephase into the xy plane except for the solvent spins which are on resonance.  This 
waiting time is adjusted to obtain maximal excitation of the imino protons.  The second pulse 
will then move the spins from the xy plane to the zy plane and the solvent spins will be 
returned to the z-axis where they started initially.  The FID which will be recorded 
immediately after will show a strongly reduced solvent signal as the solvent spins are already 
at the positive z-axis at the beginning of the FID. 
 
τ
180°
90° -90°
∆
t1
∆=1/(f-f ).4  
Figure 126: Pulse sequence of the used inversion recovery experiment used to measure the longitudinal 
relaxation, f is the frequency of the excitation maximum and fwater is the frequency of water. 
 
The pulse sequence used is shown in Figure 126.  The FID is recorded during t1, so 
immediately after the last pulse of the solvent suppression.  The delay τ is variable while the 
delay ∆ is fixed.  Nineteen values for the recovery delay τ were used for each experiment.  A 
very important practical aspect with this sequence is that the time interval between following 
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pulse sequences should be sufficiently long so that all imino-proton magnetization has time to 
relax to equilibrium.  
 
An example of a T1 experiment is shown in Figure 127.  It shows the imino-protons in the 
DNA:LNA hybrid (assignment: see paragraph 6.5.1).  The lowest NMR-profiles have the 
smallest values for τ: their magnetization is still on the negative Z-axis at the end of the delay.  
As the delay increases the Z-magnetization of each of the signals goes to zero and finally 
becomes positive.  The rate by which each signal relaxes is different but these differences are 
so small they often cannot be seen with the eye.  The plot of the intensities of each signal in 
the 19 frames should be fitted to equation 12 to obtain the T1 of each signal. 
 
 
Figure 127: T1 relaxation spectrum of the DNA:LNA duplex with 0.1M NH3. 
 
  
τ 
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6.4 Current status of base pair opening research 
6.4.1 NMR 
 
During the last two decades over thirty studies have been reported using different NMR 
methods for the study of internal motion in DNA.  For DNA duplexes the base pair lifetimes 
at room temperature for G.C pairs is typically in the range 4-40 ms and for A.T between 0.5-
7ms.250  Non-NMR experiments presented consequently larger base pair lifetimes.  When the 
first paper describing the susceptibility of imino-exchange to base catalysis appeared, it was 
suggested that the new technique was monitoring a different opening mode.  This was refuted: 
as there is a threshold below which addition of catalyst does not have an effect, both methods 
were acting on the same process.256  This is because the exchange can also take place in 
absence of added catalyst (AAC exchange): this exchange can be explained by a proton 
acceptor that is intrinsic to the DNA duplex such as a neighbouring amino-group.  If lower 
amounts of catalyst are added the exchange is dominated by the AAC exchange.   
 
The choice of the catalyst for these studies is very important as bulky catalyst might not have 
access to the imino-proton of the flipped-out base.232  Further properties of the catalyst should 
include that they come with minimal concentrations of conjugated acid and its pKa should not 
be much less than the proton acceptor.  The pH on the other hand should not be too high as 
this can induce structural changes in the DNA.234  Therefore NH3 is commonly used as 
catalyst (pKa 9.3 at room temperature) in a borate buffer solution of pH 8.8.  Base pair 
opening was shown not to be cooperative250 as neighbouring base pairs open with different 
dissociation constants and base pair lifetimes.  However certain specific DNA sequences can 
show dynamics that are dependent on their neighbours.257  This is not necessarily related to 
their duplex structure such as is the case with A-tracts234,258 and Z-DNA247 but can also have 
an energetic or dynamic origin.  Furthermore correlations can be made between specific 
structural features and helix-stability: the C5 methyl group of thymine is the stabilizing factor 
in A-tracts.259  
 
RNA was actually studied before DNA: the imino- and amino-proton exchange processes for 
poly(rA).poly(rU) and poly(rI).poly(rC) were already reported in 1985.248  This study was the 
first to state that under near physiological conditions the exchange step was the rate limiting 
step of the process rather than the opening step.  The knowledge about RNA dynamics was 
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extended with several other papers.  The base pair lifetimes in RNA for G.C pairs are slightly 
higher than in DNA (up to 50 ms) while their apparent dissociation constant is slightly smaller 
(around 10-7).  For A.T pairs the inverse is true although less pronounced (≤0.1 ms, 10-5-10-
6).260  This behaviour was attributed to a higher activation energy for base pair opening.  This 
behaviour was seen for standard RNA duplexes.  RNA has the ability to fold in different non-
canonical structures and in those the properties can be strongly different.  For example within 
one RNA structure, the binding domain of sarcin-ricin, the dissociation constant Kd spans 6 
orders of magnitude (between 7.10-9 and 6.10-3).261  Similar variations were also observed in 
the AMP-RNA aptamer complex.262 
 
Besides DNA and RNA duplexes also RNA/DNA hybrids were studied.263  However these 
experiments were conducted at low pH with a very short duplex (6-mer) and therefore the 
results of this study might not be representative. 
 
Structural features such as fraying121 and mismatches264 were also studied.  Fraying is the 
destabilization observed at the termini of the duplex.  The terminal base pair is less influenced 
by ammonia catalysis despite exposure of one face to the solvent and the intrinsic catalysis of 
this pair is less efficient than an internal one.  No exchange was observed from the closed 
state.  The dissociation constants for terminal base pairs are very large, in the range of 0.01 to 
0.6 depending on the temperature.  Mismatches also show short base pair lifetimes.  The 
effect on the dynamics of the neighbouring base pairs extends to two bases from the 
mismatch. 
 
In special DNA structures the kinetics also change compared to normal ds-DNA.  In triplexes, 
the Hoogsteen-base pairs have comparable stability to Watson-Crick base pairs in normal 
duplexes but the Watson-Crick base pairs in the triplex are stabilized up to 5000-fold.265  
Mismatches in the TFO induce changes on the neighbouring base pairs rather than on 
themselves.266  I-motifs were also studied; they have extremely long lifetimes in the range of 
hours at pH 4.8.267  Further studies have concerned exchange in DNA-drug complexes,268 
PNA-modified duplexes237 and 6-thioguanine modified duplexes.269 
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6.4.2 Molecular modeling studies 
 
The ultimate goal of the imino-exchange experiments is to fully understand the complete 
dynamics of any structure.  The problem is that with these experiments we cannot obtain 
information about the structure of the open base pair so it is difficult to correlate the dynamics 
with specific motions; we can only make educated guesses.  Modeling studies have helped to 
give information about the structure of the open base pair and also on the base pair opening 
itself.  Current processors do not allow to simulate a complete base (possible) opening as this 
process is too slow (some ms whereas only simulations of some ns can be run) but the 
energies of positions along the opening pathway can be calculated270 with umbrella sampling 
simulations.271  All studies started from the common assumption that base flipping is a two 
state process which distinguishes the open from the closed state by its ability to exchange 
imino-protons. 
 
Early on it was already shown that base flipping was energetically coupled with bending of 
the duplex.272  As bending induces structural changes on the nucleoside level it was not 
surprising to see that opening of a base also induces changes of backbone angles.  However it 
was noticed that torsion angle transitions were also occurring in the complementary strand but 
no coupling with the neighbouring bases was observed.273  Based on modeling studies the 
opening pathway is supposed to take place first by opening of both bases simultaneously until 
a small angle.  Later one base springs back to initial position while the other base flips out 
further.  From a flipping angle of at least 50° the imino-protons of T/G become sterically 
accessible and hence they can exchange.274  The equilibrium constants for opening of 
individual bases were also calculated and they were shown to be much larger for purines than 
for pyrimidines.275  From these results it was concluded that imino-exchange experiments 
predominantly monitor the opening of the purine bases. 
 
Modeling of the base flipping showed that opening take place preferentially towards the major 
groove for both purines and pyrimidines for sterical reasons.  It was further shown that the 
flipping process is coupled to the groove width and flexibility.  For proton exchange to take 
place it is predicted that a bridging water molecule aids this exchange as is observed in X-ray 
structures.276   
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Mismatched DNA (G.T or G.U) was also studied by molecular modeling.  Calculations 
suggested in this case opening of both bases simultaneously and this model was supported by 
NMR exchange results.277  This bilateral opening mode was later generalized to all base 
pairs,278 but this contrasts with the X-ray structures that observed one base flipped out with 
the complementary base left in stack.279   
 
So from molecular modeling the current theory for base flipping is described by initial 
coupled opening towards the major groove.  Subsequently one base springs back into stack 
while the other continues flipping out.  From an opening angle of 50°, the imino-proton 
exchange is possible for both nucleobases.  Base flipping is independent of the neighbouring 
nucleotides as base-pairs open one at a time, but the complementary strand can influence the 
flipping process. 
 
6.5 Results 
6.5.1 Assignment of the DNA:LNA duplex 
 
As the DNA:DNA duplex and LNA:DNA duplex were already assigned229 the same sequence 
but with DNA:LNA composition alone still had to be analyzed.  The sequences from all three 
duplexes are shown in Figure 128.   
5'-C1   A2   G3   T4   mC5 A6    G7   T8    T9   C10 A11 G12-3'
3'-G24 T23 C22 A21 G20 T19 mC18 A17 A16 G15 T14 C13-5'
m
5'-mC1 A2  G3   T4   mC5 A6     G7   T8    T9 mC10 A11 G12-3'
3'-G24 T23 C22 A21 G20 T19  mC18 A17  A16 G15 T14  C13-5'
DNA:DNA
LNA:DNA
ON36
ON37
ON38
ON37
 
Figure 128: Sequences of the reference and modified duplexes.  Bold bases represent LNA-bases,  
m
C represents cytidine methylated at position 5 
In the DNA:LNA duplex bases 1-12 are normal deoxyribonucleotides except for C5 which is 
methylated on position 5 and bases 13-24 are LNA nucleotides.  All protons except H4’, 
H5’(’) and the methylene linkage protons are assigned.  These are difficult to assign 
unambiguously and do not give substantial extra structural information about the hybrid.  The 
complete assignment is shown in Table 21. 
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H6/H8 H1' H2' H2" H3' H5/H2/CH3 H1/H3 NH2/H4 
C1 8,01 5,96 2,43 2,81 4,27 6,11 
A2 8,33 6,40 2,42 2,98 5,06 7,70 
G3 7,28 6,08 2,59 2,76 5,51 13,22 
T4 7,44 6,06 2,46 2,74 4,33 1,06 13,96 
meC5 7,57 5,94 2,45 2,63 4,84 1,59 6,60/8,31 
A6 8,02 6,26 2,44 2,81 4,91 7,05 
G7 7,04 5,95 2,51 2,69 4,54 13,06 
T8 7,38 6,04 2,34 2,70 4,30 0,98 14,01 
T9 7,65 6,13 2,35 2,69 4,88 1,48 13,12 
C10 7,54 5,95 2,22 2,56 4,86 5,53 6,75/8,08 
A11 8,11 6,17 2,64 2,86 5,01 7,30 
G12 7,53 6,12 
meC13 7,57 5,40 5,19 4,44 1,92 6,79/8,22 
T14 7,57 5,53 5,31 4,72 1,66 13,44 
G15 7,45 5,77 5,04 4,74 11,70 
A16 7,31 5,77 5,06 4,66 7,40 6,95/8,05 
A17 6,97 5,70 5,00 4,41 7,82 6,74/8,70 
meC18 6,55 5,20 4,95 4,26 1,36 6,74/8,70 
T19 7,39 5,95 5,18 4,65 1,49 13,14 
G20 7,06 5,72 4,97 4,38 11,72 
A21 7,19 5,83 5,01 4,52 7,69 6,75/8,08 
meC22 6,66 5,28 4,97 4,31 1,37 6,81/8,80 
T23 7,33 5,55 4,88 4,53 1,51 13,22 
G24 7,83 6,04 4,53 4,35 
Table 21: Chemical shifts of all assigned protons from the DNA:LNA duplex at 25°C (on a 500MhzVarian 
Inova) in ppm relative to the residual solvent peak.   
 
6.5.2 Structural implications of the base addition280 
 
In order to test if the base opening parameters obtained are from one structure, it is important 
that the structure of the molecule at the beginning of the titration is the same as at the end.  
This can be verified for example by recording NOESY spectra before and after the titration.  
If there are no significant differences in the cross-peak patterns it can be assumed no 
structural changes arise under the various conditions.  These experiments showed indeed that 
the structural changes during the titration are minimal. 
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Figure 129: CD spectrum of the dsDNA(A) duplex, the DNA:LNA hydrid (B) and the LNA:DNA 
hybrid (C) under native conditions, with high catalyst concentration and high salt concentration 
 
Analogously, circular dichroism can be used to detect changes in the global conformation.  
For example, Figure 129 shows the CD spectra of the dsDNA duplex with 100 mM KCl and 3 
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mM borate buffer (dark blue).  The zone below 220 nm cannot be used due to the high 
absorbance of the salts in the sample.  This spectrum is a representative B-type helix.  
Addition of 0.5 M ammonia to the sample leads to the pink line.  This differs very little from 
the original line, so it is a safe assumption that the ammonia has only very little influence on 
the structure in this range of catalyst concentration.  The spectrum under high salt 
concentration is also necessary as the exchange time in absence of added catalyst is present in 
equation 9.  Structural changes during the salt titration would introduce errors in the 
calculations.  The green line does not show changes in CD spectrum either so the effect on a 
DNA duplex is negligible as shown in literature.236 
 
The chimeric duplexes with one DNA and one LNA strand reveal a more A-like type of 
duplex (Figure 129 B and C).  Also here the peaks spectra are virtually unchanged with regard 
to wavelength upon increasing the concentration of salt or base catalyst.  With these results in 
hand it is possible to interpret the results of the titrations meaningfully as one knows the 
results will monitor only effect from addition of base or catalyst and not from structural 
changes. 
 
6.5.3 Base pair lifetimes 
 
The base pair lifetimes were determined for the three duplexes by measuring the longitudinal 
relaxation rates of the imino-protons at different ammonia concentrations.  The complete 
analysis of the dsDNA duplex was already reported in reference 229 and all data for this 
duplex was taken from there.  Ammonia was used as base catalyst as it catalyzes the exchange 
of imino protons in DNA very well due to its small size (α≈1) and high pKa (9.564 at 15°C).  
A borate buffer solution at pH 8.8 was used as this value is high enough to provide a fair 
amount of ammonia and it is low enough to avoid a strong influence of OH--catalysis.   
 
The imino proton spectrum of the DNA:LNA hybrid is presented in Figure 130.  The residues 
that are not observed in the reference spectrum are close to the ends of the duplex and 
therefore their exchange is very fast owing to end fraying.  Consequently, their dissociation 
constants were not measured.  
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Addition of a small amount of catalyst renders the exchange of T4 and T8 so fast that these 
imino-protons are not anymore observed.  These residues must open very fast so it is 
suggested they have a large Kd and a small base pair lifetime (<< 2 ms).  It is likely that the 
imino-proton of T9 shows similar exchange kinetics as T8 as this is the case in the other 
hybrid duplex.  This would imply that the T1 determination of the peak at 13.13 ppm would 
monitor the exchange kinetics of T19 as this would be the only signal present after addition of 
0,1 M ammonia.  However as no solid evidence for this behavior is present, analysis of the 
peak at 13.13 ppm is omitted altogether. 
 
 
Figure 130: NMR spectra of the imino-region of the DNA:LNA duplex without, with 0.1M and with 0.5M 
catalyst. 
A plot of the exchange times τex of G20 at 15°C in the dsDNA versus the inverse ammonia 
concentration is shown in Figure 131.  Addition of catalyst lowers the exchange time which 
proves the process is exchange limited and not opening limited.  The linearity of the slope 
indicates a two state model where exchange only takes place from one state, the open state.  
This is easily seen as the exchange time is in the range of ms for the duplex whereas from the 
isolated nucleoside the exchange time is in the range of ns.234 
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Figure 131: Exchange time of G20 at 15°C in dsDNA versus the inverse catalyst concentration 
The base pair lifetimes of the non-modified duplex229 are presented in Table 22.  Not all 
residues could be measured at each temperature as some signals are broadened so much they 
overlap with other protons and consequently does not allow unambiguous T1 measurement.  
The highest base pair lifetimes are for guanine residues and the lowest for thymidine residues. 
This is in agreement with literature values.  The apparent dissociation constants are highest 
for the AT pairs which is also within expectations. 
 
  dsDNA  
T(°C) T8 G7 T19 G20 
15 2.5 + 0.7 12 + 6.5 1.9 + 0.2 24 + 5.4 
 32 + 3.2 1.7 + 0.1 58 + 5.5 2.5 + 0.3 
20 1.9 + 0.5 7.2 + 3.8 - 8.8 + 2.9 
 70 + 7.5 3.1 + 0.2 - 3.7 + 0.2 
25 2.1 +0.9 6.5 + 2.6 - 8.4 + 3.3 
 156 + 71 5.2 + 0.3 - 7.0 + 0.6 
Table 22: Base-pair lifetimes (ms in italics) and their apparent dissociation constant αKd 
at different temperatures (in 10
-7
) 
The results obtained with the LNA:DNA duplex are presented in Table 23 and the  
DNA:LNA duplex’ results are shown in Table 24.  The most striking feature from these two 
tables are the extreme high base pair lifetimes for G15 and G20 in the LNA:DNA duplex and 
to a lesser extent for G7 in the DNA:LNA hybrid.  The base pair lifetime of G20 is 
approximately 6 times as high as the same residue in the natural duplex and for G7 this factor 
is approximately 3.5.  When we compare G20 over all three duplexes the shortest base pair 
lifetime is obtained when the nucleotide is located in an LNA strand.  When G15 is located in 
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a LNA strand its lifetime is also much shorter than in a DNA strand of the DNA:LNA 
hybrids.  As T8 and T9 have different base pair lifetimes, opening inside the LNA strand is 
supposed to take place one at a time, so there is no cooperative base pair opening.  All 
thymine bases in the DNA strand of a hybrid duplex exchange extremely fast, their exchange 
times are much lower than 2 ms. 
 
   LNA:DNA  
T(°C) T4 T8 T9 G15 G20 
15 2.9 + 2.2 6.6 + 2.8 1.7 + 2.7 59.8 + 9.0 126.4 + 18.6 
 12.4 + 1.0 11.6 + 0.1 14.4 + 1.6 3.0 + 0.3 1.7 + 0.2 
20 2.7 + 3.4 ≤1 1.2 + 2.8 6.8 + 5.1 73.8 + 19.7 
 14.3 + 0.7 11.9 + 0.4 16.2 + 0.6 4.3 + 0.5 1.4 + 0.6 
25 ≤1 1.3 + 0.1 ≤1 3.3 + 2.8 7.9 + 7.7 
 15.7 + 0.5 13.1 + 0.1 18.3 + 0.9 8.1 + 0.4 2.0 + 0.3 
Table 23: Base-pair lifetimes (ms in italics) and their apparent dissociation constant αKd  
at different temperatures (in 10
-7
) 
The apparent dissociation constants αKd also change in the hybrids: The dissociation is slower 
when the base is located in a DNA strand of a hybrid while for G it is faster in an LNA strand.  
In contrast the dissociation constant of T8 is reduced inside the LNA strand so the opening 
and closing of the base pair is slower. 
 
  DNA:LNA  
T(°C) G7 G15 G20 
15 44.4 ± 9.8 1.2 ± 2.2 9.2 ± 2.4 
 2.1 ± 0.5 8.5 + 0.2 6.4 ± 0.2 
20 21.7 + 7.1 4.5 + 1.9 6.8 + 2.2 
 3.4 + 0.5 14.0 + 0.4 8.8 + 0.3 
25 12.1 + 4.7 ≤1 3.9 + 1.6 
 3.7 + 0.3 6.6 + 0.2 10.1 + 0.3 
Table 24: Base-pair lifetimes (ms in italics) and their apparent dissociation constant αKd  
at different temperatures (in 10
-7
) 
 
As with these hybrids it was not possible to analyze T-residues in a DNA strand further 
experiments are needed with other hybrids to complement the information about these 
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hybrids.  Even though this is a small set of experiments some general tendencies are clear.  G 
residues in the DNA strand of a hybrid show an increased stability while those residing in an 
LNA stand show a decrease in stability.  Their dissociation constants become larger when 
they are positioned inside an LNA strand while it becomes smaller located in the DNA strand 
of a hybrid. 
 
6.5.4 Thermodynamics and activation parameters for the opening 
process 
 
Values for ∆H and ∆S can be obtained from equation 10.  The slope of the inverse 
temperature (in K) versus ln(αKd) yields ∆H° and the intercept with the Y-axis ∆S°.  From 
these parameters the standard Gibbs free energy can be calculated.  Values given in Table 25 
and Table 26 are calculated at 25°C.  Figure 132 shows the van’t Hoff plots for G20 in all 
duplexes.  Again all values for the dsDNA were taken from reference 229.  These parameters 
were all calculated on the basis of three points as experiments at lower temperature proved to 
be not reproducible.  Furthermore, these experiments are extremely time consuming, one 
experiment takes about 12 hours and two experiments are necessary for determination of the 
exchange time at one given concentration. 
 
 
Figure 132: van’t Hoff plots of G20 in dsDNA (left), LNA:DNA (middle) and DNA:LNA (right),  
X-axis:1/t, Y-axis ln(αKd) 
The activation parameters can be obtained from the Eyring plot which is a curve of ln(kop/T) 
versus the temperature-1 (equation 11).  These plots for G20 are shown in Figure 133.  Again 
from the intercept ∆S± can be calculated and from the slope ∆H± can be calculated. 
1/t (s-1) 1/t (s-1) 1/t (s-1) 
 
ln(αKd) ln(αKd) ln(αKd) 
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Figure 133: Eyring plots of G20 in dsDNA (left), LNA:DNA (middle) and DNA:LNA (right),  
X-axis:1/T (in K
-1
), Y-axis ln(kop/T)  
The standard Gibbs free energy of the open state is comparable in the natural duplex and the 
hybrids and they are all in the range between 6.8 and 9.1 kcal/mol.  Between the entropies and 
enthalpies of the different duplexes there is a lot of variation.  All thymidine residues that 
were measured in LNA strands show unique entropy-enthalpy compensation: the enthalpy has 
decreased and the entropy has also decreased which in the end adds up to a similar Gibbs free 
energy of the opening.  Similar behaviour is observed for G20 in both hybrids and G7 in the 
DNA:LNA hybrid but not for G15 which is puzzling as the sequence context for G15 and 
G20 is similar.  There is no obvious explanation for this phenomenon except that G15 is 
located nearer to the end of the duplex.  From these results it is difficult to argue whether this 
special dynamics are a property of DNA:LNA hybrids rather than of this specific sequence.  
More experiments are needed to confirm this. 
 
            dsDNA 
 T8 G7 G20 
∆Hα° (kcal/mol) 19 + 1.2 16 + 0.9 16 + 0,8 
∆Sα°(cal/mol K) 42 + 4.2 24 + 3.1 25 + 2.8 
∆Gα°(kcal/mol) 6.8 + 1.2 8.6 + 1.2 8,5 + 0,8 
∆H
≠°
(kcal/mol) 15 + 5.3 18 + 6.6 11 + 7.4 
∆S
≠°
(cal/mol K) 3.5 + 3,0 14 + 3.8 -12 + 4.3 
∆G
≠°
(kcal/mol) 14 + 0.9 14 + 1.1 14 + 1,3 
Table 25: Apparent thermodynamic parameters for the base-pair opening/closing equilibrium and 
activation parameters for the opening reaction.  ∆G is calculated at 25°C 
  
1/T 1/T 
1/T 
ln(kop/T) ln(kop/T) ln(kop/T) 
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 LNADNA 
 T4 T8 T9 G15 G20 
∆Hα° (kcal/mol) 3.7 + 0.2 2.1 + 0.06 2.6 + 0.1 17.2 + 0.2 3.3 + 0.4 
∆Sα°(cal/mol K) -14.1 + 0.5 -19.7 + 0.02 -17.8 + 0.3 29.7 + 0.7 -19.6 + 1.4 
∆Gα°(kcal/mol) 7.9 + 0.3 8.0 + 0.04 7.9 + 0.1 8.3 + 0.4 9.1 + 0.8 
∆H
≠°
(kcal/mol) - - - 54.2 + 1,5 24.8 + 1.1 
∆S
≠°
(cal/mol K) - - - 135.3 + 5,3 31.8 + 3.8 
∆G
≠°
(kcal/mol) - - - 13.9 + 3.1 15.3 + 2.2 
 DNALNA 
 G7 G15 G20 
∆Hα° (kcal/mol) 1.1 + 0.4 14.3+0.1 7.5 + 0.1 
∆Sα°(cal/mol K) -25.9 + 1.2 21.5 + 0.25 -2.2 + 0.3 
∆Gα°(kcal/mol) 8.8 + 0.7 7.9 + 0.2 8.2 + 0.2 
∆H
≠°
(kcal/mol) 22,2 + 1.1 - 15.4 + 0.9 
∆S
≠°
(cal/mol K) 21.3 + 3.8 - 4.2 + 3,2 
∆G
≠°
(kcal/mol) 15.4 + 2,2  - 14.2 + 1,9 
Table 26: Apparent thermodynamic parameters for the base-pair opening/closing equilibrium and 
activation parameters for the opening reaction.  ∆G is calculated at 25°C 
 
6.5.5 Discussion: 
 
The base pairs open one at a time as the opening and closing parameters of T8 and T9 are 
substantially different.  The assumption that base flipping is symmetrical, so that both bases 
of a pair flip out together,278 is not valid for the LNA modified duplexes as the differences in 
exchange behavior between G15 and G20 in the different hybrids cannot be explained with 
such a model: the structure of the hybrids is very much alike as seen from the CD spectra.  
Hence if opening would be symmetric it would not be important in which strand the 
observable imino proton is located, the LNA or the DNA strand.   
 
From the high base pair lifetimes of the DNA guanines in the hybrids it seems as if the LNA 
strand is stabilizing the complementary strand which makes it more difficult to flip out this 
latter’s bases.  The LNA strand itself has quite low base pair lifetimes.  These short LNA 
base-pair lifetimes might be explained by the preformed C3-endo conformation which is 
needed for base flipping.  Base opening is strongly coupled with a change in sugar pucker 
phase from C2-endo to C3-endo.  As LNA has already C3-endo conformation it is likely that 
flipping for LNA bases is easier because of this. 
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It is a well known fact that opening and bending towards the major groove are coupled.  
Bending requires changing of different torsion angles, such as the ζ-angle, which are more 
restrained in LNA nucleotides than in normal DNA nucleotides.  So from this it seems that for 
flipping of a base the bending properties of the complementary strand is important as the 
DNA strand show high base pair lifetimes and the LNA strand does not.   
 
If this could be generalized also for thymidine residues, the thymidine residues in the DNA 
strand should also exhibit high base pair lifetimes which they do not.  However, MacKerell Jr. 
and co-workers have shown that the equilibrium opening constant of an adenine base is one 
order of magnitude higher than for thymine.275  Consequently the imino- exchange 
experiments will monitor the flipping of adenine rather than thymine, as the flipping of an 
adenine base from the stack also makes imino-proton of thymine accessible for exchange.  
Thus with this model at hand, the complete set of base pair lifetimes in the LNA:DNA hybrids 
make sense: the LNA thymine imino protons are observed as they monitor the flipping of the 
adenines in the DNA strand and this latter’s stability is strongly increased by the LNA strand.  
The DNA thymine imino protons exchange very fast, they monitor the LNA adenine-flipping 
which is faster than what is observed in dsDNA.   
 
So from these experiments it appears that LNA stabilizes the duplex by stabilizing the 
complementary strand.  This leads to a reduced apparent dissociation constant and increased 
base pair lifetimes for the bases in the complementary (DNA) strand. 
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7 General conclusions and outlook 
 
In this work the development of a new method for DNA interstrand cross-linking is described 
based on a furan unit as masked aldehyde.  Furan, a common industrial solvent and 
intermediate, is toxic due to its in vivo oxidation by cytochrome P450.  The resulting oxidized 
compound, cis-butene-dial, is a very reactive dialdehyde which was shown to react with 
various nucleophiles such as peptides and nucleic acids.  A furan moiety incorporated into an 
oligonucleotide strand can also be oxidized and the resulting reactive aldehyde can react with 
nucleophilic functionalities in the complementary strand. 
 
Starting from the previously developed nucleoside building block 1, cross-linked duplexes 
were synthesized with the cross-link in the middle of a DNA-duplex.  In an attempt to 
characterize the structure and position of the cross-link, an NMR-study of the cross-linked 
duplex ON1+ON2 was started.  As the signals of the modified duplex were quite broad no 
direct information was obtained on the exact nature and site of the covalent link.  It was 
observed that the structural perturbation induced by the cross-link on the duplex can be 
observed up to two base pairs from the modification.   
NH
O
ON
O
HO
HO
NH
O
O
1a: Arabino (2')
1b: Ribo (2")  
Figure 134: Structure of the first generation furan-modified building block and corresponding duplex 
In order to obtain more information about the cross-linked structure, the chemical stability 
was tested.  The observed acid lability and reversibility, based on gel-electrophoresis 
experiments, lead to the conclusion that cross-link formation with 1a/1b probably takes place 
by imine bond formation.  Gel-electrophoresis further revealed the formation of more than 
one cross-linked duplex. 
Duplex ON1+ON2: 
ON1 5’-CTG ACG G1G TGC-3’ 
ON2 3’-GAC TGC CAC ACG-5’ 
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O
OH
HO
O
4
O
O
O
HO
HO
HO
HO
2 3  
Figure 135: Structure of novel nucleoside building blocks 2, 3 and 4 
As more tests were necessary for a full evaluation of the cross-linked structure, two simplified 
nucleoside building blocks were synthesized.  Their structure allowed a fast and easy 
synthesis of large amounts of phosphoramidite and modified oligonucleotides.  Modified 
building block 4 was obtained through collaboration with Prof. Dr. M. Hocek at the Academy 
of Sciences of the Czech Republic. 
 
A representative series of oligonucleotides incorporating 2, 3 or 4 was constructed.  On the 
one hand the nature of the opposing base was varied in order to define suitable cross-link 
targets.  On the other hand, neighbouring bases were varied to study the influence of sequence 
context upon the interstrand cross-link reaction. 
 
In all cases incorporation of the furan modified nucleoside analogues resulted in a 
destabilization of the duplex structure.  However, whereas incorporation of 2 resulted in a 
destabilization of up to 37°C, introduction of a phenyl unit in nucleoside building block 3 
restored part of the stability.  Further positive influence on the duplex stability was expected 
for incorporation of 4.  However this was not the case as the melting temperatures are in the 
same range or slightly below the melting temperatures obtained with nucleoside analogue 3. 
 
After oxidizing the modified duplex with NBS a new product was formed in some cases 
(Table 27).  MALDI-TOF analysis confirmed that these new products had a mass 
corresponding to the cross-linked duplex.  The cross-link selectivity for nucleoside 2 and 3 are 
identical.  They have the ability to form interstrand cross-links with complementary adenine 
and cytosine bases independent from the sequence context.  Cross-link formation with 
nucleoside analogue 4 on the other hand is strongly dependent on the sequence context.  The 
modification flanked by two G.C pairs allows cross-link formation to A and C while two 
neighbouring A.T pairs drive the modification to a pronounced C-selectivity. 
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X= Modification 2 3 4 
Y= Base complementary to X A C T G A C T G A C T G 
5’-CTG ACG GXG TGC-3’ + + - - + + - - + + +/- +/- 
5’-CTG ACG CXC TGC-3’ + + +/- - + + +/- - + + - - 
5’-CTG ACG AXA TGC-3’ + + - - + + - - - + - - 
5’-CTG ACG TXT TGC-3’ + + - - + + - - - + - - 
Table 27: Cross-link selectivity based on gel-electrophoresis: +: cross-link visible and isolated, 
- no cross-link visible, +/- small amount of cross-link visible but not isolated. 
Those duplexes where good cross-linking was observed were prepared on larger scale.  From 
these experiments accurate yield determination was possible after purification by RP-HPLC.  
The highest yields were obtained with building block 2.  The 73% yield obtained in one case 
is by a wide margin the highest yield ever reported for the preparation of interstrand cross-
linked duplexes.  
 
X= nucleoside analogue 2 3 4 
complement of X = A C A C A C 
5’-CTG ACG GXG TGC-3’ 34% 23% 10% 13% 18% 17% 
5’-CTG ACG CXC TGC-3’ 28% 44% 28% 15% 3% 8% 
5’-CTG ACG AXA TGC-3’ 40% 42% 21% 18% no XL 21% 
5’-CTG ACG TXT TGC-3’ 49% 73% 29% 27% no XL 19% 
Table 28: Isolated cross-link yields of all cross-linked duplexes 
As last analysis method for the duplexes, enzymatic degradation was performed with EXO III.  
This experiment allows determination of the exact position of the cross-link.  The duplexes 
with acyclic nucleosides 2 and 3 generated a different set of products compared to the sugar 
containing nucleoside 4.  Expected here is that the duplex distortion by the acyclic nucleoside 
is more pronounced which hampers the enzyme action.  As a result the enzyme always 
stopped two bases from the modification with 2 and 3 while with 4 the enzyme could also 
cleave the bases next to the modification itself.  The selectivity as obtained by enzymatic 
degradation is represented in Table 29. 
 
X= modification 2 3 4 
Y= base complementary to X A C A C A C 
5’-CTG ACG GXG TGC-3’ A C A 3’CC AC? C? 
5’-CTG ACG CXC TGC-3’ A C A C A C 
5’-CTG ACG AXA TGC-3’ A C A C - C 
5’-CTG ACG TXT TGC-3’ A C A C - C 
Table 29: Cross-link selectivity as confirmed by enzymatic degradation: A or C: cross-link to 
complementary A resp C.  3’C indicates cross-link to the 3’C neighbouring of the complement. “?” 
indicates that the position of the cross-link to C was not determined 
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As the enzyme was inhibited by the acyclic modification it was not possible to digest a cross-
linked duplex up to the stage of a dinucleotide which could be analyzed by NMR to obtain the 
structure of the cross-link.  As alternative proof of structure, each of the protected nucleosides 
2 and 3 were oxidized in the presence of deoxycytidine.  The resulting isolated molecules are 
represented in Figure 136.  The structures show a high resemblance with the natural adducts 
formed between cis-butene-dial and natural nucleosides.  The molecular weight of these 
compounds is conform to the reaction products obtained in a duplex context. 
O
O
O
O
O
OH
HO
N
N
NH
O
OH
O
O
O
O
OH
HO
N
N
NH
O
OH
8 9
 
Figure 136: Structure of the cross-linked dinucleotides 
Future research on this topic can focus on different aspects.  One of the most important 
aspects to evaluate in view of several applications is the mismatch discrimination.  Also as 
antisense can be considered as potential application the cross-link ability with RNA strands as 
complement should be investigated. 
 
There is certainly upside potential to develop new nucleosides that are more thermally stable 
and possibly have a higher selectivity.  The R-isomers of the acyclic nucleosides 2 and 3 
could be synthesized as this might position the modification more towards the minor groove 
and hence guanosine selectivity could be obtained.  Other new analogues that can be proposed 
include the meta-derivatives of nucleoside 3 and 4 (Figure 137, 153) as well as the 
introduction of hetero-aromatic or polyaromatic rings in the nucleoside.  Cross-linking could 
be tested by attaching furan by its 3-position to the different backbone structures (Figure 137, 
154).  As a dialdehyde will be generated upon oxidation of furan, the cross-link behavior will 
probably be different. 
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O
OO
O
R or S
153
OOO
O
154
R or S
 
Figure 137: Proposed structure for new nucleoside analogues 
In a next phase, alternative oxidations for furan could be explored.  As the NBS-strategy leads 
to brominated side-products, a method that does not rely on bromination of furan would have 
the ability to enhance cross-link yields.  It has been reported that furan, incorporated into a 
nucleoside can be oxidized by singlet oxygen generated upon irradiation of methylene blue281 
so this might prove to be an efficient way to alternatively oxidize furan.  As singlet oxygen 
can also be generated in vivo the study if this approach would also be a first step towards the 
study of the cross-link potential in vivo. 
 
Finally the cross-link strategy could be tested for structural applications such as detection of 
SNP’s or to probe certain structures which are only transiently formed.  By forming a 
covalent bond such structures might be stabilized which eases the study of this kind of 
structures. 
Duplex ON26+ON27 
ON26  5’-GCG CGA GAA GGA GAG AAA GCC GG-3’ 
 
 ON27 3’-CGC GCT CTT  CCT CTC TTT CGG CC-5’ 
 
TFO     ON29  5’-CT CTT CC3 CTC TTT C-3’ 
 
TFO ON32  5’-CT CTT CCT CTC TT3-3’  
 
TFO    ON33  5’-CT CTT CCT CTC TTT 3-3’ 
 
After the evaluation of the cross-link potential in a duplex context the third nucleoside 
building block was also tested for triplex cross-linking.  Upon incorporation into the middle of 
a triplex forming strand (ON29), the modification did not form cross-links upon oxidation.  
However when the modification was introduced as 3’-terminal cap in the TFO, cross-linking 
was possible when both an A.T (ON32) or a G.C (ON33) base pair was present 
complementary to the modification.  The thermal destabilization introduced by this cap is 
minimal.  More research is needed to evaluate the cross-link selectivity and structure of this 
triplex cross-linking.  Also here the previously proposed modifications as well as alternative 
oxidation methods could be evaluated for their effect on cross-link formation. 
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At the start of this PhD work, it was decided to try and study the structure of the first 
generated cross-linked duplex by NMR.  In order to gain expertise in this field a stay abroad 
was carried out at the Nucleic Acid Centre in Odense, Denmark.  During this stay, initially 
and in order to acquire hands on experience, NMR studies were executed for the 
determination of base pair dynamics in modified oligonucleotides.  The base pair lifetimes of 
DNA:LNA hybrids was studied.  The sequences used in this study are shown in Figure 138.   
 
5'-C1   A2   G3   T4   mC5 A6    G7   T8    T9   C10 A11 G12-3'
3'-G24 T23 C22 A21 G20 T19 mC18 A17 A16 G15 T14 C13-5'
5'-C1   A2     G3   T4   mC5   A6    G7   T8    T9    C10 A11   G12-3'
3'-G24 T23 mC22 A21 G20 T19 mC18 A17 A16 G15 T14 mC13-5'
5'-mC1 A2  G3   T4   mC5 A6     G7   T8    T9 mC10 A11 G12-3'
3'-G24 T23 C22 A21 G20 T19  mC18 A17  A16 G15 T14  C13-5'
DNA:DNA
DNA:LNA
LNA:DNA
ON36
ON37
ON38
ON37
ON36
ON39  
Figure 138: Sequences used for the study of base pair dynamics 
It was shown that the LNA strand stabilizes the duplex by enhancing the stability of the 
complementary strand.  The lifetimes of the DNA nucleotides in the hybrids show a 
significant increase in base pair lifetime while the LNA guanine bases show lower base pair 
lifetimes.  For DNA, the highest base pair lifetimes to date are reported.  The increase in base 
pair lifetimes for the thymine residues in ON38 could be explained by correlating these data 
with molecular modeling studies.  There it was shown that the exchange of thymine imino 
protons monitors the opening of the complementary adenine base which is located in a DNA 
strand.   
 
As several modeling studies have correlated torsion angles and changes thereof with base pair 
opening, LNA could be a great tool to confirm these models experimentally.  If the north-
locked LNA has low base pair lifetimes due to its preformed north-conformation the south-
locked LNA could be used to prove that opening is indeed more difficult with a fixed S-
conformation.  High base-pair lifetimes for these south LNA’s would for the first time prove 
experimentally this theory.    
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8 Materials and methods 
8.1 Cross-linking with first generation furan modified nucleosides 
 
All reagents were purchased from Aldrich in the highest purity grade available.  99.9% D2O 
was purchased from Cambridge Isotope Laboratories, Inc USA.  Ultracentrifugation filters 
were obtained from Pall. 
 
All NMR-spectra except the final TOCSY and ROESY‘s were recorded on a Varian Inova at 
500 MHz equipped with a 5 mm probe ( 1H, 13C).  The ROESY and TOCSY experiments  of 
the modified sample were recorded on a Bruker Avance II 700 at 700 mHz equipped with a 5 
mm TXI probe( 1H, 13C, 15N, recorded by Prof. Dr. J. Martins). Processing of the spectra was 
done using nmrPipe.282  Analysis of the spectra was done with sparky.283  NOESY spectra 
were recorded with a mixing time of 100 ms at different temperatures as indicated. 
 
8.1.1 Oligonucleotide synthesis: 
 
The phosphoramidite was freshly (re-)purified and dried for 2 days under high vacuum.  The 
coupling was performed manually during which a 0.05 M solution of phosphoramidite in 
ACN was mixed with a 0.5 M solution of pyridinium hydrochloride in ACN.  The resulting 
mixture was flushed through the reaction column over a period of at least 10 minutes.  The 
automated part of the synthesis was done on an Expedite 8909 DNA synthesizer.  
Oligonucleotides were cleaved and deprotected with standard procedures.  For purification the 
crude oligonucleotide was dissolved in 50 µl water to which 100 µl 3 M NaOAc was added.  
To this solution 600 µl ice cold ethanol (-20°C) was added for precipitation of the 
oligonucleotide.  After incubation for at least 2 hours the precipitate was centrifuged and the 
supernatant removed.  This procedure was repeated once more.  The resulting product was 
further purified by washing the oligonucleotide on an ultracentrifugation filter (Pall 
microsep). 
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8.1.2 Preparation of the reference NMR-sample 
 
The duplex strands (1 µmol each) were dissolved in 400 µl water.  Phosphate buffer (50 µl, 
100 mM in water, pH 7) and NaCl solution (50 µl, 1 M in water) are added.  The sample is 
evaporated by vacuum centrifugation and the dry product is redissolved in 500 µl D2O.  This 
sample can be used for assignment of the non-exchangeable protons.  Evaporation and 
redissolving the sample in 50 µl D2O with 450 µl H2O allows assignment of exchangeable 
protons. 
 
8.1.3 Preparation of the cross-linked NMR-sample 
  
The modified and non-modified strand were mixed in equimolar amounts (600 nmol) and 
diluted in 10 mM phosphate buffer with 100 mM NaCl (final concentrations) to 20 µM (30 
ml).  NBS (20 µl 0.03Msolution in water) was added one portion each 15 minutes, 4 portions 
in total.  After completion of the reaction the reaction mixture was purified by size exclusion 
centrifugation.  The concentrated oligonucleotide was rinsed with 6 ml deuterated 10 mM 
phosphate buffer on the size exclusion filter.  The purified sample was diluted with D2O to 
500 µl with a final buffer and salt concentration of 10 mM phosphate (pH 7) and 100 mM 
NaCl.  The resulting sample can be used for NMR experiments.  For assignment of the 
exchangeable protons the sample is evaporated by a flow of nitrogen to 1/10th of its original 
volume and 450 µl water is added. 
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8.1.4 Assignment of the spectra 
 
The assignments of the non-modified duplex are given below.  This sample was recorded at 
25°C on a Varian Inova spectrometer at 500 MHz.  The chemical shift values in the table 
below are given in ppm relative to the residual solvent signal.  The sample is recorded in D2O 
for the non-exchangeable protons and in 10 % D2O with 90 % H2O for the exchangeable 
protons.  The solution was buffered with 10 mM phosphate buffer at pH 7 with 100 mM 
NaCl. 
 
  H6/H8 H1' H2' H2" H3' H5/H2/CH3 H1/H3 H4/H4 
C1 7,83 5,97 2,09 2,78 4,71 5,97 
  T2 7,45 5,70 2,13 2,43 4,78 1,71 13,68 
 G3 7,93 5,53 2,72 2,79 5,02 
 
12,69 6,83/8,58 
A4 8,19 6,19 2,67 2,88 5,04 7,79 
  C5 7,13 5,99 2,62 2,79 4,85 5,18 
 
6,41/8,13 
G6 7,83 5,98 2,10 2,57 4,70 
 
12,89 6,54/8,47 
G7 7,88 5,88 2,10 2,55 4,96 
 
12,77 6,39/8,11 
dU8 7,36 5,88 2,54 2,68 4,90 5,09 13,57 
 G9 7,90 5,97 2,62 2,78 4,96 
 
12,52 6,51/8,10 
T10 7,16 5,81 2,02 2,41 4,87 1,44 13,66 
 G11 7,90 5,95 2,62 2,73 4,98 12,88 
C12 7,50 6,21 2,19 
 
4,50 5,52 
 
6,70/8,16 
G13 7,96 5,99 2,61 2,78 4,86 
   C14 7,64 5,64 2,12 2,44 4,88 5,47 6,53/8,45 
A15 8,28 6,21 2,73 2,89 5,05 7,74 
  C16 7,27 5,48 1,93 2,30 5,05 5,33 
 
6,53/8,12 
A17 8,20 6,18 2,67 2,88 5,01 7,61 
C18 7,24 5,78 1,98 2,40 4,81 5,24 
 
6,42/8,04 
C19 7,39 5,54 2,09 2,39 4,73 5,48 
 
6,65/8,40 
G20 7,79 5,71 2,12 2,43 12,79 6,8/ 
T21 7,23 6,00 2,05 2,44 4,85 1,42 13,68 
 C22 7,52 5,39 1,99 2,27 4,81 5,71 
 
6,83/8,58 
A23 8,20 6,04 2,72 2,87 5,03 7,79 
G24 7,75 6,03 2,46 2,29 4,63 
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The assignment of the arabinose modified duplex is given below, the spectrum was recorded 
on a Varian Inova spectrometer at 500 MHz at 5°C as this gave the best results.  The open 
spaces are from resonances that could not be assigned unambiguously.  The chemical shift 
values in the table below are given in ppm relative to the residual solvent signal.  The sample 
is recorded in D2O for the non-exchangeable protons and in 10 % D2O with 90 % H2O for the 
exchangeable protons.  The solution was buffered with 10 mM phosphate buffer at pH 7 with 
100 mM NaCl. 
 
  H6/H8 H1' H2' H2" H3' H5/H2/CH3 H1/H3 H4/H4 
C1 7,80 5,90 2,07 2,51 4,66 5,90 
  T2 7,46 5,62 2,09 2,38 4,85 1,66 
G3 7,92 5,48 
 
2,77 4,83 
 
12,73 
 A4 8,19 6,17 2,64 2,84 5,03 7,75 
  C5 7,12 1,76 2,25 6,51/8,14 
G6 7,76 
       G7 
        U*8 
G9 7,87 5,87 2,76 
     T10 7,17 5,52 2,04 2,42 4,84 1,28 
  G11 7,87 5,92 
C12 7,40 6,15 2,16 
 
4,48 5,36 
  G13 
        C14 7,42 5,60 6,61/8,78 
A15 8,26 6,19 2,18 
     C16 7,29 5,33 
A17 8,06 6,09 
C18 7,25 
    
5,09 
  C19 
G20 7,89 12,78 
T21 7,21 5,96 
  
4,83 1,37 13,75 
 C22 7,52 5,23 2,02 2,25 4,80 5,67 6,93/8,58 
A23 8,17 5,99 
 
2,70 5,02 7,72 
  G24 7,71 
 
2,44 2,21 4,61 
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8.2 Second generation furan modified oligonucleotides 
8.2.1 Instruments and reagents for organic synthesis 
 
All solvents and chemical reagents were purchased from Sigma-Aldrich in the highest purity 
available.  IR spectra were recorded on a Perin Elmer 1600 series FTIR-spectrometer.  
Intensities are reported as strong (s) or medium (m).  Optical rotations were measured on a 
Perkin Elmer 241 polarimeter.  1H-NMR and 13C-NMR spectra were recorded on a Bruker 
avance 300 operating at room temperature equipped with a BBO probe with ATM or a Bruker 
DRX 500 spectrometer operating at room temperature equipped with a TXI probe ( 1H, 13C, 
15N).  The used system is indicated in each table.  Chemical shifts are reported in parts per 
million (δ) relative to the residual solvent peak.  Multiplicities are reported as singlet (s), 
broad singlet (bs), doublet (d), doublet of doublets (dd), triplet (t) or multiplet (m).   
 
Purities were checked by HPLC-MS (Agilent-1100 series LC/MSD system) equipped with a 
Phenomenex Luna C18 column (250 x 4.6mm, 5µm at 35°C).  The used solvent system was 
5mM NH4OAC in water (A) and MeCN (B).  The used gradient went from 0 to 100% B in 15 
minutes.  Mass spectra were also recorded with this system. 
 
8.2.2 Synthesis of the building blocks 
A. Synthesis of (S)-toluene-4-sulfonic acid 2-(2,2-dimethyl-
[1,3]dioxolan-4-yl)-ethyl ester 
 
OpTsCl (1.15eq)
 
 
S-(+)-3,4-O-isopropylidenedioxybutan-1-ol (1.730 g, 11.849 mmol, 1 equivalent) was 
weighed in a 2-neck flask.  Extra dry pyridine (1.5 ml) was added followed by 
paratoluenesulfonylchloride (2.589 g, 13.6 mmol, 1.15 equivalents) in one portion and the 
flask was flushed with argon.  After a couple of minutes a white gel occurs.  After 2.5h the 
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mixture is poured into 3 ml of an aqueous 1 M HCl solution followed by extraction with 
diethylether.  The organic phase was washed 3 times with a 1 M aqueous HCl solution before 
washing 3 times with saturated NaHCO3 solution.  The organic layer was dried over 
anhydrous Na2SO4 and evaporated under reduced pressure.  The obtained S-toluene-4-sulfonic 
acid 2-(2,2-dimethyl-[1,3]dioxolan-4-yl)-ethyl ester (3.247 g, 10.82 mmol, 91%) can be used 
for further reactions without purification. 
 
Analysis: 
ESI-MS: 323,0 (M+Na)+ 
Retention time: 17.0 min 
IR (KBr-film, cm-1): 3448(b), 1598(m), 1361(s), 1189 (s), 1177, 
 
 
O
O
O S
O
O
1
2
3
4
5
6 7
8 9
10
11
12
6 7
 
NMR 
1H 300 MHz Solvent CDCl3 
atom δ (ppm) integration Multiplicity J (Hz) 
H1/H2 3.85-4.10 3 m  
H3 1.92 2 m  
H4 3.51 2 dd 7.9; 6.9 
H6 7.80 2 d 8.3 
H7 7.35 2 d 8.1 
H9 2.45 3 s  
H11/H12 1.29 3 s  
H11/H12 1.34 3 s  
NMR 
13C 75 MHz Solvent CDCl3 
atom δ(ppm) atom δ (ppm)  
C1 69.10 C 7 127.94  
C 2 72.32 C 8 132.98  
C 3 19.05 C 9 33.17  
C 4 67.42 C 10 109.06  
C 5 144.87 C 11/ C 12 25.56  
C 6 129.81 C 11/ C 12 26.86  
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B. Synthesis of (S)-4-(2-Bromo-ethyl)-2,2-dimethyl-[1,3]dioxolane 
 
O
O
O S
O
O
O
O
Br
LiBr (5eq)
DMF
60°C, 1h
108
105  
 
The tosylate (1.990g, 6.63 mmol, 1 equivalent) is concentrated under reduced pressure while 
stirring.  Extra dry DMF (10 ml) was added before adding anhydrous LiBr (prepared by 
heating LiBr under vacuum) (2.540g, 33 mmol, 5 equivalents) to the mixture.  The reaction 
mixture was warmed slowly till 60°C which dissolves all the LiBr.  The reaction mixture 
colours light brown.  After 1 hour the reaction mixture is poured into ice water.  The water 
phase is extracted 3 times with diethylether, the organic phase was collected and washed first 
with water and then with saturated NaHCO3 solution.  The organic layer was dried very 
shortly over NaSO4 filtered and evaporated under reduced pressure with the temperature of 
the water bath not turned on to avoid evaporation of the bromide (bp 90°C/19 Torr).  The 
reaction mixture was purified by flash chromatography with a mixture of EtOAc pentane 1 to 
5.  The product should be used soon after  preparation and was co-evaporated with THF in 
order to have the product dry for next reactions. 
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Analysis: 
Rf value: 0.7 (3:2 pentane: EtOAc) 
IR (KBr-film, cm-1): 1370 (s), 1252 (s), 1214(s), 1152(m), 1062(s), 847(m), 515(m) 
       
O
O
Br
1
2
3
4
5
6
7
 
NMR  
1H 300 MHz Solvent CDCl3 
atom δ (ppm) integration Multiplicity J (Hz) 
H1 3.57 1 dd 8.0/ 6.2 
H 1 4.08 1 dd 6.9/ 7.3 
H 2 4.25 1 ddd  
H 3 2.08 2 m  
H 4 3.48 4 m  
H 6/ H 7 1.34 3 s  
H 6/ H 7 1.39 3 s  
NMR 
13C 75 MHz Solvent CDCl3 
atom δ(ppm) atom δ (ppm)  
C 1 68.92 C 5 109.15  
C 2 74.00 C 6/ C 7 25.58  
C 3 29.42 C 6/ C 7 26.99  
C 4 37.11    
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C. Synthesis of (S)-4-(2-Furan-2-yl-ethyl)-2,2-dimethyl-[1,3]dioxolane 
 
O
O
1. Furan (2eq), BuLi (1.8eq), 
THF, -78°C-0°C
2. bromide 105, rt, overnight
62% over 2 steps
O
O
Br
O
105 99  
 
n-Buthyllithium (7.5 ml of a 1.6M solution in hexanes, 1.8 equivalents) was added to 6 ml 
THF under CO2/isopropanol cooling.  Furan (900 mg, 13.25 mmol, 2 equivalents) was added 
under cooling.  A white precipitation became visible.  After 15 minutes, the dry ice cooling 
was replaced with a normal ice bath.  The mixture is allowed to stir for another 2 hours before 
the bromide (1 equivalent based on starting material previous reaction) was added in 1 
portion.  The precipitation immediately disappeared and the colour turned light yellow.  The 
day after the mixture had turned brown and it was poured into ice water.  The product was 
extracted from the aqueous solution with diethyl ether and the organic layer was dried over 
Na2SO4 before evaporation under reduced pressure.  The product was purified with flash 
chromatography with 10:1 pentane:EtOAc as eluent.  This reaction resulted in 800 mg (4.08 
mmol, 62% over 2 steps) of the desired product. 
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Analysis: 
ESI-MS: 139.1 (molecule – acetone +H)+ 
Retention time= 17.0 min 
Optical rotation: αD= 2.5 
 
O
O
O
1
2
3
4
5
6 7
8
9
10
11
 
NMR  
1H 300 MHz Solvent CDCl3 
atom δ (ppm) integration Multiplicity J (Hz) 
H 1 3.48 1 dd 7.7; 7.4 
H 1 3.97 1 dd 7.8; 6.0 
H 2 3.74 1 m  
H 3 1.86 2 m  
H 4 2.69 2 m  
H 6 5.97 1 dd 0.7; 3.1 
H 7 6.23 1 dd 3.1; 1.9 
H 8 7.26 1 dd 0.6, 1.4 
H 10/ H 11 1.31 3 s  
H 10/ H 11 1.38 3 s  
NMR 
13C 75 MHz Solvent CDCl3 
atom δ(ppm) atom δ (ppm)  
C 1 69.2 C 7 110.2  
C 2 75.3 C 8 141.0  
C 3 27.0 C 9 108.8  
C 4 32.1 C 10/ C 11 24.3  
C 5 155.2 C 10/ C 11 25.8  
C 6 105.1    
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D. Synthesis of (S)-4-Furan-2-yl-butane-1,2-diol 
 
HO
HOHCl
THF
0°C, 3h
89%
O
O
OO
99 2  
 
The protected diol (309 mg, 1.57 mmol, 1 equivalent) was dissolved in 3 ml THF.  A 4 M 
solution of HCl (1.5 ml) was added under stirring and external cooling with an ice bath.  The 
reaction mixture was allowed to stir at 0°C for 3h.  The product was extracted from the 
reaction mixture with EtOAc and the organic layer was evaporated under reduced pressure.  
The traces of starting material could be removed by flash chromatography with a 1:1 mixture 
of pentane:EtOAc.  (S)-4-furan-2-yl-butane-1,2-diol was obtained in 89% yield (220 mg). 
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Analysis: 
ESI-MS: 157.1(M+H) + 
Retention time: 11.0 min 
Optical rotation: αD=-11.5 
IR (KBr-film, cm-1): 3385(b), 1596(m), 1508(m)  
 
 
HO
HO
O
1
2
3
4
5
6 7
8
9
10  
 
NMR  
1H 300 MHz Solvent CDCl3 
atom δ (ppm) integration Multiplicity J (Hz) 
H1 3.41 1 m  
H 1 3.59 1 m  
H 2 3.67 1 m  
H 3 2.73 2 m  
H 4 1.73 2 m  
H 6 5.98 1 d 3.0 
H 7 6.24 1 dd 1.9; 3.0 
H 8 7.26 1 d 0.6 
H 9/ H 10 3.14 1 bs  
H 9/ H 10 3.21 1 bs  
NMR 
13C 75 MHz Solvent CDCl3 
atom δ(ppm) atom δ (ppm)  
C1 66.60 C 5 155.41  
C 2 71.46 C 6/ C 7 105.14  
C 3 24.10 C 6/ C 7 110.20  
C 4 31.35 C 8 141.02  
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E. Synthesis of (S)-1-[Bis-(4-methoxy-phenyl)-phenyl-methoxy]-4-
furan-2-yl-butan-2-ol 
HO
O
DMTCl (1eq)
pyridine
0°C, 1.25h, 66%
O
HO
HO
O
OO
2 109  
 
The diol 2 (212 mg, 1.36 mmol, 1 equivalent) was co-evaporated 3 times with extra dry 
pyridine in order to remove possible water traces.  2 ml extra dry pyridine was added and 
dimethoxytritylchloride (DMTCl) (460 mg, 1.36 mmol, 1 equivalent) was added under 
external cooling with an ice bath.  After 1.25 hour 1 ml MeOH was added to quench the 
unreacted DMTCl and the reaction mixture was stirred for 10 minutes.  EtOAc was added and 
the organic mixture was washed 3 times with saturated NaHCO3 solution.  The organic layer 
was dried over Na2SO4 and evaporated under reduced pressure.  The crude compound was 
brought onto a normal phase column and purified with 7:1 cyclohexane:EtOAc.  410 mg of 
the mono-tritylated compound was obtained (0.90 mmol, 66%).  It was confirmed by NMR 
that the trityl group was located on the primary alcohol and not on the secondary alcohol. 
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Analysis 
ESI-MS: 481.2 (M+Na) + 
Retention time: 19.7 min 
Optical rotation: αD=4.7 
IR (KBr-film, cm-1): 3436 (b), 1607(m), 1508 (s), 1249(s), 1176(s), 1034 (m) 
 
HO
O
O
O
O
1'
2
3
4
5
6 7
8
9
10
11
12
13
14
15 16
17
18
18
17
16
16
16
15
15
15
14
11
12
H
H
1"
19  
NMR  
1H 300MHz Solvent CDCl3 
atom δ (ppm) integration Multiplicity J (Hz) 
H1' 3.05 1 dd 7.4; 9.3 
H 1" 3.17 1 dd 3.3; 9.3 
H 2/ H 18 3.79 7 s  
H 3 1.73 2 td  
H 4 2.71 2 m  
H 6 5.95 1 d 3.12 
H 7 6.26 1 dd 1.9; 3.0 
H 8 7.27 1 m  
H 11 7.42 2 dd 8.3 
H 12/ H 13/ H 15 7.31 7 m  
H 16 6.83 4 d 6.2 
H 19 2.34 1 d 3.5 
NMR 
13C 75 MHz Solvent CDCl3 
atom δ (ppm) atom δ (ppm)  
C1 67.23 C 10 144.60  
C 2 70.07 C 11 127.72  
C 3 31.15 C 12 127.99  
C 4 23.93 C 13 126.70  
C 5 155.51 C 14 135.82  
C 6 104.82 C 15 129.91  
C 7 109.94 C 16 113.00  
C 8 140.74 C 17 158.37  
C 9 85.98 C 18 55.08  
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F. Synthesis of (S)-Diisopropyl-phosphoramidous acid 1-[bis-(4-
methoxy-phenyl)-phenyl-methoxymethyl]-3-furan-2-yl-propyl ester 
2-cyano-ethyl ester 
 
ODMT
HO
O
ODMT
O
O
P
O
N
CN
(iPr2N)(NCCH2CH2O)PCl (2.5 eq)
DIPEA, CH2Cl2
rt, 2h, 79 %
109 6  
 
The DMT protected nucleoside (220 mg, 0.48 mmol, 1 equivalent) is dissolved in dry CH2Cl2 
(10 ml) and transferred to a 2-neck flask.  DIPEA (0.9ml, 0.70g, 5.4 mmol, 11 equivalents) 
was added as well as the phosphoramidite reagens (284 mg, 1.2 mmol, 2.5 equivalents).  After 
2h no more changes in the reaction mixture were observed and saturated NaHCO3 solution 
was added.  The product was extracted with CH2Cl2 and dried briefly over NaSO4, filtered 
and evaporated under reduced pressure.  The oil was brought onto column and the product 
could be separated with 7:1 cyclohexane:EtOAc.  The phosphoramidite (250 mg, 0.38 mmol, 
79%) was obtained as colourless oil. 
Analysis: 
ESI-MS: 681.3 (M+Na) + 
31P NMR (ppm, 121 MHz): 148.47, 149.26 
 
NMR  
31P 121 MHz Solvent CDCl3 
  δ (ppm) Multiplicity    
  148.47 s     
  149.26 s     
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G. Synthesis of (2S,5R,6R)-5,6-dimethoxy-5,6-dimethyl-1,4-dioxane-2-
ethanol 
OH
HO
OH
O
O OH
O
O
2,3-butanedione (1 eq), 
BF3.OEt2 (0.1 eq), CH(OMe)3 (2 eq)
MeOH, reflux, 12h, 46%
ent- 111
112  
S-1,2,4-butanetriol (400 mg, 3.77 mmol, 1 equivalent) was dissolved in MeOH  (19ml) and 
2,3-butanedione (324 mg, 3.76 mmol, 1 equivalent) together with CH(OMe)3 (800 mg, 7.55 
mmol, 2 equivalents) were added. The catalyst, BF3.OEt2 (53 mg, 0.37 mmol, 0.1 equivalent) 
was added as last.  The reaction was stirred at room temperature overnight.  The reaction was 
stopped by addition of Et3 n (5 drops).  The reaction mixture was evaporated till dryness and 
purified by flash chromatography with EtOAc:isooctane 1:1 which yielded a colourless oil of 
molecule 112 (378 mg, 1.70 mmol, 46%) 
Analysis: 
ESI-MS: 243.1 (M+Na)+ 
Retention time: 11.3 minutes 
Rf-value 0.27 (1:1 isooctane:EtOAc) 
UV: not UV active 
O
O
O
O
OH
1
2
3
4
56
6
7
7  
NMR  
1H 300 MHz Solvent CDCl3 
atom δ (ppm) integration Multiplicity J (Hz) 
H1 ax 3.46 1 t 11.1 
H1 eq 3.28 1 dd 3.2; 11.1 
H2 3.96 1 m  
H3 1.50 2 m  
H4 3.64 2 t 5.7 
H5 2.63  bs  
H6 1.15 6 s  
H7 3.15 6 s  
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H. Tosylation of (2S,5R,6R)-5,6-dimethoxy-5,6-dimethyl-1,4-dioxane-2-
ethanol 
O
O OH
O
O
O
O OTs
O
O
pTsCl (1.1eq)
Pyridine, 4h, 75%
112 114  
 
The protected alcohol 112 (170 mg, 0.766 mmol, 1 equivalent) was dissolved in extra dry 
pyridine (1 ml).  Paratoluenesulfonylchloride (162 mg, 0.85 mmol, 1.1 equivalents) added in 
1 portion and the reaction was stirred for 90 minutes at room temperature.  The colour of the 
mixture turned orange during the reaction.  The reaction was quenched with 2 ml 1 M HCl 
and the resulting mixture was stirred for 2 minutes.  Diethylether was added and the mixture 
was extracted twice.  The organic layer was washed another two times with 1 M HCl to 
remove the pyridine and finally it was washed 3 times with a saturated NaHCO3 solution.  
After drying on NaSO4 the organic layer was concentrated in vacuo to yield 217mg of tosylate 
114 (0.577 mmol, 75 %) 
Analysis: 
Rf-value 0.65 (3:2 pentane:EtOAc) 
O
O
O
O
O
1
2
3
45
6
6
7
7
S
O
O5
8
9
8
 
NMR  
1H 300 MHz Solvent CDCl3 
atom δ (ppm) integration Multiplicity J (Hz) 
H1 ax 3.46 1 t 11.1 
H1 eq 3.31 1 dd 3.4; 11.1 
H2 3.97 1 m  
H3 1.66 2 m  
H4 4.09; 4.22  2 m  
H5 1.20; 1.22 6 bs  
H6 3.13; 3.20  6 s  
H7 7.74 2 d 8.3 
H8 7.30 2 d 8.3 
H9 2.40 3 s  
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I. Synthesis of (2R, 3R, 5S) -5-(2-Bromo-ethyl)-2,3-dimethoxy-2,3-
dimethyl-[1,4]dioxane 
O
O OTs
O
O
O
O Br
O
O
LiBr (8.1eq)
DMF, 70°C, 4h
114 115  
Tosylate 114 (210 mg, 0.558 mg, 1 equivalent) was dissolved in extra dry DMF (1 ml).  LiBr 
(388 mg, 4.51 mmol, 8.1 equivalents) was added in one portion and the reaction setup was 
flushed with argon.  The mixture was slowly heated to 70°C which caused the LiBr to 
dissolve completely.   After stirring the reaction mixture for 1.5 h at 70°C the heating was 
removed and the reaction mixture was poured out onto ice.  The product was extracted with 
Et2O followed by washing steps with water and NaHCO3.  The crude reaction mixture was 
evaporated under reduced pressure and purified by column chromatography with 20:1 
pentane:EtOAc as mobile phase.  After evaporation of the solvent this product was co-
evaporated twice with fresh destilled THF before use in the next reaction. 
Analysis: 
Rf-value 0.29 (20:1 pentane:EtOAc) 
ESI-MS: 237.0 and 239.0 (MW –methyl and – methoxy-group + H)+ 
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J. Synthesis of (2R, 3R, 5S)-5-(2-Furan-2-yl-ethyl)-2,3-dimethoxy-2,3-
dimethyl-[1,4]dioxane 
O
O Br
O
O
O
O
O
O
O
1. Furan(2 eq), BuLi(1.8 eq), 
THF, -78-rt
2. bromide 115, overnight, RT
27% over 2 steps
115 116  
Furan (76 mg, 1.12 mmol, 2 equivalents based on starting material of the previous reaction) 
was mixed in a dry 2-neck flask with THF (0.6 ml).  The solution was cooled with dry 
ice/isopropanol and BuLi (2.4 M solution, 0.45 ml, 1.08 mmol, 1.9 equivalents based on 
starting material of the previous reaction).  After 15 minutes the ice bath was removed, the 
solution turned yellow.  The mixture was stirred for another 1.25h before the bromide was 
added.  The reaction was left to stir overnight after which the solution had turned brown.  The 
furan containing building block was purified from the mixture with column chromatography 
(15:1 pentane:EtOAc) which yielded 40 mg of the building block (0.148 mmol, 27% over two 
steps) 
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Analysis: 
Rf-value 0.63 (10:1 pentane:EtOAc, no separation on TLC with more apolar mobile phases) 
O
O
O
O
1
2
3
411 6
14
7
59
8
O
1012
13
 
NMR  
1H 500 MHz Solvent CDCl3 
atom δ (ppm) integration Multiplicity J (Hz) 
H1 ax 3.53 1 t 11.1 
H1 eq 3.37 1 dd 3.1; 11.1 
H2 3.88 1 m  
H3 1.67; 1.74 2 m  
H4 2.69; 2.81 2 m  
H6 5.95 1 broad d  
H7 6.23 1 broad dd  
H8 7.25 1 broad d  
H11 1.26 3 s  
H12 1.28 3 s  
H13 3.24 3 s  
H14 3.21 3 s  
NMR  
13C 500MHz Solvent CDCl3 
atom δ (ppm) atom δ (ppm)  
C1 63.5 C8 140.9  
C2 66.3 C9 98.1  
C3 29.4 C10 99.1  
C4 23.6 C11 17.6  
C5 155.4 C12 18.0  
C6 105.1  C13  48.0  
C7 110.1 C14 48.0  
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K. Cross-linking of deoxycytidine with a nucleoside 99 
O
OH
HO
N
N
N
O
OH
O
O
O
O
O O
1.NBS, THF:Acetone:H2O 5:4:2
2. deoxycytidine
O
OH
HO
N
N
N
O
O
OH
O
O
99 8
131
 
 
The building block 99 (22 mg, 0.112 mmol, 1 equivalent) was dissolved in THF:acetone:H2O 
(5:4:2, 1 ml).  Pyridine (27µl, 3 equivalents) was added as well as N-bromosuccinimide (22 
mg, 0.124 mmol, 1.1 equivalents).  The reaction mixture was cooled at -20°C and was 
allowed to stir for 2 hours.  All starting material was converted at this point and deoxycitidine 
(hydrate form, 50 mg, 0.112 mmol, 1 equivalent) was added.  The reaction was stirred for an 
additional 4 hours before being quenched by addition of acetone. A white precipitate had 
formed which was filtered and the filtrate was evaporated under reduced pressure and co-
evaporated twice with toluene to remove residual water.  The residue was brought onto 
column with 3:1 toluene:methanol as eluens and the mixture was purified by flash 
chromatography.  The purified compound (10 mg, 0.022 mmol, 20%) was a mixture of 
different stereisomers where possibly also the hemiacetal was present. 
  
 M
at
er
ia
ls
 a
nd
 m
et
ho
ds
 
220 
 
Analysis: 
ESI-MS: 440.1 (M+H) + 
Rf-value 0.14 (3:1 Toluene: MeOH) 
Retention time: 9.8 minutes 
 
N
N
N
O
OH
O
O
O
O
OH
HO
1
2
34
5
6
7
8
9
10 11
12
13
14
15
16
 
 
NMR  
1H 300MHz Solvent MeOH 
atom δ (ppm) integration Multiplicity J (Hz) 
H1 6.22 1 m  
H2 2.12 2 m  
H3 4.40 1 app d 2.3 
H4 3.84 1 m  
H5 3.67 2 m  
H6 7.51- 7.58 1 m  
H7 5.62-5.67 1 m  
H8 5.14; 5.90 1 m  
H9 4.54-4.64 1 m  
H10 
2.38-
3.08;1.98 2 m  
H10/H12 1.61-1.82 2 d 8.0 
H13 4.00 1 m  
H14 3.42/3.95 1 m  
H15 1.20; 1.25 6 s  
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L. Synthesis of (S)-4-(4-Bromo-benzyloxymethyl)-2,2-dimethyl-[1,3] 
dioxolane 
O O
OH
+
Br
Br
toluene, KOH (15 eq)
Reflux, Dean Stark
20h
O O
O
Br
119103 117  
 
4-Bromobenzylbromide (117, 1.8 g, 7.20 mmol, 0.95 equivalent) was dissolved in toluene (70 
mL).  (S)-Solketal (1 g, 7.58 mmol, 1 equivalent) and KOH (5.23 g, 113 mmol, 15 
equivalents,) were added and the mixture was refluxed under Dean-Stark conditions (oil bath 
at 160°C) for 20 hours.  The reaction was monitored by TLC (pentane:EtOAc 9:1 v/v).  When 
all starting material was consumed, the reaction mixture was allowed to cool to room 
temperature.  Next, water (30 ml) was added to the reaction mixture and after separation of 
the phases the aqueous layer was washed twice more with toluene (2 x 15 ml).  The organic 
layers were combined and washed twice with water.   The organic layer was dried with 
Na2SO4.  The Na2SO4 was filtered off and the solvent was removed under reduced pressure to 
afford 4-(4-Bromo-benzyloxymethyl)-2,2-dimethyl-[1,3] dioxolane 119 as a yellow oil (2.15 
g, 7.15 mmol, 93%). 
  
 M
at
er
ia
ls
 a
nd
 m
et
ho
ds
 
222 
 
Analysis: 
ESI-MS: 322.9 and 324.9 (M+Na) + 
Rf-value 0.23 (9:1 pentane:EtOAc) 
IR (KBr-film, cm-1): 2986 (s), 2934 (m), 2866 (s), 1594 (m), 1488 (m), 1455 (m), 1380 (s), 
1370 (s), 1256 (s), 1213 (s), 1158 (m), 1095 (s), 1071 (s), 1055 (s), 1012 (s) 
UV: λmax=230 nm (H2O/ACN) 
 
O
O
O
Br
1
2
H
H
3
4
5
6
7 8
11
12 13
H H
10
14
15
HH
9 16
 
 
NMR  
1H 300MHz Solvent CDCl3 
atom δ (ppm) integration Multiplicity J (Hz) 
H1/H2 1.38 1 s  
H1/H2 1.44 1 s  
H4 3.75 1 dd 6.3; 8.3 
H5 4.07 1 dd 6.3; 8.3 
H6 4.31 1 m  
H7 3.48 1 dd 5.5; 9.8 
H8 3.56 1 dd 5.5; 9.8 
H9/10 4.53 2 broad d  
H12/H16 7.23 2 d 8.3 
H13/H15 7.48 2 d 10,6 
NMR  
13C 300MHz Solvent CDCl3 
atom δ (ppm) atom δ (ppm)   
C1/C2 25.4 C9 72.7  
C1/C2 26.8 C11 121.6  
C3 109.5 C12/C16 129.3  
C4 66.8 C13/C15 131.5  
C6 74.7 C14 137.1  
C7 71.2      
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M. Synthesis of (S)-4-(4-Furan-2-yl-benzyloxymethyl)-2,2-dimethyl-
[1,3] dioxolane 
O a) n-BuLi (9.5 eq), THF O ZnCl
118
+
O O
O
Br
119
Pd[P(C6H5)3]4 (0.03 eq)
THF, 50°C, overnight
O O
O
O
120
51 (10 eq)
b) ZnCl2 (9.5 eq)
 
A double-necked flask was loaded with dry THF (40 mL), furan (4.8 mL, 65 mmol, 10 
equivalents) under Ar atmosphere and cooled with CO2/i-propanol.  n-BuLi (hexanes solution 
2.5 m, 25 mL, 62 mmol, 9.5 equivalents) was added dropwise to the above solution.  A white 
precipitation occurred after 5 minutes.  30 minutes after the n-BuLi addition, the CO2/i-
propanol bath was removed.  1 hour later ZnCl2 (1 M in EtO2 solution, 62 mL, 62 mmol, 9.5 
equivalents) was added under cooling with a normal ice bath.  This mixture was stirred 90 
minutes before the other reagents were added.  In a dry flask under argon atmosphere covered 
with aluminium foil, tetrakis(triphenylphosphine)palladium[0] (225 mg, 0.2 mmol, 0.03 
equivalent) was dissolved in dry THF (3 mL).  4-(4-Bromo-benzyloxymethyl)-2,2-dimethyl-
[1,3] dioxolane (119, 1.95 g, 6.48 mmol, 1 equivalent) dissolved in dry THF (12 mL) was 
added to the catalyst.  This second reaction mixture was stirred at room temperature before 
being transferred with a double tip needle to the furylzinc-chloride mixture.  The oil bath was 
heated at 50°C and the reaction was allowed to stir overnight.  When all the starting material 
was converted (checked by TLC 3:1 i-octane:acetone), the reaction flask was chilled in an ice-
bath.  The reaction mixture was quenched with cold HCl (2 M solution, 10 mL) followed by 
extraction with Et2O.  The organic layer was washed 4 times with saturated NaHCO3 solution 
before being dried with Na2SO4.  The Na2SO4 was removed and the solvent was evaporated 
under reduced pressure.  The residue was purified by flash chromatography (i-octane: acetone 
20:1 v/v) to afford 4-(4-Furan-2-yl-benzyloxymethyl)-2,2-dimethyl-[1,3] dioxolane as a 
green-blue oil (70%).   
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Analysis: 
ESI-MS: 157.0 (molecule – protected glycerol)+ 
Rf-value 0.13 (20:1 isooctane:acetone) 
IR (KBr-film, cm-1): 2986 (s), 2931 (s), 2864 (s), 1616 (m), 1517 (m), 1484 (m), 1456 (m), 
1370 (s), 1256 (s), 1214 (s), 1158 (s), 1090 (s), 1053 (s), 1009 (s) 
UV: λmax= 285 nm (H2O/ACN) 
 
O
O
O
O1
2
3
H
H
H
HH
H
4
5
6
7 8
9
10
11
12 13
1415
1312 16 17
18
 
 
NMR  
1H 300 MHz Solvent CDCl3 
atom δ (ppm) integration Multiplicity J (Hz) 
H1/H2 1.37 3 s  
H1/H2 1.43 3 s  
H4 3.75 1 d 6.4; 8.3 
H5 4.07 1 d 6.4; 8.3 
H6 4.31 1 m  
H7 3.48 1 dd 5.5; 9.8 
H8 3.56 1 dd 5.8; 9.8 
H9/H10 4.58 2 s  
H12 7.35 2 d 8.3 
H13 7.66 2 d 8.3 
H16 6.65 1 d 3.3 
H17 6.47 1 dd 1.8, 3.3 
H18 7.47 1 d 1.8 
NMR  
13C 75 MHz Solvent CDCl3 
atom δ (ppm) atom δ (ppm)   
C1/C2 25.4 C12 128.2   
C1/C2 26.8 C13 123.9   
C3 109.5 C14 137.1   
C4 66.8 C15 153.8   
C6 74.8 C16 111.7   
C7 71.2 C17 105.1   
C9 73.2 C18 142.1   
C11 130.4       
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N. Synthesis of (S)-3-(4-Furan-2-yl-benzyloxy)-propane-1,2-diol  
 
O
O
O
O
HO
HO
O
O
120
HCl (4M)
THF, 0°C
100min.
3  
 
4-(4-furan-2-yl-benzyloxymethyl)-2,2-dimethyl-[1,3] dioxolane (300 mg, 1.0 mmol) was 
dissolved in THF (8 ml)  and HCl (4 M solution, 4 mL) was added with cooling on ice.  The 
reaction was allowed to stir for 120 minutes under ice cooling (monitored by TLC with 2:1 i-
octane:acetone).  When no further conversion was visible on TLC, the reaction mixture was 
diluted with water (15 ml) and the mixture was extracted with EtOAc.  The EtOAc phase was 
washed 3 times with saturated NaHCO3 solution and the aqueous phase is checked for its pH 
(basic). The organic layer was dried over Na2SO4.  The reaction mixture was concentrated in 
vacuo to afford 3-(4-Furan-2-yl-benzyloxy)-propane-1,2-diol (265 mg, .1.0 mmol, 97%) 
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Analysis: 
ESI-MS: 157.1 (molecule - glycerol)+ 
Rf-value 0.1 (1:1 isooctane:acetone) 
IR (KBr-film, cm-1): 3289 (s), 2860 (m), 1080(s), 1010 (s) 
UV: λmax= 285 nm (H2O/ACN) 
 
HO
HO
O
O
1
2
H
H
H H
HH
3
4
5
6 7
8
9
10
11 12
1314
15 16
17
1211
 
 
NMR  
1H 300 MHz Solvent CDCl3 
atom δ (ppm) integration Multiplicity J (Hz) 
H1 2.01 1 dd 6.2; 6.0 
H2 2.53 1 d 5.0 
H3 3.53-3.77 4 m  
H4 3.53-3.77 4 m  
H5 3.91 1 m  
H6 3.53-3.77 4 m  
H7 3.53-3.77 4 m  
H8/H9 4.57 2 s  
H11 7.35 2 d 8.2 
H12 7.67 2 d 8.2 
H15 6.66 1 d 3.3 
H16 6.48 1 dd 1.6; 3.3 
H17 7.47 1 d 1.6 
NMR  
13C 75 MHz Solvent CDCl3 
atom δ(ppm) atom δ (ppm)   
C3 72.5 C12 125.0   
C5 71.2 C13 142.4   
C6 63.7 C14 170.0   
C8 73.7 C15 105.0   
C10 133.7 C16 111.3   
C11 128.7 C17 158.8   
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O. Synthesis of (S)-1-[bis-(4-methoxy-phenyl)-phenyl-methoxy]-3-(4-
furan-2-yl-benzyloxy)-  propan-2ol 
 
HO
HO
O
O
3
DMTCl (0.9 eq)
pyridine, 0°C, 
2h
HO
DMTO
O
O
121  
 
In a dry flask 5 (0.10 g, 0.40 mmol, 1 equivalent) was co-evaporated with pyridine (15 mL) 
three times.  Pyridine (1.5 mL), and 4,4’ dimethoxytritylchloride (122 mg, 0.36 mmol, 0.9 
equivalent) were added under argon atmosphere.  The reaction was allowed to stir at 0°C.  
The reaction was monitored by TLC (i-octane:acetone, 2:1 v/v) and after 2 hours it was 
quenched with MeOH (0.3 ml).  After 5 minutes stirring EtOAc (2 ml) and a saturated 
NaHCO3 solution (2 ml) were added.  After separation of the phases the aqueous phase was 
extracted twice more with EtOAc and the combined organic layers were washed with a 
saturated NaHCO3 solution.  The EtOAc-phase was dried (Na2SO4), filtered and evaporated 
under reduced pressure.  The residue was purified by flash chromatography with i-
octane:acetone (2:1) and 1% triethylamine, to afford after evaporation 1-[Bis-(4-
methoxyphenyl)-phenyl-methoxy]-3-(4-furan-2-yl-benzyloxy)-propan-2-ol (161 mg, 0.29 
mmol, 73%.). 
Analysis: 
ESI-MS: 573.1 (M+Na) + 
Rf-value 0.28 (2:1 isooctane:acetone) 
IR (KBr-film, cm-1): 2928, 1608, 1508, 1302, 1176, 829 
UV: λmax= 285 nm (H2O/ACN) 
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HO
O
O
OO
O
H
H
H H
HH
1
2
3
4
5 6
7
8
9
10 11
12 13
14 15
16
1110
19
20
21
22
22
23
21
24
24
23
22
22
21
20
21
25
26
26
27
27
28
 
 
NMR  
1H 300MHz Solvent CDCl3 
atom δ (ppm) integration Multiplicity J (Hz) 
H1 2.39 1 s  
H2/H3 3.56 2 m  
H4 3.96 1 m  
H5/H6 3.18 2 m  
H7/H8 4.51 2 s  
H11 7.61 2 d 8.1 
H10/H22/H24/H26/H27/H28 7.11-7.30 9 m  
H10/H22/H24/H26/H27/H28 7.40 2 d 7.8 
H14 6.62 1 d 3.3 
H15 6.45 1 broad dd  
H16 7.45 1 d 1.6 
H21 6.78 4 d 8.9  
H24 3.74 6 s  
NMR  
13C 75 MHz Solvent CDCl3 
atom δ (ppm) atom δ (ppm)   
C3 71.6 C16 142.1   
C4 70.0 C19    
C5 73.1 C20    
C7 64.4 C21 113.1   
C9 ND C22 130.1   
C10/C18 128.1 C23    
C11/C17 123.8 C24 55.2   
C12 136.0 C25   
C13 ND C26   
C14 105.0 C27   
C15 111.7 C28 126.8   
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P. Synthesis of diisopropyl-phosphoramidous acid 2-[bis-(4-methoxy-
phenyl)-methoxy]-1-(4-furan-2-yl-benzyloxymethyl)-ethyl ester 2 -
cyano-ethyl ester 
 
HO
DMTO
O
O
O
DMTO
O
O
PO
N
N
121
24h
0°C
7
a
(a) NC(CH2)2OP(NiPr2)2 (1.5 eq), diisopropylammonium tetrazolide, CH2Cl2  
 
121 (100 mg, 0.18 mmol, 1 equivalent) was dissolved in fresh distilled CH2Cl2 (6 mL) under 
argon atmosphere.  N,N-diisopropylammoniumtetrazolide (46 mg, 0.27 mmol, 1.5 
equivalents) was added and stirred at room temperature.  The 2-
cyanoethyltetraisopropylphosphoramidite (60 mg, 0.2 mmol, 1.1 equivalents) was added 
while cooling on an ice-bath and the reaction mixture was allowed to stir overnight at room 
temperature. 
When no further conversion occurred, the reaction mixture was quenched with MeOH (4 mL).  
The solvent was partially evaporated and water was added.  The product was extracted with 
CH2Cl2, dried on anhydrous Na2SO4, and the solvent was removed under reduced pressure.  
The residue was purified using Merck silica gel (2:8 EtOAc:petroleum ether with 1 % Et3 n) to 
afford diisopropyl-phosphoramidous acid 2-[bis-(4-methoxy-phenyl)-methoxy]-1-(4-furan-2-
yl-benzyloxymethyl)-ethyl ester 2 -cyano-ethyl ester (106 mg, 0.14 mmol, 79 %).  This 
product was used in the oligonucleotide synthesis. 
Analysis: 
ESI-MS: 793.7 (M+Na) + 
Rf-value 0.32 (2:7 EtOAc:Petroleum ether) 
IR (KBr-film, cm-1): 2928, 1608, 1508, 1302, 1176, 829 
UV: λmax= 285 nm (H2O/ACN) 
 
NMR  
31P 121 MHz Solvent CDCl3 
  δ (ppm) Multiplicity J (Hz)   
  149.44 s     
  149.62 s     
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Q. Cross-linking of deoxycytidine with modified building block 120 
N
N
N
O
OH
O
O
O
O
O
O
O
1.NBS (2 eq), 
THF:Acetone:H2O 5:4:2
2. deoxycytidine (1 eq)
O
O
OH
HO
N
N
N
O
O OH
O
O
O
O
OH
HO
9
120
153
 
Building block 120 (22 mg, 0.076 mmol, 1 equivalent) was dissolved in THF:acetone:H2O 
(5:4:2, 0.5 ml).  Pyridine (17 µl, 3 equivalent) was added as well as N-bromosuccinimide (15 
mg, 0.087 mmol, 1.1 equivalent).  The reaction mixture was cooled at -20°C and it was 
allowed to stir for 4 hours.  As t all the starting material was converted another quivalent of 
NBS was added.  After another 90 minutes all starting material was converted and 
deoxycytidine (hydrate form, 34 mg, 0.077 mmol, 1 equivalent) was added.  The reaction was 
stirred for an additional 2 hours before being quenched by addition of acetone. A white 
precipitation was formed which was filtered and the filtrate was evaporated under reduces 
pressure and co-evaporated twice with toluene to remove residual water.  The residue was 
purified by flash chromatography with 3:1 toluene:methanol as eluens.  The purified 
compound (6 mg, 0.011 mmol, 14%) was a mixture of different stereisomers and possibly 
also the hemiacetal form 153 was present. 
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Analysis: 
ESI-MS: 532.1 (M+H) +; 416.1 (M-deoxyribose+H)+ 
Rf-value 0.16 (3:1 Toluene: MeOH) 
Retention time: 11.7 minutes 
 
N
N
N
O
OH
O
O
O
O
O
OH
HO
1
2
34
5
6
7
8
9
10
11
11 12
12
13
14
15 16
17
18
H
H
19
 
 
NMR  
1H 300MHz Solvent MeOH 
atom δ (ppm) integration Multiplicity J (Hz) 
H1 6.16 1 broad m  
H2 2.08-2.22 2 m  
H3 4.21 1 m  
H4/ H10/ H14 3.60-3.70 3* m  
H5 3.46 2 d 5.0 
H6 / H12 7.87-7.90 3 m  
H7 5.72-5.88 1 broad d  
H8 5.27; 5.40 1 broad d  
H9 4.51-4.45 1 m  
H10 3.40 1* m  
H11 7.39 2 d 8.0 
H13 4.55 2 s  
H15 4.28 1 m  
H16/ H17 3.82 1 m  
H16/ H17 3.97 1 app t 7.2 
H18/H19 1.28 3 s  
H18/H19 1.24 3 s  
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R. Deprotection of the cross-linked dinucleoside 9/153 
N
N
N
O
OH
O
O
O
O
O
OH
HO
N
N
N
O
O OH
O
O
O
O
OH
HO
9
153
N
N
N
O
OH
O
HO
HO
O
O
OH
HO
N
N
N
O
O
HO
HO
O
O
OH
HO
154
155
3.8% HCl in MeOH
 
Deprotection of 9 was performed on analytical scale (1 mg) in a 550 µl of a 10:1 MeOH:HCl 
(38%).  The reaction mixture was stirred for 30 minutes before 500 µl of a saturated NaHCO3 
solution was added to quench the reaction.  The reaction mixture was evaporated till dryness 
and the residue was analyzed by RP-HPLC-MS.  Based on RP-HPLC the reaction seemed 
quantitative. 
 
Analysis 
Retention time deprotected molecule 154: 9.2 minutes  
ESI-MS: 492.1 (M+H)+ 
Retention time deprotected and dehydrated molecule 155: 10.1 min  
ESI-MS 474.1 (M+H)+ 
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S. Cross-linking of deoxyadeosine with modified building block 120 
OH
O
O
O
O
O
O
O
1.NBS (2 eq) 
THF:Acetone:H2O 5:4:2
2. deoxycytidine
O
N
NN
N
N
O
HOH
HH
HH
HO
O
OH
O
O
O
N
NN
N
N
O
HOH
HH
HH
HO
154
155
120
 
120 (22 mg, 0.076 mmol, 1 equivalent) was dissolved in THF:acetone:H2O (5:4:2, 0.5 ml).  
Pyridine (17 µl, 3 equivalents) was added as well as N-bromosuccinimide (15 mg, 0.087 
mmol, 1.1 equivalents).  The reaction mixture was cooled at -20°C and it was allowed to stir 
for 4 hours.  As t all the starting material was converted, another quivalent of NBS was added.  
After another 90 minutes, all starting material was converted and deoxyadenosine (18 mg, 
0.072 mmol, 0.95 equivalent) was added.  The reaction was stirred for 8 hours before being 
quenched by addition of acetone.  The reaction was monitored by LS-MS but almost no 
conversion to the desired product was seen.  A white precipitation was formed which was 
filtered and the filtrate was evaporated under reduces pressure and co-evaporated twice with 
toluene to remove residual water.  An attempt to purify the filtrate didn’t result in any 
recovery of the desired cross-linked product so the structure of the cross-link can only be 
confirmed by the mass spectrum of the product with a retention time of 10.4 minutes (570.7: 
M+Na+H+).  
Analysis 
Retention time: 10.4 minutes 
ESI-MS: 570.7 (M+H) 
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T. Synthesis of 2-[Bis-(4-methoxy-phenyl)-phenyl-methoxymethyl]-5-
(4-furan-2-yl-phenyl)-tetrahydro-furan-3-ol 
O
OH
HO
O
O
OH
DMTO
O
DMTCl (1.5 eq)
Pyridine, 0°C-rt
overnight
4 143  
 
The unprotected nucleoside (69 mg, 0.27 mmol, 1 equivalent) is dissolved in extra dry 
pyridine (1 ml) and a light yellow solution is obtained.  The reaction mixture is cooled with an 
ice bath.  The DMTCl (135 mg, 0.40 mmol, 1.5 equivalents) is added in one portion and the 
reaction is stirred overnight.  The day after the unreacted DMTCl is quenched by addition of 
MeOH (2 ml).  Ethylacetate was added and the organic mixture was washed 3 times with 
saturated NaHCO3 solution.  The organic layer was dried over Na2SO4 and evaporated under 
reduced pressure.  The crude reaction mixture was purified by flash chromatography with 3:1 
pentane:EtOAc.  The resulting DMT protected nucleoside 143 was obtained in 66% yield 
(0.176 mmol).  
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Analysis: 
ESI-MS: 585.2 (M+Na) + 
Retention time: 9.8 minutes 
O
OH
O
O
O
O
1
2
34
5
6
7
8
8
7
9
10
11
12
13
14
14
15
15 15
15
16
16 16
16
17
17
18
1920
21
20 19
22
22
23
 
NMR  
1H 300MHz Solvent CDCl3 
atom δ (ppm) integration Multiplicity J (Hz) 
H1 5.07 1 dd 5.5; 9.9 
H2 1.96 1 broad m  
H2’ 2.14 1 ddd 1.9; 5.9 ;13.0 
H3 4.32 1 broad m  
H4 3.96 1 broad m  
H5 3.17 1 dd 5.8; 9.9 
H5’ 3.25 1 dd 4.6; 9.9 
H7 6.71 2 m  
H8 7.51 2 m  
H11 6.51 1 d 3.4 
H12 6.34 1 dd 1.7; 3.4 
H13/H15/H16/H19/H20/H21 7.05-7.40 12 m  
H22 3.21 6 s  
NMR  
13C 75 MHz Solvent CDCl3 
atom δ (ppm) atom δ (ppm)   
C1 79.8 C11 111.7   
C2 43.8 C12 104.9   
C3 74.7 C13 142.0   
C4 86.4 C15 130.1   
C5 64.5 C16 113.2   
C6 141.0 C19 128.2   
C7 126.4 C20 127.9  
C8 123.8 C21 127.6  
C9/C14 136.1 C22 55.2   
C10/C17 158.5 C23 86.3  
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U. Diisopropyl-phosphoramidous acid 2-[bis-(4-methoxy-phenyl)-
phenyl-methoxymethyl]-5-(4-furan-2-yl-phenyl)-tetrahydro-furan-3-
yl ester 2-cyano-ethyl ester 
O
O
DMTO
O
a) (iPr2N)(NCCH2CH2O)PCl (2.5 eq)
DIPEA, CH2Cl2, rt
O
OH
DMTO
O
PO
N
NC
a
143 144
 
 Nucleoside 143 (90 mg, 0.16 mmol) was dissolved in dry CH2Cl2 (3 ml) and DIPEA (0.25 
ml) was added.  (iPr2 n)(NCCH2CH2O)PCl (95 mg, 0.4 mmol, 2.5 equivalents) was added in 1 
portion and stirred at room temperature.  After 2h the reaction was quenched by addition of 2 
ml MeOH, stirred for another 15 minutes, followed by addition of 3 ml saturated NaHCO3 
solution.  This mixture was extracted 3 times with CH2Cl2.  The organic layer was dried over 
Na2SO4 and evaporated under reduced pressure.  The reaction mixture was purified by 
column chromatography with 4:1 isooctane:EtOAc (1%TEA).  The product was collected as a 
yellow oil (co-evaporation with toluene or CHCl3 didn’t yield solid, 70 mg, 0.091 mmol, 
59%). 
Analysis: 
Rf-value 0.30 (2:7 EtOAc:Petroleum ether) 
 
NMR  
31P 121 MHz Solvent CDCl3 
  δ (ppm) Multiplicity J (Hz)   
  147.98 s     
  148.16 s     
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8.2.3 Oligonucleotide synthesis 
 
The purified amidites were used for incorporation into oligonucleotides via automated DNA 
synthesis.  The phosphoramidites were first dried overnight under high vacuum.  Next, they 
were dissolved in extra dry acetonitrile in a concentration of 0.05 M.  Molecular sieves (3Å) 
were added as the phosphoramidite is an oil and hence difficult to dry.  For the manual 
couplings dicyanoimidazole is used as a 1 M solution in ACN.   
 
The syntheses were done on 1 µmol scales for which the solid support was weighed in a flow 
cell from the synthesizer.  In general the loadings were around 40 µmol/g support so 25 mg 
solid support was used by approximation. The synthesis cycle (cycle09user) was started with 
the correct sequence.  In order to indroduce the modification an bottle with dry acetonitrile is 
installed in position 5 of the synthesizer.  The position of the modification in the DNA 
sequence is replaced by “5”.  When the synthesizer will start the coupling of this dummy 
phosphoramidite the DNA synthesizer should be stopped with the command “hold immed” at 
the time activator is flushed to the column (step 8 or 9).  The reaction column can be removed 
from the synthesizer and a mixture of 280 µl phosphoramidite solution with 420 µl activator 
(mix without molecular sieves!) is gently squeezed through the reaction column.  Total 
addition took 10 minutes.  If the coupling time becomes too long, the activated amidite might 
degrade as it is impossible to keep the reaction 100% dry.  After this process the column can 
be placed back in the synthesizer.  The synthesis will be resumed (push “resume”) with 
flushing activator (together with dummy amidite 5) through the column but this does not 
affect the synthesis.  The coupling efficiency of the modified building block can be checked 
by collecting the DMT cleavage solution before and after its introduction.  Comparison of the 
intensities gives a direct indication of the yield.  
 
8.2.4 Reversed phase RP-HPLC 
 
RP-HPLC analyses were performed on an Agilent 1100 Series instrument equipped with a 
diode array detector.  The analyses were done on a Phenomenex Clarity column (250 x 
4.6mm, 5 µm) at 50°C with 0.1 M TEAA (with 5% MeCN) and MeCN as mobile phases. 
(linear gradient: 0-30%MeCN in 15 min).  When stated the same conditions were used with a 
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Jupiter 300Å column (250 x 4.6mm, 5 µm).  The chromatograms were analyzed at 260 nm as 
this is the wavelength where the oligonucleotides can be detected with the highest sensitivity. 
 
The TEAA buffer was prepared in house with fresh distilled Et3 n and acetic acid 
(biochemistry grade).  The acetic acid was added to milliQ water followed by slow addition of 
an equimolar amount of Et3N (Et3N does not dissolve well in water whereas the ionized form, 
Et3NH+, does).  The pH was adjusted to 7 with Et3 n or acetic acid and in the end 5% MeCN 
was added. 
8.2.5 Maldi-TOF analysis 
 
HPLC-purified samples were subjected to MALDI-TOF analysis.  MALDI-TOF spectra were 
recorded in positive mode on an Applied Biosystems voyager DE-STR biospectrometry 
workstation.  The matrix was a mixture of 0.7 M 3-hydroxypicolinic acid and 0.07 M 
ammoniumcitrate for adduct suppression.284  The samples were desalted by addition of small 
amounts DOWEX beads which were thoroughly rinsed with water before use.  This was done 
in the sample tube and not on the sample plate as in certain cases (if NaCNBH3 was present) 
the sample plate corroded and presence of DOWEX beads resulted in amorphous drying 
instead of crystallization. 
 
8.2.6 UV-VIS analysis  
 
All UV experiments were recorded on a Varian Cary 300 Bio equipped with a 6 cell 
thermostatted holder.  Concentrations were measured at 260 nm for all oligonucleotides at 
room temperature.  Extinction coefficients (ε) were calculated according to the nearest 
neighbour method.122  For modified residues the extinction coefficient was not known and 
they were replaced in the calculation with a thymidine residue for monoaromatic structures 
and with a adenosine in the case of a conjugated aromatic systems. 
 
Melting curves were monitored at 260 nm with a heating rate of 0.3°C/min.  The buffer 
contained 100 mM NaCl and 10 mM phosphate buffer (pH 7).  Oligonucleotide concentration 
was 2 µM of each strand.  Melting temperatures were calculated from the first derivative of 
the heating curves.  Reported absorbance values were normalized. 
 M
at
er
ia
ls
 a
nd
 m
et
ho
ds
 
239 
 
8.2.7 Cross-link reactions 
 
Cross-link reactions were carried out by mixing equimolar amounts of modified and non-
modified oligonucleotides in a 1:1 ratio.  The solution was buffered at pH 7 with 10 mM 
sodium phosphate buffer to which 100 mM NaCl was added.  The final concentration of 
oligonucleotide duplex was 20 µM.  NBS was added under shaking in an Eppendorf 
Thermomix at 20°C.  1 equivalent was added every 15 minutes.  The total amount needed for 
small reactions (1 nmol) is indicated for each reaction.  RP-HPLC chromatograms represent 1 
nmol cross-link reactions. 
 
Cross-linking of larger amounts required more equivalents of NBS, for the cross-linking of 5 
to 19 nmol in general 1 or 2 extra equivalents were required.  These reactions were used for 
further analysis of the cross-link.  After concentration in vacuo the residue was dissolved in 
100 µl milliQ water and purified by RP-HPLC.  The different fractions were also evaporated 
by vacuum centrifugation followed by MALDI-TOF analysis.   
 
The m/z values indicated below correspond to the most intense signals in the spectra, sodium 
and potassium adducts are not reported.   
 
8.2.8 Enzymatic degradation 
 
Exonuclease III was purchased from GE healthcare or Sigma.  For the enzymatic degradations 
0.6 nmol cross-linked duplex was dissolved in 66 or 88µl containing 1X reaction buffer 
supplied with the enzyme.  200 units of the enzyme were added and the mixture was shaken at 
37°C for 55 minutes.  The reaction mixture was injected immediately onto RP-HPLC for 
purification and the peaks eluting after 7 minutes were collected.  Those eluting faster 
correspond to mononucleotides from the digestion. 
A. General structures: 
The adducts formed in the different reactions are given below and will be mentioned as such 
in the analysis 
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Cross-linked adducts: 
O
PO OH
O
O
O
P OHO
O
H O
H H
H H
O
HO
O
N
N
N
O
O
PO OH
O
O
O
P OHO
O
H O
H H
H H
O
O
N
N
N
O
Cross-link Cross-link dehydrated  
 
Oxidation of the modified strand 
O
PO OH
O
O
O
O
O
PO OH
O
O
O
O
OH
modified strand oxidized modified strand overoxidized 
 
Modified strand brominated: 
O
PO OH
O
 
 
Enzymatic degradation products will be assigned according to Figure 139.  The used enzyme 
releases 5’- monophosphates so after every step a free 3’-OH group is formed.  The modified 
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strands are labelled as in the rest of the document.  For ease the fragment originating from the 
loss of 7 bases in the non-modified strand (and 2 bases from the 3’-end of the modified 
strand) will be labeled: cross-link to A (or C) and its 5’-tail (see Figure 139A). 
O
PO OH
O
O O
P OHO
O
H O
H H
H H
O
HO
O
N
N
N
O
5
'-C
T
G
 A
C
G
 G
G
T
G
C
-3
'
3
'-G
A
C
 T
G
C
 C
C
A
C
G
-5
'
-1
-2
-3
-4
-5
-6
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-2
-1
Modified
Non-modified
O
PO OH
O
O
P OHO
O
H O
H H
H H
O
HO
O
N
N
N
O
5
'-C
T
G
 A
C
G
 G
G
T
-O
H
3'
-7
-2
Modified
Non-modified
3'H
O
O
H
5'
A
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Figure 139: Clarification of the numbering for enzymatic degradation 
Furthermore in most enzymatic degradations the modified strand -2 bases cross-linked to A 
‘or C) can be observed.  This type of fragment is represented in Figure 139B.  Fragments from 
degradation of single strands are also labeled with the same numbering, always from the 3’-
terminus. 
 
The dat analyses of the cross-link reactions and the enzymatic digestions as well as the 
melting curves of all duplexes can be found on the CD which is included in this work. 
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